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The development of a quality of life instrument for 
osteoarthritis. 
 
 
Abstract 
Osteoarthritis (OA) is a common condition and a leading cause of pain and disability.  
The aim of this thesis was to explore issues associated with living with OA, develop 
an OA specific quality of life instrument and explore the physical and psychosocial 
factors that contribute to quality of life.   
 
A multiple methodological approach was used in this thesis.  In the first study, 
analysis was undertaken of a large, community based survey to examine the 
prevalence and impact of joint problems on everyday activities.  In the second study, 
in depth, semi-structured interviews were undertaken with 44 people with OA to 
explore the issues associated with living with OA.  From these interviews, a disease 
specific, needs-based, quality of life instrument, the OAQoL, was developed and 
tested for appropriate psychometric properties.   In the final study, the effect of 
physical and psychosocial influences on quality of life was explored.  Structured 
equation modelling was used to construct a model explaining the relationship between 
pain, function, depression, anxiety, disease characteristics and demographics on 
quality of life.   
 
The key findings of this programme of work can be summarised as follows:  (i) OA has 
an often considerable and complex impact on the individual;  (ii) the OAQoL, a needs-
based, disease specific outcome measure to assess of quality of has been derived 
from a strong conceptual framework and has rigorously tested for its psychometric 
properties;  (iii)  Anxiety and depression are high in people with OA and anxiety has a 
substantial influence on their perceived quality of life; (iv) co-morbidities are common 
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in OA and are related to impairment of activities of daily living and quality of life; and 
(iv) while the location and number of painful joints in those with OA impacts on their 
ability to undertake the tasks of daily living, other aspects, such as anxiety, age and 
functional ability have a more substantial impact on quality of life.   
 
 
 
 
 
Anne-Maree Keenan 
May 2008 
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Chapter One 
Introduction 
 
Osteoarthritis (OA) is the most common cause of musculoskeletal pain1  and the most 
frequent single cause of disability2.  While the impact on the quality of life in 
individuals with OA has been identified as important, no disease specific tool exists to 
assess this impact.  Furthermore, while treatment of OA is often focused around knee 
and hip arthritis as single joint entities, the prevalence of other joint and joint 
combinations needs to be explored.  It is therefore important to establish the 
prevalence and site of joint pain, that an instrument be developed which measures the 
impact of OA on quality of life (OoL), and this impact be explored in terms of the 
general disease, joint specific influence and the impact of multiple joint problems. 
 
The hypothesis explored in this thesis is: 
 
The number and pattern of joint involvement in OA will be reflected 
in the level of patient perceived quality of life. 
 
This thesis will use four main methodologies in order to explore this hypothesis: 
i. an epidemiological analysis of the prevalence and impact of joint problems 
ii. qualitative analytical techniques to explore the issues associated with the 
impact of living with osteoarthritis and to form the base to develop a quality 
of life questionnaire for individuals with OA (OAQoL) at various sites 
iii. quantitative analytical techniques to assess the psychometric properties 
and clinical responsiveness of the OAQoL questionnaire 
iv. modelling techniques to describe the interrelationships between quality of 
life (as measured by the OAQoL) and physical and psychosocial factors. 
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The thesis has been structured thus: 
Chapter Two is a review of the literature and provides the background information 
which has informed the hypothesis of this program of work.  In this chapter, the 
prevalence, classification and site of OA is discussed.  Issues associated with ageing, 
co-morbidities and case ascertainment are identified.  An overview of outcome 
measurements commonly used in OA is presented and factors associated with patient 
orientated outcomes, disease specific and generic tools are analysed.   Finally, the 
conceptual basis of “quality of life” is explored, with an emphasis on the needs-based 
approach to quality of life. 
 
Chapter Three provides a detailed examination of the methodologies used in this 
thesis.  Chapter Three provides the conceptual framework for examining the incidence 
and impact of joint pain in a large community cohort, developing an OA specific quality 
of life tool and exploring the conceptual framework on which this tool is based through 
structural equation modelling techniques.  Chapter Three also describes the 
theoretical basis for the qualitative approaches used to explore issues associated with 
living with osteoarthritis.   
 
The results of the studies are presented in Chapters Four, Five, Six and Seven.  
 
Chapter Four reports the prevalence and interrelationships of joint dysfunction at 
different sites.  This chapter is a secondary analysis of a large, community study 
which evaluated the demand for hip and knee arthroplasty.    This analysis examines 
the prevalence of single and multiple joint problems and examines the impact of 
patterns of joint problems, particularly multiple-site joint pathology, on everyday 
activities. 
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Chapter Five reports the results of a qualitative study exploring the impact of living 
with OA.  In depth, semi-structured interviews were undertaken with 44 people with 
OA, who were purposefully selected and included those with single site foot, knee, 
hand and hip OA and multiple-site OA.  Thematic analysis was undertaken of the 
interviews, indicating complex issues associated with living with OA, including loss of 
personal and societal roles, influences on coping and perceptions of others to their 
disease. 
 
Chapter Six describes in detail the derivation, development and validation of the 
OAQoL, a needs-based, quality of life instrument.   Items were generated from in-
depth interviews with patients, tested on a small group of people with OA for clarity 
and ease of completion, mailed out to a large patient cohort for analysis of the 
psychometric properties and then examined for test-retest properties.   
 
Chapter Seven presents the results of a study analysing the effect of physical and 
psychosocial influences on quality of life.  Structured equation modelling was used to 
construct a model explaining the relationship between pain, function, depression, 
anxiety, disease characteristics and demographic information on quality of life.   
 
Finally, Chapter Eight presents a discussion of the results of each of the studies and 
an analysis of the thesis as an integrated program of work.  The discussion includes 
the relevance of the studies to the existing body of knowledge and how the current 
work may impact on clinical practice.  This chapter concludes with an outline of further 
areas of research arising as a result of this thesis. 
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Chapter Two  
Background and Review of the Literature 
 
2.1  Osteoarthritis 
2.1.1  The prevalence and burden of Osteoarthritis 
Osteoarthritis (OA) is the most frequently reported medical condition within the 
community3 and is one of the ten most disabling diseases in developed countries4.  
Worldwide estimates indicate that one in ten men and one in five women aged over 
60 have symptomatic OA4 which represents a considerable burden on health care 
expenditure5, 6.  Those with arthritis are more likely to perceive themselves as mentally 
and physically unhealthy2.  The influence of the ageing population in developed 
countries suggests that OA will have an even greater impact on health resources in 
medium to long term health economic predictions7.  
 
Osteoarthritis generally refers to a clinical syndrome of joint pain, functional loss and 
reduced quality of life. In terms of pathology, OA refers to a process of imbalanced 
degradation and repair that affects multiple joint tissues.  It is classically characterized 
by focal loss of articular cartilage, degradation of subchondral bone and the 
development of osteophytes.   While OA was previously considered to be a disease of 
the articular cartilage and bone, it is now recognised that OA is a whole joint organ 
disease8, 9.  It has been suggested that the aetiology and progression of OA may be 
due to any of the tissues of the affected organ, including the subchondral bone, 
synovium, capsule, peri-articular muscles, sensory nerve endings, ligaments and, if 
present, menisci10.   Indeed, it has been suggested that  muscle and neuromuscular 
control are of greater importance in the development of OA than the cartilage and 
bone11.  
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While the prevalence of OA increases with age, it is not exclusively a disease of the 
elderly.  This is highlighted in a community survey where the incidence of 
symptomatic OA was shown to increase two to ten fold from 30 to 65 years of age and 
increased further thereafter, to the highest prevalence in the 70 to 79 age group, after 
which time the prevalence of symptomatic OA is reduced12, 13.   In people aged 25 and 
over, the prevalence for OA is thought to be about one in ten14.   
 
OA is a chronic condition initiated by a complex interaction of biochemical, genetic 
and biomechanical factors.  The importance of each has received considerable 
attention in the recent literature.  Geneticists have identified several genes that may 
be involved in OA15.  What is clear is that biomechanical factors assume a key role, of 
which we have only limited understanding.  Recent findings have suggested that 
importance of the mechanical loading of joints in not only the progression of OA, but 
more importantly, the initiation of the disease16. 
 
One of the key barriers to understanding and treating OA is that OA may be the 
common final pathway of a group of pathological processes which has pain and joint 
failure as the clinical presentation17.  OA may therefore represent a number of 
heterogeneous conditions where joint failure and damage is triggered in a variety of 
ways.  
 
Several risk factors have been identified which are thought to contribute to OA, 
although the importance and interrelationship between each differs depending on the 
site of OA18.  Risk factors which have been associated with OA include genetic 
predisposition19, obesity20, 21, diminished bone mineral density22, female gender21 and 
insufficient nutrition18.  In addition to these factors, localised joint or direct mechanical 
influences which have been identified as predisposing to OA:  these include ongoing 
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joint overloading (including occupational23 and sporting participation24), joint 
malalignment21, 25, 26, previous joint trauma27 and existing joint pathology, such as 
ligament damage28.  A summary of these factors are represented in Figure 2.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1  Pathogenesis of osteoarthritis with putative risk factors.  Modified 
from Felson et al18, pg 637. 
 
 
2.1.2  Diagnostic Criteria 
Surprisingly, no diagnostic criteria exist for OA.  The diagnosis of OA is often made on 
radiographic evidence in conjunction with patient reported symptoms, particularly pain 
and stiffness29.   There has been however, considerable debate as to the relevance of 
radiographs in OA:  it is clear that many people have radiographic confirmation of OA 
yet no symptoms and others have severe symptoms with little radiographic 
Demographic  Risk Factors 
 Age 
 Gender 
 Ethnicity 
Systematic Risk Factors 
 Bone density 
 Oestrogen 
 replacement therapy 
 (in post menopausal 
 women) 
 Nutritional factors 
 Genetics 
 
Susceptibility to OA 
 
Systematic Risk Factors 
 Obesity 
 Joint Injury 
 Joint deformity 
 Sports participation 
 Occupation 
 Ligament damage 
 Muscle weakness 
Site and severity of 
disease 
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evidence30.  There is evidence to suggest that radiographs are of most use in knee 
OA in severe or established disease31. 
 
The American College of Rheumatologists (ACR) have developed a classification 
system for OA of the hand32, knee33 and hip34 with the aim of differentiating OA from 
other arthritides (Table 2.1).   These clinical classification criteria have become widely 
accepted and are commonly used in both practice and research settings, with 
moderate to good sensitivity and specificity.   However, no such diagnostic criteria 
exist for the other sites of OA presentation, and diagnosis  is often attributed to the 
presence of radiographic changes according to the Kellgren and Lawrence system35 .  
The validity of the ACR clinical classification criteria for OA has been questioned, 
because of concerns over inter-observer variability and issues associated with 
radiographic interpretation36, including agreement over the presence of osteophytes, 
when there is debate as to what stage in the disease osteophytes may form37. 
 
The lack of clear diagnostic criteria may arise because of disagreement to whether 
OA is a single disease or many disorders with a common final pathway.   Felson18 
suggests the following points support the latter idea: 
1. OA of the knee and hip may be associated with different risk factors, 
suggesting we should regard them as different diseases 
2. “Generalised OA” may be a distinct disease in which systemic predisposition 
(such as genetic factors) are more important than local (such as mechanical) 
factors. 
3. The classification of known (secondary) compared with unknown (primary 
cause is often adopted  
4. Hip OA has been classified into hypertrophic and atrophic forms on the basis 
of the tendency to develop large osteophytes 
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 Criteria Criteria 
H
ip
a  ACR Criteria for 
Diagnosis and 
Classification of 
Osteoarthritis of the 
Hip34 
1.  Hip pain, and 
either 
2(a).  Hip Internal rotation less than 15°  
2(b)  ESR ≤ 45 mm/hour (if ESR not available, 
        substitute hip flexion ≤115°) 
or 
3(a) Hip internal rotation greater than 15° 
3(b) Pain on hip internal rotation 
3(c) Morning stiffness of the hip ≤60 mins 
3(d) Age >50 years 
 
H
an
db
 ACR Criteria for 
Diagnosis and 
Classification of 
Osteoarthritis of the 
Hand32 
  
1. Hand pain, aching or stiffness 
2. Hard tissue enlargement of two or more of ten selected joints 
3. Fewer than 3 swollen MCPJs 
4(a).  Hard tissue enlargement of 2 or  
          more DIPJs 
or 
 4(b)  Deformity of two or more selected 
          joints 
 
Clinical and 
laboratory 
Clinical and 
radiographic Clinical 
1. Knee pain  1. Knee pain  1. Knee pain  
   + at least 5 of 9:    + at least 1 of 3:    + at least 3 of 6: 
2. Age > 50 years  2. Age > 50 years  2.  Age > 50 years  
3.  Stiffness < 30 
minutes  
3. Stiffness < 30 
minutes  
3. Stiffness < 30 
minutes  
4. Crepitus 4. Crepitus 4. Crepitus 
5. Bony Tenderness    + Osteophytes  5. Bony Tenderness 
6. Bony enlargement   6. Bony 
enlargement 
7. No palpable warmth   7. No palpable 
warmth 
8. ESR <40 mm/hour   
9. RF <1:40   
10. SF OA   
Alternative for the 
clinical category 
would be 4 of 6, which 
is 84% sensitive and 
89% specific  
K
n
ee
c  ACR Criteria for 
Diagnosis and 
Classification of 
Osteoarthritis33 
92% sensitive, 75% specific 91% sensitive; 86% 
specific 
95% sensitive; 69% 
specific 
 
Table 2.1  ACR Diagnostic Criteria for Osteoarthritis at the hip, hand and knee.  
aThis classification method yields a sensitivity of 86% and a specificity of 75%. ESR = erythrocyte sedimentation rate.  
bThe 2nd and 3rd DIPJ may be counted in both item 2 and 4(a).  The 10 selected joints are the second and third distal 
interphalangeal (DIP), the second and third proximal interphalangeal, and the first carpometacarpal joints of both 
hands. This classification method yields a sensitivity of 94% and a specificity of 87%. MCP = metacarpophalangeal. c 
 SF OA = synovial fluid signs of OA (clear, viscous, or white blood cell count <2,000/mm3). 
 
10 
Chapter 2 Background and Review of the Literature 
 
Furthermore, Huch38 supports this multi-disorder concept by demonstrating that 
5. There are differences in the pathophysiology of damaged tissues in OA at the 
different sites. 
 
Given the absence of a clear basis for the objective diagnosis of OA and the 
importance placed on symptoms, there has been a recommendation that the most 
compelling definition of OA is one that combines the joint pathology of the disease 
with the pain that occurs with joint use18.   
 
Pain in OA 
Pain is considered to be one of the most important symptoms in OA: pain as one of 
key factors considered in the assessment of patients39 and it is the major impetus for 
people with OA to seek treatment40.  Pain in OA, particularly frequency of painful 
episodes, has been related to increased demands on the health services:  for 
example, Dominick et al40 found that those who reported higher levels of OA pain 
were more likely to visit the doctor, use analgesics or anti-inflammatory medication, 
including narcotic analgesia.  However, while patients and clinicians agree that pain is 
important, the importance that each group place on pain in OA is different41. 
 
Pain in OA is a complex phenomenon with physical and psychosocial elements.  
While OA pain had previously been thought to be associated with local tissue 
damage, greater emphasis has been placed on the theory of central sensitisation of 
OA pain.  It has been noted that people with end stage knee OA waiting for knee 
arthroplasty had a decreased pain threshold elsewhere in their body, which was 
reversed after surgery where their pain thresholds return to normal42.  Furthermore, it 
has been suggested that pain associated with knee OA behaves as a regional pain 
syndrome, similar to low back pain43.   
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While pain is the dominant symptom and is the target for most OA therapies, the 
severity of pain and its impact on the individual varies enormously.  Pain has a strong 
association with reduced activities44, but OA pain has been found to be only weakly 
associated with health related quality of life43 and is not necessarily predictive of 
analgesic use45 or the decision for them to undergo joint replacement surgery46, 47.   
 
Several factors have been identified which may explain how people adapt and deal 
with pain, particularly with OA.  Pain studies have demonstrated that ability to deal 
with pain is not just related to pain intensity, but several other physical and 
psychological factors, including the functional impact of the pain (such as limiting 
activities or restricting participation) and character traits (such as self efficacy)48.  The 
link between reduced coping with OA pain and additional co-morbidities48, particularly 
depression49 and anxiety50, has been established. 
 
There has been much focus on the relationship between radiographic structure and 
pain relationships in OA.  Traditionally, radiographic changes were thought to be 
associated with greater disease activity.  This approach has been challenged in recent 
years:  there is now evidence to suggest that 50% of people in the general population 
who have radiographic evidence of OA, report no pain51.  Furthermore, over half of 
people with pain suspected to be due to OA have no definite radiographic evidence of 
the disease30.  
 
At the same time a direct relationship between pain and radiographic tissue damage 
has been questioned42,  there has also been a growing debate as to the importance of 
pain in predicting structural progression of OA.  Some authors have found that 
radiographic disease progression is more rapid and more frequent with people who 
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reported pain 12 to 24 months previously52.  Contradictory results, however, have 
challenged this where pain bore no relationship to long term structural progression53. 
 
Several theories have been proposed to explain the lack of concordance between 
pain and radiographic damage.  Firstly, there appears to be a threshold effect 
between the Kellgren and Lawrence Scores (K-L) and pain:  there is very little 
association between pain and radiographic damage in mild disease (K-L score of 0 
and 1) but a much greater association when the damage is greater (KL score 2+)54.  
Secondly, the lack of concordance between symptoms and radiographs may be 
associated with the inability of radiographs to image the tissues that are the source of 
the pain, such as synovitis or subchondral bone abnormalities. Finally, others authors 
refer to the issues that the types of x-rays that are undertaken, particularly in the knee, 
are inappropriate55 and which may not allow optimal examination of the affected area. 
 
The use of MR imaging has enabled a new approach to evaluation of the tissues 
involved in OA, including cartilage, bone, synovium, ligaments and menisci.   Studies 
have demonstrated the importance of bone marrow oedema in the progression of 
cartilage loss56.  However while there is the potential to explore the relationship 
between these tissues and joint pain, current available data has again demonstrated 
only a weak association with bone marrow oedema and pain57.  Furthermore, other 
studies have found an association between joint tissue which has little neural tissue 
(menisci and cartilage) and pain58, 59, suggesting that the causes of pain in OA is still 
not fully understood. 
 
Activity Limitation in OA 
Activity limitation (also referred to as functional ability or disability) is also commonly 
reported by patients with OA.  Whilst able to exist independently of one another, 
typically pain and functional disability occur concurrently60.   OA is the most common 
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cause of disability and the impact of activity limitation in people with OA is substantial:  
people with arthritis are more likely to report impairments in activities of daily living 
(such as personal care, household management, transportation, employment) 
compared to other causes of disability61.  Furthermore, reduced physical activity is a 
risk factor for further functional decline in older people with OA62, 63. 
 
While a direct link has been reported between knee pain and self reported disability64, 
pain is not the only factor related to disability.  As with a person’s ability to cope with 
pain, their response to activity limitation will depend on several, complex factors.  In 
hand OA for example, impairment was more strongly associated with personal factors 
such as self efficacy, rather than functional ability65.  Several studies have found that 
in addition to joint pathology and body mass index, functional limitation was related to 
depressive symptoms and anxiety64, 66.  Fear avoidance, pain intensity and pain 
catatrophising were also found to be predictive of disability48;  when compared 
together however, self efficacy was found to be the more powerful predictor of 
disability48. 
 
Depression and Anxiety in OA 
While the association between depression and rheumatoid arthritis has received 
considerable attention, there is only limited literature evaluating the association 
between depression, anxiety and osteoarthritis.  Early literature suggested that the 
prevalence of anxiety and depression was thought to be similar to that in the general 
population67.  More recent data have questioned this, with over one third of a primary 
care based OA cohort reporting borderline to high levels of anxiety and one quarter 
reporting borderline to high levels of depression68.  Much of the information published 
on anxiety and depression has been in those with severe OA undergoing joint 
replacement surgery:  people with end-stage OA waiting for joint replacement 
reported high anxiety and depression levels, both of which improved after joint 
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replacement69.  Distress has also been reported as high for those waiting for surgery 
and is also predictive of those who have poorer surgical outcomes70.  In those with 
general OA, the focus has been on depression and joint pain:  those with knee pain in 
the community report higher levels of psychological distress71, depression and 
anxiety50, 72.   
 
There is thought to be a bi-directional association between depression and functional 
ability in OA:  increased depression results in reduced activity and reduced activity 
results in increased depression66.  While the same bi-directional relationship is 
thought to exist between depression and pain73, this is less clear than the impact of 
depression on functional outcomes50.     
 
Very little attention has been given to the relationship between anxiety and OA:  
higher levels of anxiety were reported in those with knee pain and the levels of pain 
and anxiety were correlated50.  The direction of this relationship, is still unclear:  
increased anxiety may be a risk factor for reporting more OA pain, or pain may 
increase anxiety levels74. 
 
 
2.1.3  Site of OA 
While prevalence statistics have been reported for different sites of OA, lack of 
agreement over what constitutes OA has ensured that reported values vary 
considerably.   Prevalence estimates have used radiographic30, 75, symptoms76, 
physician diagnosis77 or a combination75  to report the incidence of OA.   For example, 
prevalence estimates for knee OA vary from as little as 13%30 (radiographic evidence 
and symptoms) to as high as 66%78 (evidence of radiographic change only).  The 
prevalence of knee OA over the age of 60 (based on symptoms and radiographic 
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evidence) is reported to be between 17% in men and 30% in women14, 18, 77, 79, 80.  
Reported prevalence of hip OA, based on radiographic evidence and symptoms,  
ranges from 7 to 25% in the over 55 age group77, 81, 82. 
 
While OA of the hip and knee account for the largest component of the burden of the 
disease77, 79,  there is, however, evidence to suggest that both hand and foot OA is 
very common.  In people over the age of 65,  70% have radiographic OA in the 
hand83, 84 and those with hand OA are more likely to develop knee and hip OA in the 
future85.  Most large prevalence studies have ignored other common sites of pain, 
particularly the hand and the foot.   
 
Prevalence estimates of foot OA are limited, and most of the data are based on 
radiographic or cadaveric investigations.  Symptomatic foot OA prevalence may be as 
high one in five in people aged between 24 and 7514 and in the older population (over 
75 years) this could be as high as four in five adults78.    Only one study, the 
Clearwater Osteoarthritis study15, has looked at individual sites of OA in the foot.  
Data from this study is reproduced in Table 2.2 and suggests that radiographic OA of 
foot and the hand is more prevalent than that of the knee.   
 
 
 All (%) Women (%) Men (%) 
Knee 16.6 15.7 18.6 
Hand 23.2 23.9 21.9 
Foot 20.0 17.7 25.1 
First MTPJ Not reported 25.0 18.0 
 
Table 2.2  Prevalence of radiographic grade 2+ OA.  Adapted from Wilder et al15, 
pg 212. 
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The relative lack of attention paid to foot OA may be associated with a number of 
factors.  Firstly, cadaveric and radiographic studies suggest that the OA pathology in 
the joints of the foot is often mild to moderate, rather than at the severe end of the 
spectrum14, 78 (Table 2.3).   Secondly, it has been suggested that the complex joint 
functioning of the foot may allow people with OA pain to compensate and therefore 
deflect pain and pressure away from the painful site15, which cannot be done as easily 
at the knee and the hip.  Finally, the burden on health services on large joint 
replacement may have focussed research in these areas at the expense of small joint 
surgery. 
 
 
 
 
OA Radiographic Severity (per 1,000) 
 
 
Mild, moderate and 
severe 
Moderate to severe 
Site Age Male Female Total Male Female Total 
Hands 25 to 74 years 289 301 295 48 95 73 
Feet 25 to 74 years 202 214 208 15 27 23 
Knees 63 to 93 years 309 344 33 16 155 157 
Hip 55 to 74 years 30 28 32 14 14 15 
 
Table 2.3.  Prevalence of symptomatic OA (symptoms plus radiographic changes) 
at different site, per 1,000.   Data adapted from Lawrence et al14. 
 
 
 
There has been some thought given to the concept that hand and foot OA may 
represent a more systemic form of the disease and may have a greater association 
with genetic factors.  There is evidence to suggest that the concurrence of foot OA 
with other sites, particularly the hand and the knee, is suggestive of a heritable 
association15.  Furthermore, several chromosomal locations have been identified that 
appear to contain hand OA susceptibility genes86. 
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Clear patterns have emerged for the prevalence of OA related to gender.  After the 
age of 50, women are more likely than men to be affected with hand, foot and knee 
OA18.  In a recent meta analysis of gender differences in OA13, pooled estimates of 
published literature confirmed that women were more likely than men to report knee 
and hand OA and that their knee OA was more likely to be severe.  The hip was the 
only location evaluated where men were at a greater risk of OA. 
 
While there is limited recognition that the presentation of multiple joint problems is 
common87, this has not stopped the focus of management strategies within OA being 
aimed at individual joint problems:  indeed, the functional impact on daily tasks of the 
most common multiple joint combinations has not been explored.     
 
2.1.4  Co-morbidity, Ageing and OA 
It has been estimated that almost one third of the population has two or more medical 
conditions or co-morbidities, with higher incidence reported in females88 and an 
increased incidence of medical complications associated with ageing63.  It is not 
surprising therefore, that people with OA have a higher incidence of medical 
conditions compared to those of the same age without OA89, including obesity, 
gastritis and heart disease89 and depression90, 91.   
 
It is unclear whether OA is a risk factor for other co-morbidities, or whether the impact 
of OA increases the morbidity with other health conditions.  Ettinger92 suggested the 
presence of knee OA with co-existent medical problems increases the amount of 
disability.  Furthermore, Marks93 found that those patients with hip OA and had two or 
more other medical conditions had greater degrees of functional impairment before 
and after surgery.   
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Several studies have identified key themes that illustrate the complex relationship 
between ageing and OA.  Firstly, it is common for older people to normalize their 
disease as part of ageing rather than a treatable health problem94.  Secondly, older 
people with OA tend to minimize their symptoms, preferring to accept their pain rather 
than seek treatment29, even to the point where they were reluctant to take prescribed 
painkillers45.  Finally, this perception that OA is a disease of the elderly has also been 
attributed to younger people with OA who delay in seeking advice and diagnosis as 
they consider themselves “too young” to have OA29. 
 
2.2  Measurement issues in OA 
Traditionally, the focus of measuring the outcome of OA has centred on assessing the 
impact of the disease on pain and function.   As a consequence, outcome measures 
that have been developed specifically for OA, such as the Western Ontario and 
McMasters Universities Osteoarthritis Index (WOMAC)95 and the Lequesne 
Algofunctional Index96, focus on such domains.  OMERACT (Outcome Measures in 
Rheumatology Clinical Trials) guidelines expand this slightly with the recommendation 
that only four domains be evaluated:  pain, physical functioning, joint imaging and 
patient global assessment97.   Global impact on quality of life or personal issues 
associated with the disease have commonly been assessed using generic, health-
related quality of life outcome measures, particularly the MOS SF-3690 and EuroQoL98, 
99
.   
 
In order to review the outcome measures commonly used and any potential areas for 
development of new instruments, it is important to understand the framework for the 
consequences of disease.  For over 25 years this framework has been produced by 
the World Health Organisation’s International Classification of Health. 
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2.2.1 ICF Historical perspective and theoretical constructs 
The International Classification of Impairments, Disabilities and Handicaps (ICIDH) 
was developed as a classification manual of the consequences related to disease100.  
The major aim of this document was to provide a framework and common language 
for the description of health.  The theoretical framework for ICIDH was based around 
the dimensions of health, as presented in Figure 2.2. 
 
 
 
 
 
 
Figure 2.2  Theoretical construct for the development of the ICIDH, adapted from 
De Kleijn-De, 2003101. 
 
 
 
While this classification system was valuable in assisting with disease and 
consequences, there were several concerns raised as to the linear and unidirectional 
nature of the connections of the elements of the model102.  Furthermore, the negative 
portrayal of consequence of disease (ie the logical consequence of disease ends in 
handicap) was also criticized103.   
 
As a consequence, this classification of disease was updated in 2001, with a greater 
emphasis placed on the more positive aspects (health and functioning) rather than the 
negative (disease and disability).  The new name, the International Classifcation of 
Function, Disability and Health (ICF) reflected this change.  The new classification 
also attempted to de-stigmatize disability and recognizes it as a universal experience 
and shifts the focus from the cause of the problem to the impact104.   Like the ICIDH, 
Disease or 
disorder  
 
Impairment Disability Handicap 
(exteriorized) (objectified) (socialized) 
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the ICF provides a scientific basis for understanding health, health outcomes and 
determinants of health using common language105. 
 
The ICF has been developed around a biopsychosocial model of disability.  This 
model presents and integration of the social (where disability is a socially created 
problem and not an attribute of the individual) and the medical model (where disability 
in a feature of the person caused by disease, trauma or health condition).  The other 
important change in the development of the ICF was a shift in language from negative 
terms, such as “impairment”, “disability” and “handicap” to the neutral terms of “body 
function and structure”, “activity” and “participation”.  The theoretical construct for the 
ICF is presented in Figure 2.3. 
 
The ICF is organised into the following components:  body function and structures, 
activities, participation, environmental factors and personal factors.  Body functions 
and structures are described as the physiological function of the body system, such as 
organs, limbs and their components.  Impairments to these systems may include loss 
(such as deformity) of structures (such as joints) and/or function (including pain, 
reduced range of motion, muscle weakness).  Activities are the execution of a task or 
action by an individual and represents functioning.  Difficulties in performing these 
tasks are described as activity limitation (such as walking, using stairs).  Participation 
is described as an individual’s ability to be involved in their life situation and problems 
in experiencing this (such as restrictions in recreation or leisure) is denoted as 
participation restriction.  The contextual factors (personal and environmental) make up 
the physical, social and attitudinal environment in which people live and conduct their 
lives.   
 
 
 
21 
Chapter 2 Background and Review of the Literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3  Theoretical construct for the development of the ICF, adapted from 
De Kleijn et al101). 
 
 
Contextual factors have been described less thoroughly than the other components of 
the ICF.  While body structures, activities and participation are classified and 
described in chapters.  The contextual factors (environmental and personal factors) 
have not been classified under the ICF chapters, receiving only brief 
acknowledgement.  This may be related to the issues associated with the affect that 
contextual factors have on individuals:  a contextual factor may be considered to be 
independent, moderating, mediating or confounding106, depending on the individual 
and circumstances. 
 
Health condition 
 
Body functions and 
structures 
Activities Participation 
Environmental  
Factors 
Personal 
Factors 
Contextual Factors 
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While the ICF was developed as a means to map the different constructs and 
domains of health and to describe the process of functioning and disability, it was also 
designed to assist in the development of outcome measures:  it was to provide a 
framework for the assessment of outcome tools by mapping the tools onto the ICF 
categories in order to gather information for health statistics and health users 
regarding the burden of disease107.   The two most commonly used outcome 
measures for OA, the Western Ontario and McMasters Universities (WOMAC) and 
Lequesne-Algofunctional Index have been mapped108. 
 
Since 2001, “core sets” of ICF categories for specific health conditions have been 
developed in part, to link the ICF with the International Classification of Diseases (ID-
10) and were primarily intended to provide a comprehensive approach in clinical and 
research environments.  Of note, these core sets were developed “in line with current 
concepts in outcome and quality of life research of condition-specific measures”107.   
 
In 2004, a core set was identified for OA, developed by an international panel of 
health professionals109.   A comprehensive set, containing 55 categories was 
developed along with the brief, thirteen-category set, as presented in Table 2.4 and 
have been recently evaluated113.  There remains a question of whether the core sets 
reflect the needs of patients across a variety of conditions.  It is apparent that when 
health professionals evaluate the comprehensiveness of the core sets, the results are 
generally positive110; however when patients are asked, the core sets appear to be 
inadequate111, 112. The only assessment of the OA core set has supported their 
comprehensiveness in reflecting patient needs113.   
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ICF Component Rank 
Order 
ICF 
Code 
ICF Category Title 
1 b280 Sensation of pain 
2 b710 Mobility of joint functions 
3 b730 Muscle power functions 
Body Functions 
   
1 s750 Structure of lower extremity 
2 s730 Structure of upper extremity 
3 s770 Additional musculoskeletal 
structures related to movement 
Body Structures 
   
1 d450 Walking 
2 d540 Dressing 
4(sic) d445 Hand and arm use 
Activities and 
Participation 
   
1 e310 Immediate family 
2 e115 Products and technology for 
personal use in daily living 
3 e580 Health services, systems and 
policies 
Environmental Factors 
4 e150 Design, construction and building 
products and technology of 
buildings for public use 
 
Table 2.4  ICF Categories included in the Brief ICF Core Set for OA.  The rank 
order indicates the perceived importance by health professionals.  Taken from 
Dreinhofer et al, pg 78109. 
 
 
 
2.2.2  Key features of a good outcome measure 
With the emergence of the biopsychosocial model of health in the last 20 years, the 
use of patient reported outcomes has become an integral part of the research 
process.  As the field of outcome measures has evolved, so have the methods of 
assessing the key attributes of what makes an outcome an appropriate tool.  Eight key 
attributes have been identified as appropriate in establishing the usability of an 
outcome measure114:  its conceptual framework and measurement model; reliability; 
validity; responsiveness; interpretability; administrative burden; alternate forms; and 
cultural adaptation.    
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In developing an outcome measure, it is necessary to ensure that the measures have 
been developed around an appropriate conceptual framework.  This has been 
identified as particularly important in quality of life measures where it is often the 
clinician’s interpretation as to what they think that matters their patients115.  Recently, 
the importance of the role of qualitative methodology in developing outcomes has 
been highlighted116, particularly if the outcome is patient based.  The derivation of the 
items included in an outcome measure should reflect a pre-specified measurement 
model, whereby the relationship between a response to an item in an outcome 
measure reflects his or her ability as being measured by the outcome117, 118.   
 
The measure should be both reliable and valid, and should include empirical support 
for criterion and content validity, using an appropriately rigorous method.   An 
outcome measure should also be reliable, so that the score obtained each time the 
questionnaire is administered is the same, all other things being equal119.  An outcome 
should be valid, in that it measures what it purports to measure.  Other aspects of 
validity include content validity, where a measure includes a representative range of 
the content of what is being studied; construct validity is that concerned with the 
measure is behaving in the way that is expected from a theoretical and practical 
perspective; and finally criterion validity, which is a special case of construct validity 
where a measure is assessed against a gold standard.  In quality of life measurement, 
most validity assessment is concerned with construct and content validity in the 
absence of a true gold standard.  
 
An outcome measure should also be able to detect small, but meaningful changes in 
a measure.  This is referred to as responsiveness and should capture change that is 
of importance to the individual117.  Changes in an outcome measure should also be 
interpretable, so that any change in a score has some meaning.   The measure must 
be appropriate for the population to which they are being applied:  as such, cultural 
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and language adaptations are necessary outside of the population from which the 
measure was developed120.  Finally, the level of respondent and administration 
burden, both to the responder and the researcher/clinician, should established and 
acceptable to both groups114. 
 
2.2.3  Outcome measures commonly used in OA 
As noted previously, several outcome-based tools have been developed to evaluate 
pain and physical function in OA, including the WOMAC95, Lequesne Index96 and the 
AIMS121.   A summary table of measures commonly used in OA is presented in Tables 
2.5 and 2.6.  While there are several instruments that have been used to determine 
pain and physical ability in knee and hip OA, there are, for example, no instruments 
that have been developed for use specifically in OA of the foot.  A recent systematic 
review of measures for use in hand OA122 indicated that only two measures were 
developed specifically for hand OA:  the AUSCAN and the FIHOA.  A brief description 
of commonly used measures is presented below: 
 
 
(a)  The WOMAC 
The WOMAC (Western Ontario and McMasters Universities Osteoarthritis Index) is a 
disease specific, self administered questionnaire which was developed for patients 
with hip and knee OA123, 124 and consists of three domains: pain, stiffness and 
functional ability. The WOMAC contains a series of statements such as “how much 
pain do you have walking on a flat surface?” which are rated on a zero (no problem) to 
4 (extreme problem) Likert scale over three domains, which include pain, stiffness and 
physical function (WOMAC LK).  A version of the WOMAC which uses a 100mm 
visual analogue scale (WOMAC VAS) was adapted in order to address issues with 
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summing an ordinal scale.  However, the use of either scales as an interval score has 
not be supported125.  
 
The WOMAC in both its forms is widely used in the OA literature, has been shown to 
be more responsive than other measures of knee pain126, 127.  It demonstrates good 
construct validity124, 126 and has been found to be a stable and reliable postal survey 
tool128 for pain and physical function domains.   
 
Both versions of the WOMAC have been assessed for their internal construct validity.  
Rasch analysis of the WOMAC VAS has indicated that while the pain and function 
items work well, 129the pain and function domains works well individually, but may  not 
define a single construct.130.  There were problems with several items, including pain 
at night, rising from sitting130, getting in/out of the bath and doing heavy domestic 
chores129.  Items were also clustered around the middle of the scale, indicating not  
only redundancy, but also lack of discriminating items.  Problems were also reported 
with the stiffness domain, most likely due to problems the stiffness domain containing 
only two items130.   
 
The Likert version of WOMAC has also been subjected to Rasch analysis131  and as 
with the 100mm VAS version, problems were also found with doing heavy domestic 
duties, getting in and out of the bath, and getting on and off the toilet).  The authors 
suggest a modified 14 item physical function scale be used in place of the published 
17 item scale.   
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Instrument Questionnaire 
Focus 
Domains  (Number of items) Derivation UK 
Validation 
Target 
population 
Comments 
WOMAC124 Symptoms 
Function 
Pain (5) 
Stiffness (2) 
Physical functional disability 
(17)  
Derived from 
health care 
professionals  
Yes Knee and hip OA 
and for people 
over the age of 55 
yrs 
It has been shown to be 
responsive than other 
measures of knee pain126, 127 
and demonstrates good 
construct validity124, 126.  
Rasch analysis of the 
instrument indicates 
problems with the stiffness 
domains130 and two of the 
physical function items129, 131.    
Lequesne 
Index132 
Symptoms 
Function 
Pain or discomfort (5) 
Max walking distance (1) 
Activities of daily living (4) 
Derived from 
health care 
professionals  
No Knee and hip OA  There is no evidence for the 
internal content validity and 
unidimensionality of the 
questionnaire.    
AIMS2121 Health Status/ 
Health Related 
Quality of Life 
Mobility  (5) 
Walking and bending (5)  
Hand and finger function (5) 
Arm function (5) 
Self care (4) 
Household tasks (4) 
Social activity  (5) 
Support from family and 
friends(4) 
Arthritis pain (5) 
Work (5) 
Level of tension (5) 
Mood  (5) 
Derived from 
health care 
professionals 
and trialled on 
participants with 
OA and RA 
Yes Patients with 
rheumatic 
disease 
Internal consistency and test 
re-test  in OA patients was 
reported as good121 .  There 
is no evidence for the internal 
content validity and 
unidimensionality of the 
questionnaire.    
AUSCAN133, 134 Symptoms  
Function 
Pain (5) 
Stiffness (1) 
Function (9) 
Derived from 
health care 
professionals  
and patients with 
hand OA 
Yes Hand OA Developed according to the 
same conceptual framework 
as the WOMAC instruments. 
Table 2.5  Summary table of commonly used OA Specific Outcome Measures 
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Instrument Questionnaire 
Focus 
Domains  (Number of items) Derivation UK 
Validation 
Target 
population 
Comments 
OAKHQOL135 Health Status/ 
Health Related 
Quality of Life 
Pain (?) 
pysical activity (?) 
Mental health (?) 
Social functioning(?) 
Social Support (?) 
Number of items not stated 
Derived from 
health care 
professionals 
and participants 
with OA of the 
knee and hip 
No Hip and Knee OA The internal consistency, 
reliability and content validity 
were reported in the original 
publication as good135.   
HOOS136 Symptoms 
Function 
Pain (9) 
Symptoms (5) 
Activity limitations – daily living (17) 
Activity limitations – sport and 
recreation (4) 
Hip related quality of life (4) 
Derived from 
health care 
professionals 
and trialled on 
hip disability and 
OA 
No Hip OA and 
disability 
As for OAHKQOL 
WOOS137 Symptoms 
Function 
Pain and physical  symptoms (6) 
Sport, recreation and work (4) 
Lifestyle function (5) 
Emotional functioning (3) 
Derived from 
health care 
professionals 
and trialled on 
shoulder OA 
No Shoulder OA As for OAHKQOL 
Cochin138 Function Kitchen activities (8) 
Dressing (2) 
Hygiene (2) 
Office (2) 
Other (4) 
Derived from 
health care 
professionals 
No Hand function in 
OA and RA 
Developed originally for RA, 
but has been tested in an OA 
cohort139.  
FIHOA140 Function Function (10) Derived from 
clinicians 
No Hand OA Interview administered 
questionnaire.   
Ankle 
Osteoarthritis 
Scale141 
Symptoms 
Function 
Pain (9) 
Function (9) 
Derived from 
clinicians 
No Ankle OA Little evidence is available on 
this measure. 
Table 2.5  Summary table of commonly used OA Specific Outcome Measures (Continued)
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 (b)  The Lequesne Algofunctional Index 
The Lequesne’s Algofunctional Index was developed to assess the pain and 
functional status of people with hip or knee OA132.  It was originally designed as a 
physician completed tool, however it quickly became adopted as a patient completed 
questionnaire.  The questionnaire contains 10 items which have Likert 3, 5 or 7 point 
response scales.   Rather than have separate scales which assess pain and function, 
the Lequesne combines both constructs into one scale.  The Lequesne Index has 
been used relatively little, perhaps due to one report suggesting the WOMAC 
demonstrated superior sensitivity142 at the time Lequesne was being considered as an 
outcome measure.   No data exists on the internal construct validity (such as fit to the 
Rasch model) of the Lequesne Index. 
 
(c)  AIMS 
The Arthritis Impact Measurement Scale (AIMS) is a questionnaire developed for use 
across the rheumatic diseases in order to measure changes in global health, pain, 
mobility and social function.  It was initially developed in 1980 and revised in 1992 as 
the 66 item AIMS2121 and is comprised of the following domains:  mobility level, 
walking and bending, hand and finger function, arm function, self care, household 
tasks, social activities, support from friends and family, arthritis pain, work, level of 
tension and mood.  It was developed specifically using patients with OA and RA and 
has been used more extensively in the RA literature.  The AIMS demonstrates similar 
responsiveness compared to a generic impact scale143, however there has been little 
work undertaken on the internal construct validity of the AIMS or AIMS2. 
 
 
(d)  OAKHQOL 
The Osteoarthritis Knee and Hip Quality of Life Questionnaire (OAKHQOL)135 was 
developed in France and is a 43 item health status questionnaire that assess five 
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domains (pain, physical activity, mental health, social functioning and social support).  
The questionnaire was developed by health care professionals and patients with knee 
and/or hip OA and was developed in line with the ICF classification of health and, as 
such, is more appropriately classified as a health related quality of life instrument, 
rather than a quality of life instrument144.  As this instrument was only published in 
2005, there is limited literature assessing its properties.  Currently, there is no 
validated English translation version available. 
 
(e)  KOOS 
The Knee Injury and Osteoarthritis Outcome Score (KOOS)145 was developed as a 
derivation of the WOMAC, but to allow for greater responsiveness in younger people 
with OA.  As such, it included all WOMAC items and an additional 18 items, with 
evaluated sport and recreation function and knee-related quality of life.   KOOS has 
been validated predominantly for surgical groups145 and has been recommended for 
use in younger people with knee injury and OA146.  There have been no studies which 
have evaluated the instrument’s internal construct validity. 
 
(f)  HOOS 
The Hip disability and Osteoarthritis Outcome Score (HOOS)136 was developed to 
enhance the specificity the WOMAC scale to people with hip disability, with or without 
OA.  Similar to the KOOS, the HOOS includes all 18 items of the WOMAC with the 
word “hip” inserted instead of “knee” and included an additional 15 items developed 
specifically for the hip.  As with the KOOS, the HOOS contained a group of questions 
relating to sport and recreation.  To date, only one study has investigated the validity 
and responsiveness of the HOOS and found it to function better than the WOMAC, 
particularly in the younger age group147.  As for the KOOS, there have been no 
studies which have evaluated the instrument’s internal construct validity. 
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(g)  WOOS 
Developed from the same philosophy as the HOOS and KOOS, the Western Ontario 
Osteoarthritis of the Shoulder (WOOS) index137 was developed to assess disease 
specific dimensions of shoulder OA.  It does not, however, contain all WOMAC items, 
but does contain pain, sport/recreation/work, lifestyle and emotional functioning 
domains.  Apart from the original article, very little information exists on this tool. 
 
(h)  Cochin Scale 
While the Cochin Scale was developed to determine the functional impact of 
rheumatoid arthritis in the hand138, it has also been validated for use in OA of the 
hand139.  The scale consists of 18 function-related items where people are asked if 
they have problems in the kitchen, dressing hygiene, work or other activities.  The 
items have a six-point scale Likert response option, ranging from 0 (“Yes, without 
difficulty”) to 5 (“impossible to do”).  The test re-test reliability is reported to be high 
and the scale correlates highly with visual analogue scales for handicap and the 
FIHOA139.  While the scale has been published in English, it has not been validated in 
an English population. 
 
(i)   AUSCAN 
The Australian/Canadian Osteoarthritis (AUSCAN) Hand Index was developed by the 
same group who developed the WOMAC133, 134.  It was designed to assess pain, 
stiffness and function of hand OA and has been validated for use in a UK 
population148.   As with the WOMAC, there are two response versions:  a Likert scale 
(AUSCAN L.K 3.0) with responses from 0 (none) to 4 (extreme) or a visual analogue 
scales (AUSCAN V 3.0).  The test re-test reliability of the AUSCAN has been reported 
to be moderate148 and the construct validity against clinician and observed measures 
of hand function was reported to be good133.  While Rasch analysis has not been 
undertaken on the AUSCAN, a recent study using confirmatory factor analysis149 has 
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indicated that all three subscales loaded onto one factor, indicating that there may be 
some cross-over in what the scales are measuring. 
 
(j)  FIHOA 
The Functional Index of Hand OA, (FIHOA) was developed for use in a large clinical 
trial150 and consists of ten items which focus on the fine motor skills involving the 
hand.  The questionnaire is interview-administered where the participant is asked if 
they can perform particular tasks on a scale rated 0 (“possible without difficulty”), 1 
(“possible with difficulty”) or 2 (“impossible”). There is only limited literature using the 
FIHOA, however the test re-test of the instrument was reported as moderate to high140 
and the sensitivity to change, while not as powerful as a visual analogue pain scale, 
was more sensitive than other observed measures, such as grip strength151.  As with 
the Cochin Scale, while the FIHOA scale has been published in English, it has not 
been validated in an English population. 
 
(k)  The Ankle Osteoarthritis Scale 
The Ankle Osteoarthritis Scale (AOS) was developed as a patient-completed outcome 
measure for OA of the ankle141.  The scale consists of two sub-scales (pain and 
disability) each of which is composed of nine items. Individual items are scored on a 
visual analogue measure to give each sub-scales total score and the overall score. A 
higher score indicates greater pain or disability.  The only literature available on the 
measurement properties of the AOS is in the original report, which reports good 
reliability and construct validity when compared to the SF-36 and the WOMAC.  To 
date, it has only been used as to evaluate surgical procedures of the ankle152. 
 
There are three main generic measures that have been used in OA research over the 
last ten years:  the SF-36, EuroQoL and the Nottingham Health Profile. 
 
33 
Chapter 2 Background and Review of the Literature 
(l) SF-36 
The Medical Outcomes Study (MOS) 36-item SF-36153 is a generic outcome tool that 
measures “health related” quality of life for the purposes of health service evaluation, 
particularly across different health conditions.  The SF-36 focuses on eight domains:  
physical functioning, role physical, bodily pain, general health, vitality, social 
functioning, role emotional and mental health.  The questionnaire comprises 
statements such as “does your health now limit you in walking up several flights of 
stairs”, to which the responses, depending on the question, are either Likert 
scales(yes, limited a lot/yes, limited a little/not limited at all) or dichotomous (yes/no).  
The answers are then entered into a spread sheet where a loading algorithm is 
applied and the resulting scores range from “0” (extreme symptoms/poor health) to 
“100” (no symptoms/perfect health).  A shortened version, the SF-12154 has also been 
developed, which includes only 12 items. 
 
The SF-36 has been used extensively in OA studies, particularly pharmaceutical 
studies, however there are doubts as to its sensitivity and discriminate ability in this 
group.    While the SF-36 was able to distinguish between patients with OA (n=122) 
and rheumatoid arthritis (n=28)155, there appeared to be little difference between those 
with OA and an age and gender matched control group156.  Discriminant validity of the 
SF-36 was compared to the WOMAC in patients after knee replacement157 and 
suggested that WOMAC discriminates better among individuals with knee problems, 
whereas SF-36 discriminates better among individuals with varying levels of self 
reported general health and co-morbidities.  The major advantage of an instrument 
such as the SF-36 is for cross comparison over the domains across different diseases 
(see Section 2.4).   
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(m)  EQ-5D 
EuroQoL’s EQ-5D158 was developed to assess health outcomes over a wide variety of 
interventions for the purpose of health economic evaluation and has been 
recommended specifically for use in rheumatic populations99.  As it contains five 
domains, with only three individual responses for each domain, it has been criticised 
for being unable to discriminate change, particularly in specific diseases.   For 
example, the question relating to mobility gives the following three choices:  “I have no 
problems walking about”, “I have some problems walking about” or “I am confined to 
bed”.   While it is used in a number of pharmaceutical studies in OA, the major use of 
the EQ-5D is not to detect change, but for its use as a health utility indicator and is 
used to measure the QALYS (Quality-Adjusted-Life-Years)159. 
 
 (n) Nottingham Health Profile 
The Nottingham Health Profile160 (NHP) is a generic outcome measure developed to 
provide an indication of emotional, social and physical aspects of health problems 
from the individual’s perspective.   It is divided into two sections, the first addressing 
the experience of the condition (pain, physical mobility, sleep, emotional reactions, 
energy and social isolation) and the second, the effect of this experience on aspects 
of daily life (employment, household work, personal relationships, social life, sexual 
activity, interest and hobbies and vacations).  Items are written as statements, such as 
“I find it hard to bend” and have a yes/no response, although a recent publication has 
recommended a 5 point Likert response scale161.  While it was recommended for use 
in OA soon after the original publication160, there have been concerns raised as to its 
ability to discriminate change in OA162.  It has been used extensively in hip and knee 
replacement surgery and indeed it was found to be more responsive than the 15D 
(see below) in measuring change in this group163. 
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The content validity and psychometric properties of the NHP has been assessed in 
several diseases, including cardiac surgery, asthma and chronic lung disease and has 
demonstrated moderate internal consistency.   Unfortunately, no assessments of its 
other psychometric properties in OA have been published. 
 
(o)  Other HRQoL instruments 
The 15D is a quality of life instrument that was developed in Finland which contains 
15 health related quality of life items.  While considerable work has been undertaken 
on this tool in its native language, there is limited information published in English.  It 
has been used for joint replacement studies163. 
 
The Quality Well Being Scale (QWB)164 is a generic health utility and health related 
quality of life instrument which contains 24 items.  It was found to be sensitive to 
change in people with OA165.  No internal construct validity testing has been 
undertaken on the QWB. 
 
In order to provide a cross-cultural, generic quality of life measure the World Health 
Organisation developed the WHOQOL166, which contains 100 questions that cover 25 
dimensions of quality of life.  Two modifications of the WHOQOL have been 
developed:  the WHOQOL-BREF167, a short form 26-item question and the WHOQOL-
SRBP168, which contains an additional 32 questions on spirituality, religion and 
personal beliefs.   Psychometric testing of the WHOQOL and the WHOQOL-BREF 
have indicated that the questionnaires demonstrates acceptable internal consistency, 
discriminant validity and construct validity169-171.  
 
To date, only the WHOQOL-BREF has been used in OA patients:  a study evaluating 
the effect of quality of life pre and post joint replacement169 found that all domains of 
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the WHOQOL with the exception of social relationships improved after joint 
replacement surgery. 
 
The Assessment Quality of Life (AQoL)172 was developed in Australia as a generic, 
health related quality of life instrument as a shorter alternative to the WHOQOL.  It 
contains 12 items and covers four domains:  independent living, social relationships, 
physical senses and psychological well-being.  The internal consistency of the AQoL 
was found to be adequate173.  While the AQoL has been used predominantly in an 
Australian context, its use in an OA cohort has been explored and has been found to 
discriminate change as consistently as WOMAC and the SF-36174. 
 
Finally, global scales have been used to assess quality of life where participants are 
asked to rate their quality of life on a single question.  Such measures have included  
visual analogue scales, where  people are asked to place a mark along a 100mm line, 
with zero indicating “the worst possible quality of life” and 100 “the best possible 
quality of life”175;  and Likert type scales176, where people are asked to tick a box 
indicating that their quality of life is “worse possible”, “poor”, “adequate”, “good” or 
“best possible”.  Ibrahim177 explored the differences between older African-American 
and white patients with OA by using a single item, global question based on a five 
point ordinal scale – “how would you rate your overall quality of life?:  excellent, very 
good, good, fair, poor”.  Such tools have been heavily criticised for their lack of 
theoretical foundation and specificity. 
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Instrument Domains (Number of items) Levels of response UK Validation Specific Population Comments 
SF-36153 Physical function (10) 
Role limitations – physical (4) 
Bodily pain (2) 
Social functioning (2) 
Mental health (5) 
Role limitations – emotional (3) 
Vitality – (4) 
Health perceptions (5) 
 
 
Varies with each item 
Yes Male and female, ages 
14 years +, across a 
the spectrum of 
healthy and various 
diseases 
Commonly used in OA studies, 
particularly pharmaceutical studies. 
EQ-5D158 Mobility (1) 
Self care (1) 
Usual activities (1) 
Pain/discomfort (1) 
Anxiety/depression (1) 
3 
 
Yes Male and female, ages 
12 to 90, across a the 
spectrum of healthy 
and various diseases 
Major use as a clinical utility measure 
and has been more commonly used in 
RA compared to OA 
NHP160 Physical mobility (8) 
Sleep (5) 
Pain (8) 
Emotional reactions (9) 
Energy (3) 
Social Isolation (5) 
2 
 
Yes Male and female, ages 
12 to 90, across a the 
spectrum of healthy 
and various diseases 
There are questions as to its sensitivity 
in an OA population162, however it is 
commonly used in joint replacement 
surgery.  
15-D163 15 dimension of health (including 
moving/seeing/hearing/social 
participation/working etc) 
Varies, generally 4-5 
levels for each item 
Yes Male and females, 16 
years + 
Originally designed in Finnish, it has 
been used in joint replacement surgery 
QWB164 Symptoms (27)  
Mobility (4) 
Physical activity (4) 
Social activity (4) 
Varies, but all scores 
are combined to a 
single scale score 
No Male and female, 18 
years+ 
Used predominantly in the calculation of 
QALYs in the United States. 
 
Table 2.6  Summary table of Generic Quality of Life/Health-Related Quality of life Measures  
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Instrument Domains (Number of items) Levels of response UK Validation Specific Population Comments 
WHOQoL166 Physical Health  (12) 
Psychological (16) 
Level of Independence (16) 
Social relationships (12) 
Environment (32) 
Spirituality/Religion/Beliefs (12) 
Ordinal scale 
response with 5 
levels for each item 
Yes Male and female, 18 
years+ 
Developed as a cross cultural 
instrument which included 15 countries 
in the initial development 
WHOQOL-
BREF167 
Physical  (7) 
Psychological (6)  
Social Relationships (3) 
Environment (8) 
Ordinal scale 
response with 5 
levels for each item 
Yes Male and female, 18 
years+ 
Brief version of the WHOQOL 
AQoL Independent Living (3) 
Social Relationships (3) 
Physical senses (3) 
Psychological well-being (3) 
Ordinal scale 
response with 4levels 
for each item 
No Male and female, 18 
years+ 
Designed and used predominantly in an 
Australian Context. 
 
Table 2.6 Summary table of Generic Quality of Life/Health-Related Quality of life Measures (Continued)
39 
Chapter 2 Background and Review of the Literature 
2.2.4  Specific vs Generic Outcomes Instruments 
When choosing an appropriate outcome for a condition, consideration must be given 
to whether a disease specific or a generic instrument is used.  Generic, non disease 
specific instruments, including the SF-36178 and the and the Nottingham Health 
Profile179 are commonly used in musculoskeletal research.  Each of these tools 
demonstrates strong psychometric qualities and they have provided an opportunity to 
compare outcomes across diagnostic groups and between interventions.  While a 
good generic instrument would allow for comparison across diseases, generic 
measurements are less able to discriminate change across conditions where 
impairment and disability is due to biological attributes of the disease180.   Several 
studies have highlighted the differences in results when disease specific and generic 
outcomes instruments are used181, 182.  Disease specific measures have been found to 
be more sensitive to change182 and have been found to better predict clinical changes 
when compared to generic measures specific measures181. 
 
 
2.2.5  Patient versus clinician based measures 
As indicated in Table 2.5, most of the outcome measures that are used in OA have 
been developed by clinicians in order to provide important information on the level of 
physical impairment or pain as experienced by the patients.  It is therefore not 
surprising to discover that pain and function, together with the severity of radiographic 
changes with OA, were considered important in assessing the impact of osteoarthritis 
on an individual183.  Concern has been expressed, however, that outcome measures 
are too often derived from what clinicians, rather than patients, deem to be important.  
It is argued that the fundamental flaw in this approach is that clinicians are more likely 
to catastrophise disability184, ignore the socioeconomic and psychosocial issues183 
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and are simply not good at predicting what patients consider to be important185, 186.  
Indeed, it has been argued that developing and validating outcome tools that are 
devised by clinicians without the inclusion of patient needs may be invalid and 
compromises the usefulness, validity and accuracy of the tool118.   
 
 
2.3  Quality of Life 
In recent years there has been a growing interest in measuring the ‘real world’ impact 
of disease on patients through formal assessment of Quality of Life (QoL)118, 144, 187.   
Improvements in the provision of health care over the last 50 years has moved the 
focus from life threatening illness to the social impact of living with chronic, disabling 
diseases188.  In addition, the move away from patients as passive recipients of 
medical care to patients as partners in their own health has been supported by 
government initiatives189, 190.    
 
The first clinical publications reporting QoL appeared in the 1960s191 and this has 
since grown exponentially.  The use of QoL measures crosses such diverse areas of 
interest as clinical research, social science, psychology, environmental science, moral 
philosophy and political science192.  The term has been adopted by economists to 
evaluate the value of treatments in terms of QALYS (Quality Adjusted Life Years)193.    
It is therefore important to define the term “quality of life” and discuss the theoretical 
constructs which underpin this understanding and measurement. 
 
2.3.1  Definition 
While there has been a growing interest in measuring the QoL, there has been 
considerable debate as to definition of the term “quality of life”.  Nord144 pointed out 
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that QoL is a subjective, overall feeling of well being.  There appears to be a necessity 
in the traditional, medically focused environment, for clinicians to describe QoL in 
terms of the absence or presence of disease and its consequences.  This is often 
referred to as “health-related” QoL and instruments such as the SF36 and EuroQoL 
measure this construct.   While it is important to measure pain and functional 
impairment, QoL, is a much broader concept than this and encapsulates a good QoL 
as “life free of disability”.  QoL represents a holistic concept and goes beyond the 
activities of daily living and disease categories - it encompasses social, psychological 
and spiritual being of the person and how they interact with their environment194. 
Under this model, health is not seen as inherent or even necessary component of 
QoL, but only as a potential influence195. 
 
2.3.2  The disability paradox 
Part of the confusion with QoL can be attributed to the complexity, adaptability and 
subjective nature of health and well being.  It is well documented that people with 
serious and persistent disabilities or ill health may still report a good or an excellent 
quality of life.  It is often difficult to reconcile that an individual’s well being and life 
satisfaction can be anything but poor when they face serious, long term disability.  
This phenomenon is referred to as the disability paradox196 and represents an 
important underlying construct in QoL: that quality of life is a balance between body, 
mind and spirituality in the context of an individual’s interaction with their external 
environment. 
 
Albrecht and Devlieger197 interviewed 153 people with physical disability in order to 
explore the issue of the disability paradox.  They found that many of those who 
reported excellent to good QoL said that in spite of their disabilities, they had control 
over their mind, bodies and lives.  Many reported that their disability had positive 
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consequences, such as a greater inner strength, resilience and maturity and 
satisfaction that they were able to provide support to others coming to terms with their 
disability.  In contrast, of those with a poor to fair QoL, many reported loss of control 
over their body and circumstances, and feeling that their bodies were particularly 
“vulnerable” or unpredictable.  Several people who reported poor QOL also reported 
pain being important in their perception of QoL.  The authors note that across a range 
of diseases and disabilities, it was not those with very obvious and functional 
disabilities who reported poor QoL, but those with communicative and cognitive 
disabilities, impairments that were not necessarily visible and those with episodic pain 
and/or general fatigue.    
 
This disability paradox highlights the important weaknesses of health related QoL.  
While impairments such as pain and activity limitation are undoubtedly pivotal in the 
determination of one’s QoL, the construct is more complex than a simple equating of 
physical ability with QoL.  The overemphasis on physical ability as the determinant in 
QoL is prevalent within the general community, but particularly emphasized in health 
care professionals197, where disabilities are generally seen in terms of only negative 
consequences.  Examples of this are seen specifically in the rheumatology literature: 
clinicians working with patients with rheumatoid arthritis are more likely to rate 
patient’s disability higher than the patients themselves rate their disability198. 
 
2.3.3  Adapting to disease 
A further interesting paradox arises in the finding that patients who are disabled or 
who have a chronic disease generally rate the value of their lives in a given health 
state higher than individuals imagining themselves to have a disease184.  A source of 
this unexpected finding is the issue of adaptation or response shift199. Indeed, Carr 
and colleagues200 argue that QoL is influenced by expectations and experience, and 
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as such, cannot be considered linear or constant.  A person with a chronic illness may 
accommodate and adapt to their situation, thereby altering their self reported well-
being which causes problems of interpretation of health related QoL, where the 
emphasis is on pain and disability. 
 
2.3.4  Theoretical Constructs for Measuring Patient Based QoL 
Since as far back as 1988, there has been concern expressed about the inadequacy 
of the conceptual basis for many of the tools developed to measure quality of life201.   
Initial quality of life tools continued to focus on the medical model of measuring 
success. It was quite common to include “objective” measures of quality of life, that 
were not undertaken by the person, but assessed by an observer/clinician rating what 
they considered the patient’s quality of life202.   
 
SEIQoL 
Individualized QoL measures, such as the SEIQoL203, 204, offer an assessment of QoL 
that is developed to be customized for each person.  The SEIQoL takes the form of an 
interview, where the respondent identifies what elements that he/she contributes to 
their own QoL.  The person then identifies their satisfaction with the current status of 
each element on a visual analogue scale.  The person then weights how important 
each are and the full score is given by the sum of the products of each element.  This 
approach, while clearly beneficial in the clinical situation, cannot be validated by 
nature of its individual uniqueness, and thus has limited use in research.   
 
Needs-based quality of life 
Where it is necessary to make group comparisons, the needs-based QoL approach is 
gaining wide acceptance.  The needs-based approach to QoL was developed by Hunt 
and McKenna205 and  has been used in the development of several condition specific 
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QoL measures. The model is based upon a validated development technique 
involving in-depth qualitative interviews with patients who are living with a health 
condition205 and has been used to develop a number of disease specific QoL tools, 
including depression206, rheumatoid arthritis207, psoriasis208, psoriatic arthritis209, 
ankylosing spondylitis210 and multiple sclerosis211.  Using this model, the needs 
relevant to each condition are identified, maximising the content validity and 
responsiveness of the final instruments.   
 
The needs-based model is drawn from the understanding that individuals are driven or 
motivated by their need, as described by Maslow’s hierarchy of human needs212.  The 
needs-based philosophy is centred on the understanding that life gains its quality from 
the ability and capacity of individuals to satisfy their need191.  Functions such as 
hobbies, social activities and employment are important only insofar as they provide a 
mechanism by which such needs can be met.  When our needs are met, our QoL is 
high and when such needs are not fulfilled, our QoL low.   
 
Unlike the HRQoL approach, needs-based QoL is a different construct to our physical 
ability or health status.  Indeed, QoL is an complex interaction between the way in 
which people perceive their health and how it relates to other non medical aspects of 
their lives213 (Figure 2.4).  As such, the needs-based quality of life approach to 
measuring quality of life presents a conceptual construct which is not dependent on a 
medical model.  It reflects the issues of what is important to defining issues that are 
important and not simply related to the physician’s understanding of quality of life as 
pain or physical ability. 
 
Interestingly, while OA is the most prevalent of the rheumatic diseases and several 
needs-based QoL instruments for rheumatological conditions exist207, 209, 210, currently 
there is no disease-specific, needs-based QoL instrument available for this condition. 
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Figure 2.4  Interactions and influences on QoL.  Adapted from Doward and 
McKenna214. 
 
 
 
2.4  Measuring the impact of OA on Health-Related QoL 
While pain and functional limitations have received much attention in OA research, 
little is known on the impact on an individual’s quality of life.  A recent systematic 
review on the impact of hip and knee complaints highlighted the lack of studies which 
have evaluated quality of life in such patients215.  This may indeed be related to the 
lack of an OA specific QoL outcome measure for OA.  The handful of studies that 
Disease Treatment 
Impairments 
(symptoms) 
Disability 
(functioning) 
Health Related 
Quality of Life 
Quality of Life 
Social support 
Culture 
Economy Environment 
Social roles and 
functioning 
Personality 
46 
Chapter 2 Background and Review of the Literature 
have explored the impact of OA on QoL using health-related quality of life measures, 
such as the SF-36153.   
 
Chronic musculoskeletal problems216 and painful joints217 in general have been found 
to account for a lowered HRQoL.     However, when the specific effect of OA is 
explored, the impact is remarkably high.   Those with OA had more pain, functional 
limitations and diminished HRQoL compared to age and gender matched controls.  
This has been found not only in those with severe OA waiting for joint replacement218, 
but also in a community setting219,  where the severity of OA would be most likely in 
the mild to moderate range.  While not specifically investigated, there may also be a 
difference in HRQoL related to the site of OA:  combined chronic hip and knee 
problems demonstrated a much lower HRQoL than those who had only hip or only 
knee problems215  and those with hip OA scored the lowest overall HRQoL98.   
 
The major advantage with using a generic instrument for HRQoL is for comparison of 
the impact of different diseases.  In a study comparing chronic conditions and their 
impact on HRQoL, arthritis had the greatest influence on the SF-36 score of eight 
chronic conditions, worse than congestive heart failure, ischaemic heart disease and 
chronic lung disease3.   This is highlighted when the SF-36 scores are compared 
across several medical conditions.  Figure 2.5 presents a graphical representation of  
several chronic diseases, where lower scores represent poorer health.  OA of the hip, 
knee220 and lower limb221 (presented in grey and black) are compared against Charcot 
Marie Tooth Disease222, amputees223, Parkinson’s Disease224, stroke225, 226, coronary 
arterial disease227, intermittent claudication228 and population norms224.   Remarkably, 
OA of the lower limb represents the lowest score across every domain with the 
exception of general health, where Parkinson Disease and stroke record greater 
impact. 
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Figure 2.5  Comparison of SF-36 scores across a range of chronic conditions.  The SF-36 scores compared with the scores from 
published studies describing health status in a range of conditions.  The ABS population normal population, and a second normative 
group are presented in green. Parkinson’s disease is presented in orange, stroke is presented in pinks/purples, other cardiovascular 
disease in blues, and OA is presented in shades of grey/black.  Image reproduced with permission from Redmond229. 
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The complex interaction between HRQoL and psychosocial, personal and 
environmental factors has been identified, but unfortunately, not fully explored.  A 
direct link has been found between HRQoL and depression219, however it is not 
known whether the depression results in reduced HRQoL or whether reduced HRQoL 
results in depression. This complex interaction is further highlighted by two other 
studies which have indicated a direct link between and HRQoL and social support230 
and global QoL and ethnicity, where African Americans with OA reported worse QoL 
than white Americans with OA176.  Whether it is the social support or ethnicity that 
causes reduced quality of life or whether they are mediators for other factors, such as 
lower socioeconomic status, remains unclear. 
 
 
2.5 Summary and Hypothesis 
OA is a prevalent and disabling disease which results in a considerable impact on the 
individual.   Most research has focussed on the knee and hip OA, with very little work 
undertaken on other sites, particularly the hand and foot.  While there is limited 
recognition that the presentation of multiple joint problems is common, little is known 
about the prevalence of multiple-site pain in OA or indeed which joints are most likely 
to be affected.  This review has highlighted that study of the functional impact on daily 
tasks of the most common multiple joint combinations is required.   
 
While most research in OA has focused on pain and physical disability, there also 
been an increasingly well articulated desire to understand and measure in the ‘real 
world’ impact of living with OA.   Exploring the impact of quality of life in OA has been 
limited by the lack of a disease specific, quality of life instrument.  Quality of life has 
been measured using the health related quality of life approach, which has a focus on 
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the function and pain.  While pain in OA has received considerable attention, it is 
unclear how pain contributes to the overall quality of life of the individual.   
 
This review has identified a need in the literature for a true QoL measure devised from 
people with OA, for assessment of QoL in those with OA, which is grounded in an 
appropriate conceptual framework and demonstrates appropriate psychometric 
measurement properties.    Furthermore, the interaction and relationships between the 
physical and psychosocial aspects and their contribution to quality of life needs to be 
explored.   
 
The hypothesis of this thesis can be summarised as follows: 
 
 
The number and pattern of joint involvement in OA will be reflected in the level of 
patient perceived quality of life 
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Chapter Three 
Methodology 
3.1 Introduction 
This chapter details the methodologies that were used in the studies included in this 
thesis.  In order to fully explore the hypothesis “the number and pattern of joint 
involvement in OA will be reflected in the level of patient perceived quality of life” a 
mixed methodological approach, using both quantitative and qualitative methods, was 
adopted.  The methods were designed to describe the prevalence and impact of joint 
pathologies (Section 3.2), to explore the personal issues of living with OA (Section 
3.3), to develop a needs-based quality of life questionnaire specifically for OA (Section 
3.4) and investigate the key components that contribute to quality of life in OA 
(Section 3.5).   The outline of the thesis is presented in Figure 3.1.   The details of 
each method are described in this Chapter. 
 
In order to understand the prevalence and burden of joint pain, an epidemiological 
study was undertaken.  The first study, An Epidemiological Investigation of Joint Pain 
in the Community, involves secondary analysis of a large, community based dataset.  
In the original study, which was commissioned to explore the demand for hip and 
knee arthroplasty, surveys were sent to people 55 years and over in the North 
Yorkshire region registered with a GP practice.  The aim of the secondary analysis 
undertaken as part of this thesis was to investigate the prevalence of multiple-joint 
involvement in the community and its impact on activity limitation.  Such a large 
community based survey of more than 16,000 could not include a formal, clinician 
diagnosis of OA; instead the prevalence and burden of joint pain was explored.  This 
study provides the contextual rationale for focussing on multiple-site pathology by 
describing the extent and impact of multiple-site presentation in the community. The 
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frequency and pattern of joint pain was described and the impact of the joint pain on 
daily activities, such as walking and rising from a seated position, was investigated.  
The results of this study are presented in Chapter Four. 
 
The second study is a qualitative analysis of the impact of Living with OA.  The aim of 
this study was to take a small number of people with OA and explore, in depth, the 
issues associated with living with OA.  This methodology was used in order to capture 
rich descriptions from the individual’s point of view as to what it is like living with OA 
and the impact on their lives, relationships and sense of well being.  The results of this 
study are presented in Chapter Five. 
 
Based on these interviews, an OA specific quality of life measure, the OAQoL, was 
developed.  The third study, Development of a Quality of Life Instrument for 
Osteoarthritis, describes the development of the disease specific, QoL outcome 
measure for OA, the OAQoL.  Quotes taken directly from the in-depth qualitative 
analysis interviews were used to form the basis of a draft quality of life questionnaire 
(OAQoL).  This draft OAQoL was then examined for the relevance, clarity and ease of 
completion by people with OA who participated in structured feedback interviews 
(n=17).  The psychometric properties of the questionnaire were then undertaken using 
a postal questionnaire (n=259).  A second draft of the OAQoL was then investigated 
for test-retest properties with 60 participants returning a further questionnaire.  The 
results of the development and validation phases of the OAQoL are presented in 
Chapter Six. 
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Figure 3.1   An overview of the structure of the studies of the thesis.   
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The fourth study, Physical and Psychosocial Influences of Quality of Life in 
Osteoarthritis, used structural equation modelling techniques to explore the factors 
identified in the previous studies that contribute to quality of life in OA.  The results of 
this study are presented in Chapter Seven.   
 
Each study described in this thesis was conducted in compliance with the Helsinki 
Declaration with institutional review and ethical approval granted by the North 
Yorkshire Local Research Ethics Committee or the Leeds West Local Research 
Ethics Committee. 
 
 
3.2 Epidemiological Investigation of Joint Pathology in the 
Community 
 
In order to establish the prevalence and burden of multiple-site joint problems, an 
epidemiological investigation of joint pathology in the community was undertaken.    
This study was a secondary analysis of an existing, large community based project 
that had been conducted within the University of Leeds231.  As described in Chapter 
Two, while there is limited recognition that the presentation of multiple joint problems 
is common87, this has not stopped the focus of management strategies being aimed at 
individual joint problems:  indeed, the prevalence and functional impact on daily tasks 
of the potentially summative effects of most common multiple joint combinations has 
not been explored.   
 
The aim of the original study was to determine the numbers of people aged 55 years 
or more who may benefit from knee arthroplasty.  The aim of the secondary analysis 
was to explore the prevalence and associated functional limitations of joint problems 
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in the older age community, and to evaluate the impact of each joint separately and 
the interaction of multiple-site joint problems on physical abilities. 
 
3.2.1  Participants 
A community based postal survey, approved by the North Yorkshire local ethics 
committee and was originally commissioned by North Yorkshire Health as part of a 
study to determine the predicted need for knee arthroplasty in the community.  Names 
of 18,227 people over 55 years were selected randomly from the North Yorkshire 
Family Health Services Authority, which is coterminous with North Yorkshire District 
Health Authority.  The population estimate for the over 55 age group in this population 
is 210,000.   
 
As a community based survey, the focus of the questionnaire was built around self 
reported joint problems and self reported activity limitations.   No diagnosis of joint 
pathology, particularly OA, was possible with this study design.   
 
3.2.2  Questionnaire 
A postal questionnaire was used to describe population estimates of joint problems 
and to identify patients with functional limitations associated with joint pathology.  
Individuals who reported knee and hip problems in the initial study were invited to 
complete a more comprehensive questionnaire, which formed the basis of work that 
has been published elsewhere231.  In the original study, data were captured on a 
whole body manikin but only knee and hip data were analysed.  The data used in the 
current study were derived from this first questionnaire and had not been analysed in 
this way or published previously.   
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The questionnaire asked for demographic information and clinician diagnosed co-
morbidities (Figure 3.2).  Participants were asked whether they had experienced any 
swelling, pain or stiffness in the any of their joints, neck or back which has lasted for 
more than six weeks in the previous three months.  In order to establish loci of pain, 
participants indicated the location of joint problems on a manikin, with major joints 
identified on the manikin as boxes.  Participants were also asked to indicate whether 
they experienced difficulties with a number of activities of daily living or required 
assistance with daily tasks, as described in Figure 3.2. 
 
3.2.3  Strategy for data analysis 
The strategy for data analysis was driven by a need to code the data into clinically 
meaningful information, explore for non responder bias, establish the prevalence of 
joint problem at the individual joint site, establish the prevalence of common patterns 
of joint involvement and finally to investigate the impact of joint problems on simple 
daily activities.   
 
Non responder bias 
In the original study, completed questionnaires were explored for non-response bias.  
A pre-determined strategy was used to weight data by age and gender to adjust for 
non response bias and to determine prevalence estimates, with 95% confidence 
intervals (95% CI) calculated according to Schoenberg232.   For all modelling and 
inferential statistics, the data were analyzed in its un-weighted form.   All prevalence 
data were expressed per 1,000 members of the population.
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Demographics 
Age (yrs) 
Gender (Male/Female) 
 
Co-morbidities 
Have you ever been told by a doctor or other health professional: 
      That you have arthritis or rheumatism?   Yes  No 
      That you have high blood pressure?     Yes  No 
      That you have diabetes?     Yes  No 
      That you have had a stroke?    Yes  No 
 
Functional ability 
In the last three months, have you had any difficulties with any of the following activities 
because of health problems or disabilities? 
Gripping or holding things    Yes  No 
Brushing or combing your hair    Yes  No 
Getting up and down stairs    Yes  No 
Getting up from a chair or the toilet   Yes  No 
Putting on shoes, socks or stockings   Yes  No 
Standing or walking     Yes  No 
 
Joint pathology 
In the last three months, have you suffered from any swelling, pain or stiffness in any of your 
joints, your neck or back which has lasted for more than six weeks? 
Yes  No 
 
Please look at the chart below and tick the joints which are troublesome to you 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.  Summary of questions and format of items included in the survey.  
Note, other questions asked, but not included in the final analysis as they did not meet 
the assumptions for the logistic regression are presented in Table 3.1. 
    Neck 
Shoulder 
Elbow 
Wrist 
Hand 
  Thumb 
 Back 
 Hip 
  Knee 
  Ankle 
 Foot 
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Managing the data 
While the manikin was designed to collect data on wrist, thumb, hand, ankle and foot, 
there was some concern that people could not differentiate the pain at that level of 
refinement accurately.  Therefore, data for hands and wrists were combined and are 
presented as “hand” data, and feet and ankle and are presented as “foot” data.  All 
other joints were reported as indicated on the manikin.  In order to explore the 
geometric patterns of joint involvement, each possible joint combination was 
established using syntax code.  A total of 1,024 possible combinations were 
established. 
 
In order to determine the prevalence and impact of single or bilateral joint problems, 
data were coded and explored.  In the first instance, joint pain in the right, the left or 
both joints was considered a positive response for that joint and data in subsequent 
analyses were explored for the impact of unilateral and bilateral pain.  Data were 
analyzed using the computer program Statistical Package for the Social Sciences 
(SPSS) Version 11.01.   
 
Strategy for Logistic Regression Modelling 
Site of joint problems, presence of one or more co-morbidities, gender and age and 
were used in logistic regression modelling in order to quantify the “risk” or likelihood of 
difficulties with activities of daily living.   In order to determine the contribution of  joints 
to functional problems (including site of  joint pain, the most common joint 
combinations and then unilateral and bilateral presentations), each was included in a 
forward, step-wise, logistic regression model.   
 
Assumptions for logistic regression model were checked and multiple co-linearity 
between variables explored.  The Logistic Regression Omnibus of Model Co-efficients 
were used to determine how well the model performs233.  Each step-wise regression 
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was accepted only if the 2-log-likelihood chi-square was significant at p≥0.05.  Multi 
co-linearity was assessed using a two-step approach.  First, all variables were 
assessed for correlation.  For example, age and hip pain, knee pain and hand pain, 
etc.  No variables demonstrating an association of greater than 0.9 were included in 
the model233.  Following this process, Hosmer-Lemeshow good-of-fit statistic was 
calculated for each of the functional indicators.  Models were only accepted if the 
Hosmer-Lemeshow statistic was not significant.   
 
In order to estimate the odds ratio for the risk factor of common joint patterns, a 
summative odds risk was estimated using a hierarchically well-formulated model.  
This was calculated by taking the logit of the each joint as a main effect,  then the 
combination of joints as interaction effects, adding the difference between the logits, 
computing the value and finally exponentiating this value234, 235. For models where 
there were more than two joints analyzed, all factors were included into the equation, 
including interaction effects between all joint combinations.  For example, to establish 
the odds ratio for a person with feet, hands and knee problems experiencing difficulty 
in going up and down stairs, the odds ratios for feet, hands and knee as single joints 
were undertaken, and then interaction between feet-hands, feet-knees, knees-hands 
and hands-knees-feet were included in the model.  Interaction effects were chosen 
based on the prevalence of multiple joint sites. 
 
 All joints that were considered in the interaction effects were also considered as main 
effects233.  In order to estimate the odds ratio for the risk factor and the variable that is 
interacting with, the following equation is used234, 235: 
(i) Identify the expression for the logit and the two levels of the risk factor 
being analyzed 
(ii) Algebraically sum the difference between the two logits and compute its 
value 
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(iii) Exponentiate the value obtained in step 2 
 
The equation therefore becomes 
OR=exp[β1(f1 – f0) +β2(f1 – f0)]+ β3x(f1 – f0)] 
Where  
β = Odds ratio 
f = Risk factor.  Note in dichotomous logistic regression, this value is the 
value that is given when the factor is present (ie when it equals 1) 
x = Interaction 
 
As an example, to describe the total interaction effect between knee and hip, the 
following equation would be performed to calculate the odds ratio for person who has 
both hip and knee problems to have difficulty in walking and standing  
 
OR  = Exp [(Constant or intercept) + (exp hip x 1) + (exp knee x 1) + (exp 
hip and knee x 1)] 
= Exp [-0.897  + 1.329 + 1.024 + (-0.536)] 
 = Exp (0.92) 
 = 2.50929 
 
For models where there may be more than two joints are being analyzed, a 
hierarchically well-formulated model was used236, where all factors are included into 
the equation, even if they may not have reached statistical significance.  Interaction 
effects between each combination of the independent variables are included for 
analysis.  For example, to establish the odds ratio for a person with feet, hands and 
knee problems experiencing difficulty in going up and down stairs, the following 
equation would be used 
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OR = Exp [(Constant or intercept) + (exp feet x 1) + (exp knee x 1) + (exp 
hands x 1) +(exp feet, knee and hands x 1) + (exp feet and knees x 
1) + (exp feet and hands x 1) + (exp knee and hands)] 
 
While data for several functional indicators were captured, only those whose 
predictive capacity was greater than R2=0.250 were included.  As such, data captured 
for the following were not included in the final analysis: putting on shoes, brushing 
hair, gripping things, regular GP visits, hospital specialists’ visits, prescription 
medication and non prescription medication (Figure 3.1 and Table 3.1).   
 
Results of this study are presented in Chapter Four. 
 
 
 
In the last three months, have needed any help with the following: 
 Yes No 
Dressing and/or undressing 
 
  
Getting in or out of bed 
 
  
Getting in and out of the house 
 
  
Because of your troublesome joints,  
 
 
  
Have you seen your GP (family doctor) in the last year 
 Yes No 
Have you seen a hospital specialist at any time 
 
  
Do you regularly take medicine or tablets prescribed 
by a doctor 
 
  
Do you regularly take non-prescription painkillers 
(eg aspirin, paracetamol) 
 
  
 
Table 3.1  List of items included in the survey, but not included in the final analysis 
due to restricted predictive capacity (R2<0.25). 
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3.3 Qualitative Analysis of Living with OA 
3.3.1  Introduction 
The importance of understanding the experience of living with musculoskeletal 
disease, rather than focusing on the disease processes has recently been 
highlighted237, 238.   The biopsychosocial model239 looks at complex contextual and 
personal issues and the interaction with the disease process.   Qualitative 
methodological approaches are particularly effective in exploring an individual’s view 
of living with disease from the biopsychosocial model, as this form of research gives 
the experience of the individual meaning  with reference to their social and cultural 
context238.     In order to explore the issues of living with OA from the perspective of 
the individual, qualitative analysis of in-depth, semi-structured interviews was 
undertaken, using the needs-based approach to quality of life. 
 
3.3.2  Theoretical Philosophy of Methodology 
The aim of this study was to understand the ‘meaning’ of the impact of living with OA 
and as such, a phenomenological framework was adopted, where the essence of 
meaning would emerge through the reflective description of participants own world240-
242
.   Phenomenology was first described by Edmund Husserl (1859-1938) and was 
developed as a way to establish meaning, rather than simply the existence, of 
constructs.    Phenomenological qualitative research aims to clarify and explore 
situations lived by individuals based on their own experiences within the context in 
which the experience takes place.  Phenomenological analysis attempts to seek the 
meaning of an individual’s lived experience within the context of that individual’s life.   
 
Thematic analysis is method of organizing and structuring themes in order to gain an 
understanding into the comprehension or meaning of a concept243.  Thematic analysis 
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is commonly used in phenomenological approaches to data analysis (Figure 3.3) and 
is considered a structured method of exploring themes through a conceptual matrix.  
In essence, it is a method of bringing together components or fragments of an idea 
that relate, which are often meaningless when viewed alone, but form a 
comprehensive picture of the collective experience244.  Thematic analysis is often 
used interchangeably with “conceptual analysis” and “content analysis”, although the 
latter refers to a much broader approach of qualitative analysis and may include data 
reduction and relational/semantic analysis.   
 
The strength of thematic analysis is the bringing together separate ideas or 
components which, when linked, together offer insight in a cohesive and meaningful 
way.  It is a particularly useful method when summarising a large body of data and 
allows for social as well as psychological interpretations of the data.  It is particularly 
useful in large data sets, generating unanticipated insights and when rich descriptions 
are sought245. 
 
While a useful and potentially powerful tool, thematic analysis is limited when it is not 
underpinned by a sound theoretical framework or the approach to thematic 
development and review is not undertaken in a structured and transparent manner245.  
In these circumstances, thematic analysis is criticised as simply a shopping list.  
Thematic analysis has less interpretive power than other methodologies, particularly 
those such as Interpretive Phenomenological Analysis246 and Narrative Psychology247, 
which require a detailed psychological interpretation of the individual’s perceptions 
and account of events in their life or world245.  In these approaches, the number of 
interviews is, by necessity, small. 
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Figure  3.3  Overview of thematic analysis in Qualitative Research Types.  Adapted from Aronsen244. 
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3.3.4  Sampling Technique 
In order to explore issues associated with living with OA, in-depth, semi-structured 
interviews were conducted with participants from the primary care Leeds 
Musculoskeletal Service and the secondary care Leeds NHS Trust Rheumatology and 
Orthopaedics Clinics.  Patients with OA attending these clinics were invited to 
participate.  It was important that representation was sought from both primary and 
secondary care as most patients with mild to moderate OA are seen in primary care 
and only infrequently consult hospital specialists.  Those patients attending tertiary 
care outpatient clinics are more likely to be those at the severe end of the OA 
symptom spectrum. 
 
To ensure a sample that represented the commonly prevalence of OA, a matrix was 
constructed with forced representation for gender, age (≤55 years; ≥56 years) and site 
of OA (hip, knee, hand, foot and multiple-sites) with approximately equal participation 
sought for each group.  The minimum required sample size was determined to 40.  All 
participants with hip, hand and knee OA fulfilled the ACR Criteria for the Diagnosis of 
OA32-34. In the absence of any such criteria for patients with OA of the foot, 
participants were included if they had symptomatic, clinically diagnosed OA that was 
confirmed by radiographic evidence.  Participants with significant co-morbidity, 
(including heart and circulatory conditions, depression, stroke and other 
musculoskeletal disorders) were excluded from this phase of the study. 
 
3.3.5  Interviews 
In-depth, semi structured interviews were conducted with each participant.  The aims 
of the interviews were two fold:  (1) to explore the issues associated with living with 
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OA and (2) to derive items based on direct quotes from people who had OA to be 
used in the development of the QoL instrument (Section 3.4).   
 
The interviews were undertaken by eight researchers who were experienced 
qualitative interviewers and included psychologists and allied health professionals.   A 
panel of interviewers were chosen for two reasons:  firstly, the candidate was a novice 
interviewer and the panel provided a formal mechanism for review and mentorship as 
the candidate developed these new skills; and secondly, by including a number of 
interviewers, the aim was to reduce the impact an individual directing the outcome or 
direction of an interview248.  The majority of the interviews (n=25) were undertaken by 
the candidate. The interviews were conducted either at home or at a location of the 
participant’s choice, including a private room at the outpatient department of the 
hospital where the patient was visiting and an interview room at the university.  The 
interviews took the form of an informal, focussed conversation248.    
 
In keeping with the needs-based quality of life approach, issues associated with OA 
impacting on the needs of the individual being fulfilled, as described by Maslow212, 
were explored.  A diagrammatic representation of these needs is presented in Figure 
3.4. 
 
To initiate the interview, participants were asked a general question about their 
arthritis:  “how long have you had arthritis” and what symptoms do you have”.  After 
this initial discussion, participants were then asked “tell me how your arthritis has an 
impact on your day to day life” and were encouraged to discuss any aspect of their 
lives.  Interviewers were required to probe in depth any issues raised by the 
interviewees. For example, where a respondent raised an aspect of functioning as 
being problematic they were then asked to state how they were affected by the 
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Physical needs 
Impact of symptoms 
Impact of disturbed sleep 
 
Impact of living with 
OA on quality of life 
Safety and security 
Fear of being isolated 
Reliance on others 
Fear of being stranded 
with symptoms 
 
Belongingness and love 
Need for sharing  
Need for intimacy 
Feelings of being isolated 
Impact on family 
Impact on social participation 
Need to identify with others 
Loss of social contact 
Fear of isolation 
 
 
Cognitive needs 
Need for creative 
expression 
Need to pursue knowledge 
and understanding 
Need to feel intellectually 
stimulated 
 
Esteem needs 
Need for approval and 
acceptance 
Impact on self perception 
Impact on perceived role in 
society 
Impact on perceived role in 
family/friends 
Loss of identity 
Need to achieve 
Need to be recognised 
 
 
Self fulfilment needs 
Need to set goals 
Uncertainty of future 
Restriction in life 
choices 
Need to achieve 
Loss of control 
 
Figure 3.4  Needs-based approach to participant interviews 
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functional disability. In this way the interview went beyond determining the impact of 
OA on symptoms and functioning (Health Related QoL) by determining how this 
affected need fulfilment and about their emotional response to the restrictions. While 
free conversation was encouraged, if the participants were unable to think of any 
impact on their lives, prompt questions based on social activities, mood, feelings  
about the future and relationships with others were asked, according to the interview 
guide (Appendix 1).    Interviews were audio-recorded with the permission of the 
interviewee and transcribed verbatim for data exploration and analysis. 
 
Following the transcription of each tape, the interview was checked by the interviewer 
for accuracy and clarity and then cross-checked by one of the other researchers.  On 
completion of the patient interviews, the transcripts were analysed using two different 
techniques:  thematic analysis for the qualitative study (Section 3.3.6) and potential 
item identification for the quality of life measure (Section 3.4).   
 
3.3.6 Strategy for analysis of the data 
Data obtained from the interviews was subjected to qualitative thematic analysis, 
which involves identifying, categorizing and coding themes that were common 
throughout the interviews.  For the thematic analysis, a coding scheme was 
developed from the issues identified in the interviews and based around the needs-
based approach to quality of life.   All transcripts were coded using NVivo 2.0 and all 
qualitative data analysis was undertaken by the candidate.  
 
The approach to thematic selection and review was taken from Braun245, which 
involves a rigorous and systematic approach to the analysis.   The first step of this 
process is the familiarisation of the data.  While transcripts were checked by the 
interviewer, and re-checked by a second member of the research team, all transcripts 
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were read at least twice by the candidate prior to data analysis.  An initial coding 
strategy was developed by the research team during the interview process, each 
transcript was reviewed and coded.  Once the initial coding had been completed, the 
categories were reviewed and collapsed into clusters in order to reduce duplication of 
themes and allow appropriate cross referencing of themes.  Following coding of the 
transcripts, themes linking the codes were explored.  The themes were then reviewed 
in relation to individual responses and to the group analysis.  The transcripts were 
then reviewed once more and recoded in order to explore for any evidence of new 
themes through the revised coding.  This iterative process continued until the point 
was reached that no new information was emerging.  The transcripts were then 
reviewed in order to determine the frequency of interviewees who responded to each 
code. 
 
Results of this study are presented in Chapter Five. 
 
 
3.4  Development of a Quality of Life Instrument for 
Osteoarthritis 
The methodology used in the development and validation of the OAQoL was a well 
recognised method employed in the development of needs-based QoL instruments249, 
191
 and was conducted in four phases: in-depth interviews; cognitive debriefing; initial 
psychometric testing and test-retest assessment  (Figure 3.5).   
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1.  Interviews 
In-depth interviews 
N=44 
2. Cognitive debriefing 
Structured interviews 
N=17 
Draft OAQoL (Version 1) 
3.  Scaling Properties 
and Construct Validity 
Postal Survey 
N=259 
Draft OAQoL (Version 2) 
Draft OAQoL (Version 3) 
To derive items for an OAQoL 
questionnaire, based on direct 
quotations from people with OA 
4.  Test Re-test 
Postal Survey 
N=60 
 
Final OAQoL  
Phases Objective of the Phase 
To assess the draft OAQoL for 
clarity, applicability, relevance, 
completeness and comprehensibility 
and to make appropriate 
amendments 
To test the internal construct validity 
and psychometric properties of the 
draft OAQoL and make appropriate 
amendments 
To determine the test-retest reliability 
of the OAQoL and make appropriate 
amendments 
Figure 3.5. Summary of the Project Phases for the Development of the OAQoL 
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3.4.1  Item Selection from Interviews 
On completion of the participant interviews and in conjunction with the qualitative data 
analysis, the transcriptions were read and coded for item selection.  Each transcript 
was coded by two of the eight researchers to identify statements that related to the 
impact of OA on the respondents’ needs.  Actual quotations from the  
interviewees were used to form potential items for the measure wherever possible.  
Items were selected if they were consonant with the needs-based model for quality of 
life, were expressive of a single idea, applicable to all potential respondents (therefore 
not age or gender biased), capable of being expressed in the first person and, where 
possible, capable of being expressed in the respondent’s own words.   Items that 
were a truism or a statement of fact, such as “I feel tired when I have had a poor 
night’s sleep” were not included. 
 
In order to ensure clarity and ease of future translation into other languages, care was 
taken to avoid problematic terminology250.  Words such as “frustration”, which can 
have a sexual association in Latin languages and “things”, which is too non specific 
for translation, were avoided.  The initial list of items was then reviewed by six 
researchers, four of whom had previous experience in item identification using the 
needs-based model.  Duplicated, idiosyncratic or gender based items were removed 
at this stage. The remaining 38 items formed the basis of a draft questionnaire 
(OAQoL Version1). 
 
3.4.2 Cognitive debriefing 
The draft OAQoL (Version 1) was field-tested with relevant OA patients in order to test 
the applicability, relevance, comprehensibility and completeness of the draft 
questionnaire.  A group of 17 patients, different to those who completed the in-depth 
interviews were recruited.  These patients were attending OA clinics at the Leeds 
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Musculoskeletal Service clinic and fulfilled the OA diagnostic criteria outlined in phase 
1.  Respondents’ general comments and actions during the completion were noted by 
the interviewer.  On completion of the questionnaire, participants were then 
interviewed and asked general questions about the relevance, clarity and ease of 
completion of the questionnaire.  Following this, participants were asked about any 
items with which they had appeared to have difficulty.  Finally, each participant was 
asked for their comment on specific items that the research team had identified as 
potentially problematic. 
 
3.4.3  Scaling Properties and Construct Validity 
In order to evaluate the scaling properties and construct validity of the draft 
questionnaire, a postal survey was sent to 635 patients from primary or secondary 
care who had a diagnosis of OA, as per the phase 1 criteria.  Non-responders were 
sent two reminders letters, after which they were deemed unwilling to participate in 
the study.  The questionnaire pack included demographic questions, the draft OAQoL 
and a number of outcome measures commonly used in OA, in order to explore the 
relation of each to the OAQoL.  These measures were the Western Ontario 
McMasters University (WOMAC) Osteoarthritis Index (for lower limb OA)123, 124, the 
Cochin Scale (for hand OA)138 and the General Well Being Index (GWBI)164, 251.   
 
Scaling properties of the draft OAQoL were assessed using Rasch analysis252 with 
data entered using SPSS (SPSS Version 14) and analysed using RUMM2020 
software package253.  Construct validity was assessed using SPSS Version 14. 
 
Rasch analysis is a probabilistic mathematical modelling technique used to assess 
properties of outcome measures and is the current standard for the development of 
quality outcomes in health care254.  Data collected from ordinal questionnaires or 
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scales, that are intended to be summated into an overall score, are tested against the 
expectations of this measurement model.  Rasch analysis has been widely used in the 
development and validation of a number of outcome measures255, 256. 
 
The Rasch model, named after Georg Rasch (1901-1980) is based on a series of 
assumptions which, when met, are in line with the measurement being on a metric 
scale.  The model defines the ideal item response characteristics if measurement (at 
the interval level) is to be achieved.  Real data is then tested against this model, and a 
series of statistics are undertaken in order to evaluate whether the real data and the 
modelled data are similar. The observed response patterns achieved are tested 
against expected patterns (a probabilistic form of Guttman scaling)257. 
 
The Rasch model shows what should be expected in responses to items if 
measurement (at the metric level) is to be achieved. The model assumes that the 
probability that a person will affirm an item is a logistic function of the difference 
between the person’s level of, for example well-being [θ ] and the level of well-being 
expressed by the item [b], and only a function of that difference   
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where ln is the normal log,  P is the probability of person n affirming item i; θ  is the 
person’s level of well-being, and b is the level of well-being expressed by the item.   
 
The objective is to test how well the observed data fit the expectations of the 
measurement model, and so a range of fit statistics are considered258.  These fit 
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statistics, what they represent and their criteria for acceptance are presented in Table 
3.2.   
 
 
Invariance of the items 
Invariance of the items quantifies the fit of the observed data to the predicted model 
across the scale.  This statistic, represented by the chi-square (χ2) value, reflects the 
degree of invariance of each of the items and how they function together, so it 
represents how the items function across the one trait (or construct).  A significant chi-
square indicates that there are problems with fit of all the items: i.e. that the measure 
is not unidimensional.    
 
Item Difficulty 
Components should cover a range of less extreme and extreme characteristics 
(difficulty or severity) coherently. This is referred to as item difficulty or hierarchy and 
is expressed as a logit value, the natural logarithm of the odds of a person being able 
to perform a certain task255.  A questionnaire should have a spread of logit values 
across all items and an appropriate hierarchy in the OAQoL items relates to 
representation of the range of differing impact on quality of life.    
 
Residual Fit Statistics 
A further test to explore the unidimensionality of the instrument is to look at the 
Residual Fit Statistics. The residuals are the standardized person-item differences 
between the observed data and what is expected by the model for every person’s 
response to every item.  As it is standardized, a perfect fit to the model would give a 
mean of zero and a standard deviation of one when summed over all items259.   
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Construct Interpretation Assessment Level 
Individual Item/Questionnaire  
Fit test /Criteria 
Invariance of the 
items  
 
A check to explore if the ratios of 
items remain the same 
Individual Item, but taken in 
consideration of all items in the 
questionnaire 
A non significant χ2  
Item difficulty The relative difficulty of the items 
along the Rasch ruler 
Individual Item, but taken in 
consideration of all items in the 
questionnaire 
A range (or spread) of items, as 
indicated by the item threshold 
distribution graph 
Residual Fit Statistic The difference (or residuals) 
between the observed data from the 
questionnaire and what would be 
expected from the Rasch Model 
across all items 
Overall questionnaire A perfect person-item difference 
would have a mean =0 and a 
standard deviation =1 
Principal Components 
Analysis 
A further test of unidimensionality; a 
secondary analysis of the data once 
the Rasch Factor has been taken 
away 
Overall questionnaire Less than 5% of significant t-
tests when comparing items 
which appear to be loading onto 
a similar construct 
Differential Item 
Functioning (DIF) 
The stability of the items, 
irrespective of the group being 
evaluated 
Individual item No DIF 
Person separation Extent to which items distinguish 
between different levels of 
functioning 
Overall questionnaire Person separation Index (PSI) 
should be between 0.7 and 0.8 
Unidimensionality A check to explore if the items 
belong to the same construct 
Overall questionnaire Individual t-tests 
 
 
Table 3.2  Summary of Fit Statistics.   This table presents the fit statistics used in RUMM2020 and the criteria on which the 
assessment of each is made.  The Assessment Level column represents what level of the questionnaire is being evaluated with each fit 
statistic. 
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Principal Components Analysis  
Associated with the residual fit statistics, further evidence to support unidimensionality 
can be gathered by evaluating patterns in the residuals using Principal Components 
Analysis of the fit residuals.  The aim of this is to identify patterns of the residuals 
once the “Rasch factor” has been extracted.  This is important in order to identify any 
subsets of items that may be loading together. The absence of any meaningful pattern 
in the residuals will be deemed to support the assumption of local independence of 
the items259.  If any patterns are identified in the residuals, the significance of the 
pattern can be tested by a method proposed by Smith260.  In this method, the 
patterning of items in the residuals, looking at the correlation between items and the 
first residual factor, is identified and these patterns are used to define two subsets of 
items (i.e. the positively and negatively correlated items).   The person ability 
estimates are then compared via independent t-tests. If less than 5% of the 
independent t-tests are shown to be significant, then the assumption of local 
independence is supported260.  
 
Differential Item Functioning  
As well as considering unidimensionality, the fit statistics also consider the stability of 
the instrument, irrespective of the group being evaluated.  While groups may be 
expected to vary in their quality of life (for instance a 90 year old person may have a 
poorer quality of life score than someone who is 30; or people with other co-
morbidities may have a poorer quality of life than those who are otherwise generally 
healthy), their group membership at any given level of the trait should not influence 
how they are scored.  This type of analysis is referred to as Differential Item 
Functioning (DIF) and is identified by a two way analysis of variance (ANOVA) of the 
residuals261 with statistical significance indicating the presence of differential item 
functioning and compromise to the unidimensionality of the scale. 
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Person Separation Index 
The ability of the scale to discriminate amongst different groups of such patients is 
determined by the person separation index (PSI).  Values above 0.7 indicate the 
ability to identify at least two groups of patients262.  The PSI in the Rasch model is 
analogous to Cronbach α, and 0.7 is considered a minimal value for group use; 0.85 
for individual patient use263.  
 
Strategy for Rasch Analysis 
With the large number of statistics to evaluate in Rasch Analysis and the impact of 
removing items on total questionnaire fit, an a priori strategy for model and item 
analysis was devised. In the first instance, the response patterns of individual were 
evaluated and those with extreme fit residuals were excluded.  Following this, items 
were analysed as for high fit residuals, then DIF and the remaining fit statistics.  A 
diagrammatic representation of the approach to the analysis of fit statistics is 
represented in Figure 3.6. 
 
Construct Validity 
External construct validity, or how the scale performs relative to other measures, was 
assessed by relating scores on the OAQoL to those on measures of physical ability 
commonly used in OA research:  the WOMAC and the Cochin Scale.  In order to 
provide a comparison with a generic measure of quality of life, the General Well-Being 
Index (GWBI) was included.  The GWBI is a quality of life measure that has been 
specifically designed to assess psychological distress rather than physical 
incapacitation. It has been used in numerous clinical and non patient based groups264.    
It has demonstrated good internal consistency265 and high test re-test reliability264 and 
has been specifically adapted and validated for use in England266.    While it has been 
used extensively as a measure of well being in cardiac, gastro-intestinal and 
gynecological studies, it has also been used in rheumatology267, pain management268 
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and extensively in primary care settings268-270.  Finally, a 100mm visual analog scale 
(VAS) indicating “worst possible quality of life” to “best possible quality of life” were 
included. 
 
It was predicted that there would be moderate associations between the OAQoL and 
these scales, indicating that they assess related but different outcome constructs.  
Relations between the instruments were undertaken using Spearmans Rho (ρ) and 
data were analysed using SPSS Version 14. 
 
3.4.4  Test-retest reliability 
The revised OAQoL was sent to 201 patients from the primary and secondary health 
services.  Using the same method as described for phase 3, a further cohort of 
recently seen patients with OA were sent an invitation to participate.  Participants who 
responded were sent another questionnaire two weeks later and the test-retest 
reliability of the instrument assessed using Rasch analysis, Spearmans Rho (ρ) and 
Cohen’s kappa (κ). 
 
Results of this study are presented in Chapter Six. 
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Re-run Analysis 
Monitor PSI, µ≈0, 
SD≈1, check residual 
correlations for 
redundancy 
Check summary statistics 
χ2, df, p 
Check fit residuals for 
individuals 
Poor fit 
Good 
 fit Poor fit 
Remove 
individuals  
Good fit 
Check fit residuals for 
items 
Remove items 
Poor fit 
Good fit 
DIF Check for DIF Remove item 
No DIF 
Check for Patterns in 
the PCA residuals 
 
Fit to the Rasch Model 
Remove item 
> 5% T-tests 
significant 
End 
< 5% T-tests 
significant 
Run Initial 
Analysis 
 
Figure 3.6  Algorithm for Rasch analysis for new scale development. 
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 3.5  Structural Equation Modelling 
3.5.1  Introduction 
As described in Section 2.3, quality of life is a complex and multifaceted construct.  In 
OA, several factors have been implicated in affecting “quality of life” including physical 
and psychosocial factors.  Traditionally, the complex interaction of these factors in OA 
has focussed on either pain271 or the affect of psychosocial factors on pain49, 272 and 
functional ability273-275.  The relationship between such factors and quality of life has 
not yet been explored.  The development of the OAQoL offered the opportunity to 
investigate the complex relationship between factors identified in the literature as 
important to those with OA, and quality of life as defined by the needs-based model.  
The aim of this study was to examine the relationship between physical, psychosocial, 
demographic and disease factors on quality of life using structural equation modelling. 
 
Overview of Structural Equation Modelling 
Structural Equation Modelling (SEM) is powerful analysis technique used to explore 
the relationship between several independent and dependent variables.  SEM is a 
sophisticated form of examining correlations and relationships, and addresses some 
of the limitations with commonly used analysis techniques.  For example, to explore 
the relationship between an independent variable (for example pain) and a dependent 
variable (such as quality of life), correlation statistics may be used.  From such 
analysis, the strength of the association of the variables is indicated by the correlation 
value (r or Rho).  The disadvantage of correlation is that only one variable can be 
evaluated at a time and the variables are each considered in isolation, which may also 
be significant.  To explore the combined impact of several independent variables 
(such as pain, function and age) on a dependent variable (such as quality of life), 
regression analysis is used.  In addition to the impact that each of the independent 
variables have on the dependent variable when considering all of the variables 
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together (β weights), regression analysis also provides us with an estimate of how 
much of the dependent variable is explained by all independent variables 
combined(R2).  While regression is a very powerful analysis tool, it is constrained by 
three major issues: the first is that only look at one dependent variable can be 
explored at a time; secondly, the direction of a relationship is treated in only one 
direction (such as pain impacts on quality of life and not that quality of life may impact 
on pain perception); and finally, regression does not take into account error 
associated with the outcome measures. 
 
SEM is an analysis method which explores the relationships between several 
variables.  It has been developed from two areas:  path analysis (ie multiple 
regression, which is concerned with the relationships between measured or observed 
variables of interest) and factor analysis (which considers the extent to which items or 
measures capture latent variables).   As such, SEM offers a solution to some of the 
issues inherent in multiple regression techniques. 
 
SEM is driven by a conceptual theory about a set of variables and how they relate to 
one another.  The procedure requires a theoretical model, underpinned by the 
hypothesis that is to be tested.  As SEM involves an iterative analysis technique 
where relationship between variables can be changed in order to fit the model, it is 
essential that the model is hypothesis driven, either by evidence from the literature or 
a conceptual understanding of the variables276.    
 
In SEM, there are two major types of variables:   
i. observed variables:  variables which are measured directly (such as pain 
visual analogue pain scale).  In SEM graphical models (or drawings), these 
are represented as a rectangular shape.   
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ii. latent variables:  variables which are not directly measured, but are 
inferred constructs based on what observed variables we have selected 
(such as “pain”).  In SEM drawings, these are represented as an oval 
shape. 
 
There are a number of advantages in using SEM to explore the relationship between 
multiple variables:   
 SEM takes into account measurement error that is ignored in regression 
modelling and factor analysis 
 SEM estimates the strength and direction of relationships amongst variables, 
including direct and indirect effects, feedback (or reciprocal) relationships and 
mediating relationships 
 SEM also estimates relationships amongst latent constructs, that were not 
directly measured, but are important to the theory underpinning what we are 
investigating 
 
While SEM is a very powerful technique, it is important to understand the assumptions 
which underpin this approach.  First, as the technique is built around regression, the 
assumptions are that the data is interval in nature and normally distributed.  The data 
needs to be explored to evaluate the validity of such assumptions.  Second, SEM 
cannot deal with missing data and extreme outliers; such data points need to be 
explored and accounted for in an appropriate manner, prior to modelling. 
 
 
SEM and Rasch analysis 
While SEM provides a framework for modelling relationships between variables and 
accounting for error in measurement, Rasch analysis provides us with a strong 
conceptual basis for determining that error.  It is useful in three ways:  first, we can 
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use the Rasch transformed scores of measures as true interval data; secondly we can 
export the error estimates and regression co-effecients directly from the RUMM2020 
results; and finally, Rasch can estimate missing values, which are vital to SEM. 
 
3.5.2  Hypothesis testing 
In order to explore the physical and psychosocial factors associated with quality of life 
in OA, an a priori model was devised, based on the ICF framework and informed by 
the literature and the results of our qualitative study.   The hypothesis to be tested was 
that there is a relationship between quality of life and personal factors, impairment, 
factors associated with their OA and psychosocial factors. 
 
3.5.3  Participants  
The data for this study were collected in Phase 3 of the development and validation of 
the OAQoL (Chapter 6).  As described in Chapter 6.4, data was received from 259 
respondents from both primary and secondary care and with OA at a variety of sites 
including the knee, foot, hip, hand and multiple-site presentation (Table 6.1).    A 
majority of the respondents were females (68.7% female), with a mean age of 66.5 
years (range: 21 to 98, SD+12.5yrs).   
 
3.5.4  Measures for the model 
Based on our qualitative interviews with patients (Chapter 5), a range of outcomes 
that reflected particular constructs were explored for inclusion in the modelling for 
factors thought to be associated with quality of life.  These are summarised in Table 
3.3 and included the following: pain, physical ability/function, anxiety, depression.   
Furthermore, items that had been indicated in the literature that may impact on quality 
of life and OA were included, particularly age, gender and co-morbidities.  Finally,  
83 
3 Methodologies 
 
Construct ICF Construct Measure  Data 
Demographics Personal factor 
Personal factor 
Personal factor 
Environmental 
factor 
Gender 
Age 
Ethnicity 
Education levels 
Nominal:  Male/Female 
In Years 
Nominal:  categories taken from UK Census data format  
Nominal:  categories reflect UK equivalent achievement levels 
Disease 
Characteristics 
Health Condition 
Health Condition 
Duration of OA 
Number of joints 
involved 
Location of OA 
Joint pattern 
In Years 
Count taken from self reported areas of arthritis on the manikin 
Co-morbidities NA Self reported, GP 
or hospital 
specialist 
diagnosed  
Nominal, with categories of co-morbidities adapted taken from Wolfe277 
and Kadam89 
Pain Body function 
and structures 
Visual analogue 
pain scale 
How painful has your arthritis been over the last 7 days? 
Function 
 
Activities WOMAC Composite score of 17 questions with each question rated on a 0 (no 
difficulty) to 4 (extreme difficulty) scale 
Anxiety Body function 
and structures 
HADS Composite score of 7 items with each question scored from 0 (no 
anxiety) to 3 (extreme anxiety) 
Depression Body function 
and structures 
HADS Composite score of 7 items with each question scored from 0 (no 
depression) to 3 (extreme depression) 
Participation Participation PIPP Twenty-three item which assess the impact and distress of five domains 
(mobility, participation, self care, psychological well being and 
relationships)  
Quality of life No corresponding 
factor 
OAQoL Composite score of 22 questions, each with a “true” or “not true” 
response 
 
Table 3.3  Summary of constructs and measures considered in the modelling of the quality of life data. 
84 
3 Methodologies 
based on our findings reported in Chapter 4, the number and location of joints 
involved was also captured. As it was not possible to include all joint combinations, 
the six most prevalent joint combinations (derived from Chapter 4) were included in 
the analysis.  This included the following joint combinations:  knee and foot; knee and 
back; knee and hands; knee, foot and hands; knee and hips; and knee and shoulder.  
As this was a postal questionnaire, all measures were self reported.   
 
i.  Function: 
Two measures were included that measure function:  WOMAC for lower limb function 
and the Cochin Hand Function Scale for upper limb function.  As described in Chapter 
2, the WOMAC is a disease specific, self administered questionnaire which was 
developed for patients with hip and knee OA123, 124.  While three domains are included 
in the scale (pain, physical ability and stiffness), only the physical ability scale was 
used for the SEM.   
 
 
ii.  Pain 
For modelling purposes, a 100mm visual analogue pain scale (VAS) was used to 
represent pain.   The rationale for using this rather than the pain subscale of the  
WOMAC was twofold:  first the WOMAC subscale relates only to lower limb OA; and 
secondly, with items such as “how much pain do you have going up and down stairs”, 
the WOMAC pain subscale is influenced by function.   
 
iii.  Anxiety and Depression 
In order to establish indicators of anxiety and distress, the Hospital Anxiety and 
Depression Scale (HADS) was included.  HADS is a widely used measure of 
psychological distress.  It was developed to be used in clinical populations, specifically 
with people with physical symptoms of disease.  It has been widely used in 
musculoskeletal conditions278, 279.  HADS consists of 14 items, each answered on a 
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four point rating scale (0 to 3, with 3 representing higher distress or anxiety).  It has 
been established in the literature that the scale demonstrates two domains (anxiety 
and depression)280 281.  It has seven anxiety items and seven depression items and it 
is scored by summing the value of each item. 
 
iv.  PIPP 
While participation has been identified as essential in the ICF framework for 
classification of disease, there is a dearth of participation based measures.  This has 
been identified specifically as an issue in OA research282.  The Perceived Impact of 
Problem Profile (PIPP) is a recently developed measure which was developed as a 
generic research and clinical measurement tool to assess the impact and distress of a 
health problem from the individual’s perspective283.  It contains 23 items which focus 
on five domains:  self care, mobility, participation, relationships and psychological well 
being.  Each item, respondents are asked to rate on a six point scale (0 = none, 6 = 
extreme) “how much impact has your current health problems had on ..” and “how 
much distress has been caused”.    
 
The psychometric properties of the PIPP were previously assessed using Rasch 
analysis in a sample of those with locomotor disorders283. While all subscales 
recorded adequate person separation reliability and no evidence of item bias for sex, 
age, educational level or rural versus urban residence, it had not been tested in an 
osteoarthritis population. 
 
v. OAQoL: 
Quality of life was measured using the 22-item, final version of the OAQoL, which was 
developed as part of this candidature and described in this thesis (Section 3.4 and 
Chapter 6). 
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3.5.5  Strategy for data analysis 
Prior to model testing, all data were explored for descriptive information.  Means, 
standard deviations, assessment for normal distribution and the presence of outliers 
were checked for each variable.  Analysis was undertaken using SPSS (Version 14) 
and AMOS (Version 6).   
 
i.  Input of data into model (Rasch analysis of each instrument) 
All outcome measures (WOMAC, OAQoL, HADS and PIPP) were analysed using the 
Rasch programme in RUMM2020.  Due to the problems associated with anchoring 
items for a VAS284, the pain data was not Rasched.  In order for the data to be 
considered interval, Rasch transformed scores for all Rasch data were imported for all 
analysis. 
 
 
ii.  Outliers and Missing Data 
As data points which are considered to be outliers are problematic in SEM, data for 
each variable were explored and outliers, and extreme outliers (identified though box 
plot review) removed.  Missing data was adjusted for by using a correlation matrix, 
which has the added advantage of providing both standardised and non-standardised 
variables for the analysis276.   
 
Data on continuous scales were explored for normality and appropriate correlation 
statistics (either Spearman’s rho or Pearson’s R) were included in the correlation 
matrix.  Correlations between gender (nominal data) and each of the ordinal variables 
were established using gamma correlations.   Data with correlations above 0.8 were 
noted and relationships between those variables excluded from the final SEM, as 
these indicate redundancy for modelling. 
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iii. Sequential linear regression models 
In order to explore the multivariate relationships between each of the variables, 
hierarchical multiple regression analysis for each of the major outcomes:  pain, 
function, depression, anxiety and quality of life.   This approach was adopted in order 
to explore significant relationship for each of the outcomes and the direction of the 
outcomes which would inform the theoretical model for the SEM.  For each dependent 
variable, blocks were entered into the regression model in the following order:  
demographic factors (age, gender, ethnicity, educational achievement); disease 
activity (included duration of disease, number of joints affected and joint pattern); co-
morbidities (number of co-morbidities); physical factors (pain and function); 
psychosocial factors.  The sequence and make up of the last two blocks were varied, 
depending on what factors was included as the dependent variable.  The order of the 
blocks was changed in order to improve the overall regression model and explore the 
strength of the relationships between the independent variables on the dependent 
variable. 
 
Co-linearity diagnostics were performed on each analysis.  Models were only 
accepted if the Tolerance was greater than 0.10 and the Variance Inflation Factor was 
less than 10.   
 
iv.  SEM 
From the hierarchical regression analysis, an initial structural equation model was 
developed which proposed a model of relationships between the independent 
variables, including demographics, disease activity, co-morbidities, physical factors 
and psychosocial factors.  SEM is an iterative process, where a model is proposed, 
the relationships and directions of the relationship are explored and modifications 
made to improve the model.   
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The assessment of model fit for SEM is based on based on several statistics, as 
outlined in Table 3.4.  The χ2 goodness-of-fit statistic measures the fit between the 
expected model correlation matrix and the actual data.  A significant χ2 indicates that 
there is a difference between the predicted model predicting and the data.  Model and 
data fit is indicated by a non-significant χ2.   The RMSEA (Root mean-square of 
approximation) compares the error in the actual data compared to an ideal model.  
RMSEA should be a significant, or less than 0.05 to indicate that error does not vary 
from an ideal model.  The GFI (Goodness of fit index) is a measure of the amount of 
variance and covariance in the data and the model being tested.  As such, a perfect fit 
would be 1.0, but values above 0.95 indicate adequate fit the model.  Finally, the CFI 
(Comparative Fit Index) compares the χ2 for the predicted model with the χ2 for our 
data.  Once again, a perfect fit would be 1.0, but CFI above 0.95 indicates that the 
model is working.  
 
As SEM modelling is an iterative process, the following steps were undertaken for 
each model: 
1. Model was generated 
2. Output for the notes for the model generated was checked to ensure that the 
model was acceptable 
3. Fit to the model was assessed by the overall fit to the model by examining the 
global fit statistic (χ2) statistics 
4. Relationships between individual variables were explored (both direct and 
indirect effects) 
5. The amount of variance explained by each solution for each of the 
endogenous variables (QoL) was explored (R2 value) 
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6. Fit indices were checked, including RMSEA, SRMR, CFI and the AGFI 
(defined in Table 3.4) 
 
If the model did not fit the criteria, modifications were made by exploring the 
regression weights and variances of each of the variables.  Those regression weights 
or variances that were not significant (ie greater than 0.05) were systematically 
removed, commencing with the estimate that had the highest p value.  Model fit was 
evaluated after each estimate was removed and continued until there were no 
significant estimates remaining.  Once all significant regression weights and variances 
were accounted for, the modification indices were then checked.   As with the 
estimates, the modifications were made on an iterative basis, commencing with those 
relationships with the highest modification index.  Model fit was checked following 
each iteration. 
 
Results of this study are presented in Chapter Seven. 
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 Statistic Abbreviation  Interpretation Fit test /Criteria 
Chi-square (χ2) fit 
statistic 
χ2 Measures the fit between the expected 
model correlation matrix and the actual 
data.   
Non significant χ2 
p.0.05 
 
A
b
s
o
l
u
t
e
 
Root mean-square of 
approximation 
RMSEA Compares the error of approximation in our 
data compared to an ideal model 
  
RMSEA <0.05 
acceptable up to 0.08 
GFI Goodness of fit index  A measure of the amount of variance and 
covariance in the data and the model that 
we are testing.  As such, a perfect fit would 
be 1.0, but anything above 0.95 indicates 
our data fits the model. 
GFI>0.95 
acceptable 0.90 
C
o
m
p
a
r
a
t
i
v
e
 
CFI 
 
Comparative Fit Index Compares the χ2 for the predicted model 
with the χ2 for our data.  Once again, a 
perfect fit would be 1.0, but CFI above 0.95 
indicates fit to the model. 
CFI>0.95 
acceptable 0.90 
 
Table 3.4  Summary table of fit statistics used in Structural Equation Modelling. 
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Chapter Four 
Epidemiology of Joint Pain in the Community 
 
The results of this study have been published in Arthritis & Rheumatism285. 
4.1  Overview 
This chapter presents the results of the epidemiological investigation of joint pathology in 
the Community, the methods of which are described in Section 3.2.  This study is a 
secondary analysis of a large community based survey commissioned to determine the 
prevalence and impact of knee and hip replacement in the community.  Surveys were 
sent to a sample people 55 years and over in the North Yorkshire region who were 
registered with a GP practice.  The results of this initial survey have been published231.  
The aim of the secondary analysis of the survey that forms the first study in this thesis 
was to establish the impact of joint pain across the population, including healthy, well 
individuals, and to explore the consequences of joint pain at individual sites and at 
several sites on day to day activities and to apply these findings to the general 
community. 
 
4.2  Participant Profile 
Completed questionnaires were received from 16,222 people, a response rate of 86%231.   
As per the protocol described in Section 3.2, the data were explored for non-response 
bias.  Those who responded were slightly younger than non-respondents (mean age 66.5 
vs 66.3 years, t=5.0, p=0.01) and women were more likely to respond compared to men 
92 
Chapter 4 Results – Epidemiological Study 
(56.5% vs 43.5%, χ2=46.6, df=1, p=0.01).  Data were therefore weighted by age and 
gender to adjust for non response bias to determine prevalence estimates.  For all 
modelling and inferential statistics, the data were analyzed in its un-weighted form.   All 
prevalence data were expressed per 1,000 members of the population.  
 
4.3  Prevalence Estimates 
Of the respondents, 39.11% of people reported joint pain, swelling or stiffness in their 
joints over the last three months that lasted for more than six weeks or more, with higher 
rates in women (417.55 per 1,000) compared to men (330.34 per 1,000, χ2=148.966, 
df=1, p<0.001) and the older age group (75yrs and over=409.71 per 1,000) compared 
with those 55- to 64 years (362.73; χ2=93.135, df=2, p<0.001).   People with joint 
problems were also more likely to report co-morbidities (χ2=30.635, df=1, p<0.001). 
 
4.3  Multiple Joint Presentation 
Prevalence estimates for joint pain, swelling and/or stiffness per 1,000 population for 
each site are presented in Table 4.1.   The median reported number of joints involved 
was 4 (range= 1 to 8; 25th quartile=2; 75th quartile=8.00).  Only one in eight (12.5%) 
people who had reported joint problems experienced this in a single joint (Table 4.2).  In 
the most commonly affected joint, the knee, only one in 11 reported pain only in the knee.  
The most common joint combinations are presented in Table 4.2. Problems with knees 
and the feet, or the knees and back, or the knees and hands were also regularly reported.  
The ratio of single to multiple joint problems was even greater in the hands, feet, 
shoulders, neck, hips and elbows.   
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Joints Male Female Total 
Neck Total 125.26 (112.83 - 138.49) 171.74 (157.85 - 185.63) 151.54 (138.24 – 168.84) 
Age: 55 to 64 yrs 130.80  (118.18-143.42) 174.57  (160.61 - 188.53) 153.11 (139.76 - 166.46) 
      65 to 75 yrs 130.98(118.35 - 143.61) 173.48  (159.55 - 187.41) 154.24  (140.86 - 167.62) 
        75 year plus 106.14 (94.44 - 117.84) 167.24  (153.48 – 181.00) 146.32 (133.18 - 159.46) 
 
   
Shoulder Total 131.38  (118.74 - 144.02) 182.80  (168.62 - 196.98) 160.45  (146.88 - 174.02) 
Age: 55 to 64 yrs 136.84 (124.01 - 149.67) 159.03  (145.51 - 172.55) 148.15  (134.96 - 161.34) 
       65 to 75 yrs 125.51 (113.07 - 137.95) 179.48  (165.38 - 193.58) 155.05  (141.64 - 168.46) 
       75 year plus 130.61 (117.99 - 143.23) 209.60  (194.77 - 224.43) 182.56  (168.38 - 196.74) 
 
   
Back Total 134.33  (121.59 - 147.07) 183.48  (169.28 - 197.68) 162.12  (148.51 - 175.73) 
Age: 55 to 64 yrs 144.60  (131.52 - 157.68) 177.77  (163.72 - 191.82)   161.50  (147.90 - 175.10) 
        65 to 75 yrs 135.13  (122.36 - 147.90) 182.41  (168.24 - 196.58) 161.00  (147.42 - 174.58) 
       75 year plus 114.30  (102.28 - 126.32) 190.20  (175.83 - 204.57) 164.22  (150.54 - 177.90) 
 
   
Elbow Total 59.51  (50.07 - 68.95) 73.64  (63.42 - 83.86) 67.50  (57.61 - 77.39) 
Age: 55 to 64 yrs 77.67  (67.25 - 88.09) 73.85  (63.62 - 84.08) 75.72  (64.89 - 85.55) 
        65 to 75 yrs 48.52  (39.77 - 57.27) 63.71  (54.03 - 73.39) 56.83  (47.55 - 66.11) 
       75 year plus 43.54  (35.13 - 52.15) 83.24  (72.54 - 93.94) 69.65  (59.64 – 79.66) 
 
   
Hands Total 133.44  (120.73 - 146.15)  233.66 (218.32 – 249.00) 190.09  (175.72 - 204.46) 
Age: 55 to 64 yrs 135.60  (122.81 - 148.39) 214.91  (199.96 - 229.86) 176.02  (162.02 – 200.02) 
65 to 75 yrs 142.26  (129.59 - 155.61) 233.20  (217.87 - 248.53) 192.03  (177.61 - 206.45) 
75 year plus 115.65  (103.58 - 127.72) 252.66  (236.96 - 268.36) 205.76  (191.02 - 220.50) 
 
   
Hip Total 94.43  (83.22 - 105.64) 151.53  (138.23 - 164.83) 126.71  (114.23 - 139.19) 
Age: 55 to 64 yrs 99.34 (87.92 - 110.76) 137.68  (124.82 - 150.54) 118.88  (106.69 - 131.07) 
   65 to 75 yrs 102.08  (90.55 - 113.61) 144.43  (131.35 - 157.51) 125.26  (112.83 - 137.69) 
75 year plus 73.46  (63.25 - 83.67) 172.26  (158.36 - 186.16) 138.44  (125.56 - 151.32) 
 
   
Knee Total 176.64  (162.62 - 190.66) 253.92  (238.20 - 269.64) 220.33  (205.26 - 235.40) 
Age: 55 to 64 yrs 168.77 (154.97 - 182.57) 207.80  (193.01 - 222.59) 188.66  (174.33 - 202.99) 
    65 to 75 yrs 187.40 (173.10 - 173.10) 241.84  (226.34 - 257.34) 217.20  (202.20 – 232.20) 
    75 year plus 174.15 (160.20 - 188.10) 311.51  (294.91 - 328.11) 264.48  (248.57 - 280.39) 
 
   
Feet Total 136.28 (123.47 - 149.09) 221.28  (206.19 - 236.37) 184.33  (170.11 - 198.55) 
Age: 55 to 64 yrs 130.48 (117.87 - 143.09) 186.98  (172.69 - 201.27) 159.28  (145.75 - 172.81) 
     65 to 75 yrs 140.57 (127.62 - 153.52) 207.18  (192.40 - 221.96) 177.02  (162.99 - 191.05) 
    75 year plus 140.17 (127.23 - 153.11) 269.17  (253.18 - 283.16) 225.01  (209.84 - 240.18) 
 
Table 4.1.  Prevalence estimates of joint pain, swelling and/or stiffness over the last 
3 months, lasting for more than 6 weeks, per 1000 for each joint.  Estimates have 
been adjusted for age and gender, with the upper and lower 95%confidence intervals 
presented in italics.
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Specific 
Joint 
Prevalence 
of specific 
joint alone 
problems 
Prevalence 
when the 
specific joint is 
involved 
Ratio of all joint 
problems:specific 
joint problem 
alone 
Most common joint 
combinations with 
specific joint* 
Knee 18.95 
(12.58 - 25.12) 
220.33 
(20.526 – 235.40) 
11.63 : 1 Knee and feet 
Knee and back 
Knee and hands 
Knee and hips 
Hands  7.13 
(2.51 - 11.75) 
190.09 
(175.72 – 204.46) 
26.66 : 1 Hands and knees 
Hands, knees and 
feet 
Feet and hands 
Feet  4.87 
(0.71 - 9.03) 
184.33 
(170.11 – 198.55) 
37.85 : 1 Feet and knees 
Feet, knees and 
hands 
Feet, knees and hips 
Feet and hands 
Back 13.59 
(7.97 - 19.21) 
162.12 
(148.51 – 175.33) 
11.93 : 1 Back and knees 
Back and neck 
Back, knee and feet 
Knee, back, feet and 
hip 
Shoulders 6.74 
(2.19 - 11.29) 
160.45 
(146.88 – 174.02) 
23.81 : 1 Shoulder and neck 
Shoulder and knee 
 
Neck 7.69 
(2.97 - 12.41) 
151.54 
(138.24 – 168.84) 
 
19.71 : 1 Neck and shoulder 
Neck and back 
Neck and knee 
Hips 6.42 
(1.93 - 10.91) 
126.71 
(114.23 – 139.19) 
19.74 : 1 Hips and knees 
Hip, knees and feet 
Hip, back, knee and 
feet 
Elbows 
 
 
1.55 
(-1.65 - 4.75) 
67.50 
(57.60 – 73.39) 
43.55 : 1 Elbow and shoulder 
 
Table 4.2  Prevalence of single joint problems per 1,000.  Estimates have been 
adjusted for age and gender, with the upper and lower 95% confidence intervals 
presented in italics. *Presented in order of most common combinations. 
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4.4  Indicators of Functional Ability 
Logistic Regression modelling for standing and walking is presented in Table 4.3.  Almost 
one third of all respondents reported difficulty waking and standing (32.16%).  When 
adjusted for gender, age and the presence of co-morbidities, people with joint problems 
reported two to three times more difficulty with this task than those without joint problems 
(R2=0.408): those people with hip problems were over three and a half times more likely 
to report difficulty than those without hip problems (OR=3.713, p<0.001); people who 
reported knee problems were three times more likely to report difficulty than those with no 
knee problems (OR=3.0205, p<0.001); and those with foot problems were two and a half 
times more likely to report difficulty than those with no foot problems (OR=2.5907, 
p<0.001).  People who reported back problems were just under two times more likely to 
report difficulty than those with reported joint problem without back pathology 
(OR=1.9374, p<0.001) and those with neck problems were less likely to report difficulty 
with standing and walking compared to those with no neck problems (OR=0.0563, 
p<0.001). 
 
One quarter (25.81%) of the cohort reported difficulties going up and down stairs and this 
was particularly influenced by the joints of the lower limb (Table 4.4).  People with 
individual joint problems reported difficulty (R2=0.344):  those with knee problems were 
three and a half times more likely to report problems than those without knee pathology 
(OR=3.4720, p<0.001); foot problems were just under two and a half times more likely 
than those with no foot pathology (OR=2.3378, p<0.001); and people with hip problems 
just over two and a half times more likely to report difficulty compared to those without hip 
problems (OR=2.5883, p<0.001).  Most of the upper limb problems did not influence 
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95% CI  Site Co-eff 
(β) 
Stan 
Error 
Wald 
χ2 
P OR 
Lower Upper 
Prevalence 
(per 1000) 
 
Constant 0.6172 0.451 - - -  -  
Co morbidities 1.5754 0.1365 133.1728 <0.001 4.8329 3.6983 6.3155 404.39 
Hip 1.3130 0.1773 54.8343 <0.001 3.7173 2.6260 5.2620 126.71 
Knee 1.1054 0.1228 80.9713 <0.001 3.0205 2.3742 3.8427 220.33 
Foot  0.9519 0.1040 83.8412 <0.001 2.5907 2.1131 3.1762 184.33 
Back 0.6614 0.1005 43.2930 <0.001 1.9374 1.5910 2.3593 162.12 
Neck -2.8765 0.4440 41.9726 <0.001 0.0563 0.0236 0.1345 151.54 
Shoulder 0.2533 0.1046 5.8649 0.015 1.2883 1.0495 1.5814 160.45 
Elbow -0.1863 0.1331 1.9594 0.162 0.8301 0.6395 1.0774 67.50 
Hands 0.3199 0.1075 8.8519 0.003 1.3770 1.1154 1.7001 190.09 
Age: 55 to 64 years -1.0022 0.1293 60.0409 <0.001 0.3671 0.2849 0.4730  
Gender (Female) -0.1295 0.1048 1.5276 0.216 0.8785 0.7155 1.0788  
M
a
i
n
 
e
f
f
e
c
t
s
 
 
 
Table 4.3  Logistic regression modelling for standing and walking.  This table presents a summary of the main effects for each of 
the individual joint sites (R2=0.408) . Abbreviations co-eff (β) = the mathematical weighting of each variable in the model; Stan Error = the 
estimated error of the mathematical weighting; OR = odds ratio; 95% CI = the 95% confidence interval for the estimated odds ratio. 
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95% CI  Site Co-eff 
(β) 
Stan. 
Error 
Wald 
χ2 
P OR 
Lower Upper 
Prevalence 
(per 1000) 
 
Constant -0.4661 0.3748       
Co morbidities 1.1792 0.1404 70.5675 <0.001 3.2518 2.4696 4.2816 404.39 
Hip 0.9510 0.1249 57.9796 <0.001 2.5883 2.0263 3.3062 126.71 
Knee 1.2447 0.1079 133.0922 <0.001 3.4720 2.8102 4.2896 220.33 
Foot  0.8745 0.1118 61.2101 <0.001 2.3978 1.9260 2.9851 184.33 
Back 0.3423 0.0972 12.4108 <0.001 1.4082 1.1640 1.7036 162.12 
Neck -1.8567 0.3652 25.8478 <0.001 0.1562 0.0763 0.3195 151.54 
Shoulder 0.1162 0.1025 1.2851 0.2569 1.1232 0.9188 1.3730 160.45 
Elbow 0.1320 0.1231 1.1500 0.2835 1.1411 0.8965 1.4523 67.50 
Hands 0.1794 0.1031 3.0303 0.0817 1.1965 0.9777 1.4643 190.09 
Age: 55 to 64 years -1.0582 0.1223 74.9161 <0.001 0.3471 0.2731 0.4411  
M
a
i
n
 
e
f
f
e
c
t
s
 
Gender (Female) -0.0780 0.1011 0.5958 0.4402 0.9249 0.7587 1.1276  
 
 
Table 4.4  Logistic regression modelling for getting up and down stairs.  This table presents a summary of the main effects for each 
of the individual joint sites (R2=0.344). Abbreviations co-eff (β) = the mathematical weighting of each variable in the model; Stan Error = 
the estimated error of the mathematical weighting; OR = odds ratio; 95% CI = the 95% confidence interval for the estimated odds ratio. 
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95% CI  Site Co-eff 
(β) 
Stan. 
Error 
Wald 
χ2 
P OR 
Lower Upper 
Prevalence 
(per 1000) 
 
Constant -0.4300 0.3677       
Co morbidities 0.8941 0.1392 41.2778 <0.001 2.4451 1.8614 3.2118 404.39 
Hip 1.1417 0.1730 43.5453 <0.001 3.1321 2.2313 4.3964 126.71 
Knee 1.1962 0.1641 53.1378 <0.001 3.3074 2.3978 4.5621 220.33 
Foot  0.6868 0.1003 46.8530 <0.001 1.9873 1.6325 2.4191 184.33 
Back 0.8878 0.1604 30.6214 <0.001 2.4297 1.7742 3.3274 162.12 
Neck -2.0073 0.3666 29.9781 <0.001 0.1344 0.0655 0.2756 151.54 
Shoulder 0.2125 0.1010 4.4282 0.0353 1.2368 1.0147 1.5075 160.45 
Elbow 0.0856 0.1181 0.5250 0.4687 1.0893 0.8642 1.3731 67.50 
Hands 0.2929 0.1007 8.4554 0.0036 1.3402 1.1002 1.6327 190.09 
Age: 55 to 64 years -0.7925 0.1186 44.6663 <0.001 0.4527 0.3588 0.5712  
M
a
i
n
 
e
f
f
e
c
t
s
 
Gender (Female) -0.3355 0.1000 11.2618 0.0008 0.7150 0.5878 0.8697  
 
Table 4.5   Logistic regression modelling for rising from a seated position.  This table presents a summary of the main effects for 
each of the individual joint sites (R2=0.276). Abbreviations co-eff (β) = the mathematical weighting of each variable in the model; Stan 
Error = the estimated error of the mathematical weighting; OR = odds ratio; 95% CI = the 95% confidence interval for the estimated odds 
ratio. 
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the risk of difficulty significantly, with the exception of the neck; those with neck 
problems were six times less likely to report difficulty (OR=0.1562, p<0.001).   
 
For difficulty in rising from a seated position, twenty percent (20.80%) of all 
respondents reported difficulty.  Those with hip problems or knee problems were three 
times more likely to report difficulty (R2=0.276; OR=3.1321, p<0.001; OR=3.3074, 
p<0.001); those with back problems were two and a half times more likely to report 
difficulty (OR=2.4927, p<0.001); foot problems were two times more likely 
(OR=1.9873, p<0.001); those with shoulder problems were 24% more likely to report 
difficulty (OR=1.2368, p=0.0353) and those with hand problems increased their risk by 
34% (OR=1.3402, p<0.001).   People who reported neck problems were less likely to 
report difficulty in rising from a seated position.  Data are presented in Table 4.5. 
 
4.5  Multiple-site problems 
When the most common joint combinations are explained, the penalty for having 
multiple joint involvement becomes clear (Table 4.6).  While those with knee problems 
were three times more likely to report difficulty in walking and standing, this risk 
increased dramatically if they had concomitant foot (OR=14.5048, p<0.001), back 
(OR=10.8478) or hip problems (OR=12.4344).  Those with knee, back, foot and hip 
problems were 60 times more likely to report difficulty.  A similar pattern emerged with 
going up and down stairs:  those people with knee and hand problems were two and a 
half times more likely to report difficulty compared to those without knee and hand 
problems (OR=2.6064) and as did those with combined  knee and shoulder problems 
(OR=2.4468).  Once again, those with knee, back, foot and hip problems increased 
their risk of difficulty by twenty fold (OR=20.6380).  Combined knee and foot and knee  
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Combined odds ratio for functional indicators 
 
Joint Combination Standing and 
walking 
Climbing  
stairs 
Seated 
position 
Knee and foot 
 
14.50 
(9.30 – 22.62) 
5.22 
(3.40 – 8.03) 
4.05 
(2.55 – 7.18) 
Knee and back 
 
10.85 
(7.00 – 16.81) 
3.33 
(2.05 – 4.58) 
1.93 
(1.15 – 8.96) 
Knee and hands 
 
7.71 
(4.91 – 12.11) 
2.61 
(1.72 – 3.94) 
1.73 
(1.72 – 4.85) 
Neck and shoulder 
 
0.13 
(0.05 – 0.39) 
0.11 
(0.04 – 0.28) 
0.11 
(0.04 – 0.27) 
Knee and hips 
 
12.43 
(4.45 – 34.71) 
5.64 
(1.38 – 8.24) 
2.21 
(0.36 – 11.37) 
Knee, hands and foot 
 
19.97 
(10.37 – 38.46) 
2.61 
(1.73 – 11.76) 
1.73 
(0.11 – 11.72) 
Knee and shoulders 
 
7.21 
(4.62 – 11.26) 
2.45 
(1.62 – 3.70) 
1.60 
(1.08 – 2.37) 
Back and neck 
 
0.20 
(0.07 – 0.59) 
0.15 
(0.06 – 0.34) 
0.21 
(0.08 – 0.60) 
Knee and neck 
 
0.32 
(0.10 – 0.96) 
0.34 
(0.13 – 0.86) 
0.17 
(0.10 – 0.82) 
Knee, back and foot 
 
28.10 
(14.80 – 53.38) 
7.97 
(3.95 – 13.69) 
6.45 
(1.73 – 15.76) 
Knee, back, foot and 
hip 
62.41 
(14.97 –260.12) 
20.64 
(2.59 – 14.97) 
16.82 
(3.66 – 86.24) 
Foot and hands 
 
6.61 
(4.37 – 10.01) 
1.80 
(0.79 – 2.05) 
1.73 
(1.17 – 2.57) 
 
 
Table 4.6  Combined odds ratio for most common multiple joint problems for 
each of the functional indicators.  Combined odds ratio are a summative calculation 
taking into account the odds ratio for each joint, plus the odds ratio for the interactions 
between all significant joint combinations.  The upper and lower 95% confidence 
intervals presented in italics. 
 
 
 
 
and hip problems had a five fold increase in reporting difficulty using stairs compared 
to those without such joint pathology (OR=5.2233 and OR=5.6383, respectively). 
 
When the common combinations of joint problems were analyzed for rising from a 
seated position, the likelihood of reporting difficulty for this category were also 
increased.  Those who had knee and foot problems increased their risk to four fold 
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(OR=4.0488) and those who had knee and hip problems increased their risk by over 
two (OR=2.2103).  Of note, for those with knee, hip and hand problems had a 10 fold 
increased risk of reporting difficulty (OR=10.3483).  Those with knee and foot 
(OR=4.0488) increased their risk in reporting difficulty more than if they had either 
knee or foot problems alone. 
 
4.6  Unilateral vs Bilateral joint problems 
To explore the impact of unilateral pain or bilateral pain at each site, logistic 
regression modelling was repeated for each of the joint sites for main effects and 
compared analyzing the log likelihood statistics13.  The predictive capacity of each of 
the functional activities was only increased marginally:  for using stairs the predictive 
capacity increased from R2=0.321 to 0.330; for walking and standing from R2=0.347 to 
0.349; and for rising from a seated position, R2=0.264 to 0.271 for the most influential 
joints, which were the knee, hip and foot.  As expected, bilateral pain increased the 
risk of reporting difficulty with each of the functional tasks compared to unilateral 
problems (Table 4.7): bilateral knee problems increased the difficulty in using stairs by 
three and a half times compared to people with no knee pain, where as those with 
only one knee affected increased their risk by two fold.  In general, there was an 
increased difficulty reported were both joints were affected compared with unilateral 
joint problems, and these figures averaged out to that reported when unilateral and 
bilateral joint problems were considered simply as joint pain. 
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 Going up and 
down stairs 
Odd ratio (95% CI) 
Walking and 
standing 
Odd ratio (95% CI) 
Rising from a seated 
position 
Odd ratio (95% CI) 
Knees 
   
     One Knee 2.014 
(1.924 to 2.097) 
1.975  
(1.897 to 2.057) 
1.387  
(1.332 to 1.445) 
     Both knees 3.628  
(3.493 to 3.767) 
2.644 
 (2.545 to 2.748) 
2.289  
(2.157 to 2.354) 
Hips    
     One hip 1.540  
(1.478 to 1.605) 
2.059  
(1.972 to 2.150) 
1.887  
(1.804 to 1.954) 
     Both hips 2.646  
(2.517 to 2.782) 
3.031  
(2.880 to 3.219) 
3.023  
(2.882 to 3.170) 
Foot and ankle   
     One foot 1.364  
(1.283 to 1.449) 
1.726  
(1.623 to 18.35) 
1.146  
(1.077 to 1.219) 
     Both feet 1.941  
(1.876 to 2.008) 
2.512  
(2.424 to 2.604) 
1.713  
(1.665 to 1.773) 
 
Table 4.7   Logistic regression modelling unilateral and bilateral problems at the 
major joints of the lower limb.  Modelling included joint site, gender, age and co-
morbidities as main effects.  Abbreviations; 95% CI = the upper and lower 95% 
confidence interval for the estimated odds ratio. 
 
 
 
 
 
 
4.7  Discussion of Main Findings 
This aim of this study was to report the prevalence, pattern and impact of multiple joint 
problems in the community.  Almost 40% of people in this community cohort aged 
over 55 years reported some pain, swelling or stiffness lasting for more than 6 weeks 
over the previous three month period.  In addition to the high prevalence, joint 
pathology represented a substantial impact on a person’s ability to undertake common 
functional tasks.   
 
Whilst the prevalence of individual joint problems was similar to that previously 
reported, particularly knee pain87, 197, 286-289, this study demonstrates that multiple 
rather than single joint problems were common (median joint count of 4).  While more 
than 20% of people over the age of 55 had knee problems, fewer than one in 11 of 
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this group reported pain only in their knee.  Other joints were associated with even 
higher ratios of multiple joint involvement, such as in the hip, where only one in 20 
reported hip only pain and the feet, where only one in 38 people reported foot only 
pain.   
 
Specific joint problems contributed to the difficulty which people found in undertaking 
particular upper or lower-limb related tasks.  People with knee problems were more 
likely to report difficulty in tasks associated with locomotion, such as standing and 
going up and downstairs.  Those with hip problems were more likely to experience 
difficulty in rising from a seated position.  Of note, the impact of foot and ankle 
problems, which have been rarely documented in the literature, had an impact similar 
to that reported for knee and back problems.   
 
The presence of bilateral joint problems increased the likelihood of difficulty in using 
stairs, rising from a seated position and standing and walking compared to those with 
only unilateral pathology.  However this was only minor in comparison to joint 
problems that occurred in combination.  For example, knee and foot pathology, 
increased the risk of functional impairment to a much greater degree than if the risk of 
difficulty for each of the individual joint problems were simply added together.  The 
most obvious example of this disproportionate increase in difficulty was the impact of 
a combination of the knee, back, foot and hip, which increased the risk of difficulty in 
climbing stairs 20 fold and walking 60 fold.   
 
The impact of joint problems in the upper limb for locomotor tasks was generally 
insignificant or even appeared to reduce the risk of difficulty in the tasks associated 
with locomotion.  The exception to this which was hands and shoulder involvement, 
which increased the risk of difficulty in both walking/standing and rising from a seated 
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position.  We attempted to investigate functional tasks that we predicted would be 
related to upper limb joint pathology, (such as gripping and holding things) however 
the resulting poor predictive capacity precluded these results being reported. 
 
While the ability to undertake functional tasks is influenced by many factors, it is 
important to note the significant effect of co-morbidities.  These data considered the 
effect of co-morbidities in the logistic modelling and it is important to recognize that 
when considered as a main effect, co-morbidities was the single greatest predictor of 
who would report difficulty in standing/walking and getting up and down stairs.  It was 
second only to the hip as the single main influence on rising from a seated position.  
So while we understand that the presence of co-morbidities in the older population is 
high290, particularly in those with pain291 and joint pathologies89, 292, they must be 
considered as an important factor in the ability to undertake simple functional tasks.    
 
The limitations of this study are acknowledged.  While it has been suggested that self 
reporting can be unreliable293 and overestimates specific joint pathology, the 
prevalence figures reported here are similar to those reported in much more rigorously 
validated data sets reported on hip294 and knee pathology80.  We also recognize that 
other variables that were not considered in the logistic regression modelling may also 
be likely to impact on functional ability.   
 
 
4.8  Conclusion 
There is a high prevalence of joint problems in the older community, which increases 
with age and is more common in women.  Multiple-site involvement of pain is 
extremely common and the impact and interaction of the different sites of pain will 
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substantially influence people’s ability to undertake the tasks of daily living.  Co-
morbidities are high in this group and they also have a considerable influence, often 
above and beyond that of joint problems, in people’s functional impairment. 
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Chapter Five 
Living with Osteoarthritis 
 
5.1  Overview 
This chapter presents the results of the qualitative study.  The purpose of this study 
was to explore the issues associated with living with OA, and their impact on an 
individual’s quality of life. 
 
5.2  Participant Profile 
Forty-five participants were interviewed over a 12 month period, which consisted of 19 
males and 26 females.  One female participant was excluded after the interview as it 
emerged during the interview that she had co-morbidities which were not revealed in 
the screening process.  Of the remaining 44 participants, the median age was 65 
years, with an age range from 19 to 76 years.  Nineteen of the interviewees were 55 
years of age or less.   
 
In order to encompass issues associated with OA at different sites, purposeful 
sampling was undertaken which forced representation across different sites, ages and 
gender.  The majority of those interviewed had knee or hip OA, and fewer reporting 
hand, foot or mixed site OA as their primary source of concern (Table 5.1).  While 
representation was sought for each cell in the sampling matrix, there was no 
representation of males 55 years and under with just hand or just foot OA. 
 
The audio recordings of the interviews, which lasted from between 45 minutes to four 
and a half hours, were transcribed verbatim for data exploration and analysis.  
Following the transcription of each tape, the manuscript was checked by the 
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interviewer for accuracy and clarity and then cross-checked by one of the other 
members of the researcher team involved with the interviews.   
 
 
 
 
 
Male Female Total 
 
< 55 yrs ≥ 55 yrs < 55 yrs ≥ 55 yrs  
Hip 3 
 
2 2 3 10 
Knee 2 6  3 5 
 
16 
Foot 1 
 
1 2 2 6 
Hand 
 1 1 
 
3 
 
5 
Mixed site 
 
 3 1 3 7 
 
Total 
 
6 13 9 16 44 
 
Table 5.1   Sampling matrix and participant numbers for the interviews.  The pre-
interview strategy was to secure representation for each cell of the matrix. 
 
 
 
5.3  Thematic Selection 
As described in Section 3.3.6, an initial coding strategy developed by the research 
team on completion of all interviews.   Following this, the entire set of transcripts was 
reviewed by the candidate in order to get a holistic sense of possible themes and 
codes.   Codes were initially abbreviated phrases, describing concepts or themes, for 
example “embarrassment about appearance”, “positive success with treatment” and 
“inability to do things”.  The codes were then applied to the data to establish potential  
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Affected by weather  
Age vs arthritis  
Comparison to others  
Control of own destiny  
Dependent on others  
Feeling embarrassed  
Feeling of being overwhelmed  
Feeling old  
Feeling slowed down  
Impact on family and friends  
Making a joke of it  
Old in other's eyes  
Others perceptions  
Pacing yourself  
Planning ahead  
Quality of life  
Restrictions of activities 
Shared dependency  
The future  
Trouble with activities 
Pain  
 Pain on activity 
 Pain at night 
Pain relief  
Coping  
 Coping with activities 
 Coping with pain 
 Coping with dependency issues 
Symptoms  
 Pain 
 Stiffness 
 Fatigue 
 Difficulty sleeping 
 Difficulty walking 
 Possible consequences 
 Instability 
 Swelling 
 Flares 
 Fluctuating symptoms 
Impact on feelings  
 Fear 
 Anger 
 Frustration 
 Depression 
 Helplessness 
 Embarrassment 
 Dreading the future 
 Guilt 
 Feeling a nuisance 
 Missing out 
 
 
 
 
 
 Can’t be bothered 
 Opting out 
 Non acceptance 
 Feeling left out 
Support from others  
 Positive support from family and 
friends 
 Negative support from family and 
friends 
 Negative support at work 
 Positive support at work 
Medication and treatment  
 Lack of efficacy 
 Pessimism with treatment 
 Dependency on drugs 
 Positive experiences with 
medications 
 Manipulating the system for better 
treatment 
 Adverse reactions to treatments 
 Walking and other aids 
 Frustration with how treated 
 Weight and arthritis 
 Physiotherapy  
 Vicious cycle with weight 
 Avoiding taking medications 
 Surgery 
 Impact of other people’s 
experience with treatment 
 Problems in diagnosis 
Impact and site of pain  
 Hands 
 Knees  
 Feet 
 Footwear 
 Hip  
 Other sites 
 Multiple-site 
 People ignoring other sites of pain 
Self esteem  
 Perception of self before arthritis 
 Perception of self with arthritis 
 Appearance 
Adapting and innovation  
Working Issues 
 Adapting activities 
 Perceptions of others 
 Limitations to tasks 
 
Table 5.2    Summary of initial codes used for thematic analysis 
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categories.  Cross referencing between phrases that would come under different 
codes was also undertaken at this stage of analysis.  For example the phrase: 
“I am embarrassed when I have to ask my son to come over and 
help me with to do things around the house, little things that were 
never a problem before” 
was coded under “embarrassment”; “loss of independence”; “impact on family” and 
“coping with loss of independence”.  A summary of the raw codes is provided in Table 
5.2. 
 
Following this initial coding, categories were developed which served to organise the 
code into meaningful clusters.  Code and categories were collapsed to evaluate 
emerging themes until the point was reached where no new information was being 
generated.   The codes are presented in Figure 5.1. 
 
5.4  Emergent Themes 
As demonstrated in Figure 5.1, the experiences of living with OA are multi-faceted, 
consisting of complex associations and relationships.  Participants differed in terms of 
how OA impacted on their day to day life and the relative importance of each in terms 
of contributing to their overall quality of life.  The major emergent themes are 
described below. 
 
5.4.1  Impact on self perception 
Several participants reported a substantial shift in their sense of self and their roles 
within their family and close personal friends.  This was distressing for several of the 
participants who felt their role within their intimate support network was being lost. 
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They have all noticed how much my personality has changed because 
of it, they expect me to always be the one whose shoulder gets cried 
on, and now I am trying to cry on other peoples shoulders because I 
am in pain and it doesn’t feel right, and it really does not feel right and 
it upsets me.  
DH, Male with multiple-site OA, 62 years 
 
 
Several participants expressed concern and guilt at how their illness was impacting 
on their family members, through lack of participation or increased dependency.  
This was highlighted with the concerns of a young mother of a two year old: 
I try and take her to playgroup but if I’m not feeling good I can't 
because I can't run after her and obviously it restricts, I feel bad 
because I'm giving the restrictions to her and she's missing out on 
things you know..   
DS, Female with hip OA, 38 years. 
 
The impact on family relationships associated with frustration and anger at the 
condition was also expressed by several participants.  Ill feelings towards family 
members were often associated with a perceived lack of understanding of what it was 
like to live with the condition. 
She blames me and I blame her, I know for a fact that it makes me 
queer at times, same as going shopping or, if you go shopping you 
can guarantee that the way you are walking everybody is walking 
straight towards you, and I cant move out of way, I cant  go 
sideways and they are coming straight at you with pushchairs and 
everything and you are getting madder and madder, and I 
111 
Chapter 5 Results – Qualitative Study 
 
 
 
Experience of disease Personal biography 
Experience and medical treatment 
 Positive treatment experiences  
 Negative treatment experiences 
 Experiences of others 
 Access to treatment 
 Information and education 
 
Coping with OA 
 Personality 
 Self efficacy 
 Needs fulfilment 
 Social network 
Frustration 
 Age vs ageing 
 Activity impairment 
 Participation limitation 
Pessimism 
 The future 
 No treatment options 
 Confusion over course 
of OA 
 Lack of treatment 
efficacy 
 
Guilt 
 Dependency/impact on others 
 Self blame for OA (weight, 
activities, footwear). 
Perceptions of others 
 Appearance 
 Not being taken 
seriously 
 OA in younger 
people a joke 
Self perception 
 Societal and family role 
 Impact on others 
 Self esteem 
 Impact on sense of self 
Figure 5.1  Emergent themes from analysis of the interviews 
Limited time; limited information 
 Access to treatment 
 Information and education 
 Focusing on just one problem 
 
Disease characteristics 
 Site of OA 
 Duration of disease 
 Symptoms 
 Flares 
 
Sociodemographic Characteristics 
 Age  
 Gender 
 Living alone 
 Working 
 Retired 
 Social support 
 
Impact on quality of life 
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think well it is a waste of time, I says I will sit down, you carry on, so I 
don’t know I don’t what is up with her really, whether she is getting 
queer and all, and whether it is with her or what, I don’t know, you are 
angry and you are miserable.   
AM, Male with multiple-site OA, 65 years. 
 
 
Several interviewees talked about opting out of life and feeling excluded with their 
arthritis.  One participant expressed their concern particularly succinctly:  
Life goes on whether you’re there or not. But when you’re there you 
want to be an active part of life, which is rather difficult because 
arthritis is slowing me down and it makes me feel like that; you’re 
on outside, looking in. 
DH, Male with knee, hands and shoulder OA, Age 55. 
 
 
Two different concerns were raised about the impact of OA on appearance:  unsightly 
or ugly joints and the additional weight gain related to inability to exercise both of 
which had an impact on their self esteem.    Of note, those with hand OA spoke of the 
embarrassment of the change in appearance of their fingers, particularly in social 
situations where attention was drawn to their hands, such as shaking hands and 
handing over money. 
 
Participants commonly expressed an embarrassment about their arthritis.  This 
embarrassment stemmed not only from the physical disfigurement, which was mostly 
associated with the hands, but also from physical ability.  One woman in particular 
highlighted the feelings that she had when being confronted with her limitations with 
using stairs:   
113 
Chapter 5 Results – Qualitative Study 
When you have to walk very slowly because striding out doesn’t help 
- you know it's not an option and you're on a slope going down and 
it’s hurting, so you're going really slowly and carefully and you're on 
stairs and you're going down one at a time.  I just feel, I mean, you 
know in reality, it doesn’t happen - people are rushing with their own 
agenda, they're off to catch their bus, they’re going past and this that 
and the other, but I feel as if people are looking at you - you are 
blocking up a pathway.  You're blocking the stairs.  You're doing 
things like that and you feel there is a huge embarrassment factor. 
PA, Female with knee OA, Age 55. 
 
 
5.4.2  Perceptions of others 
Frustration was expressed by participants that other people did not take their arthritis 
seriously.  There were several issues which emerged through the transcripts: firstly, 
arthritis is commonly perceived simply as a disease of ageing;   secondly, participants 
were embarrassed at their physical appearance; thirdly there was a perception that 
OA was thought of as a joke; and finally, seven of the participants expressed 
concerns that the perception of others was that somehow they were guilty and 
contributed to their condition. 
 
Issues associated with ageing and OA as part of the ageing process were commonly 
expressed.  However, several of the participants expressed concern that they were 
perceived to be “whingers” and were making more out of their condition, when it was 
just part of the aches and pains of getting older and that “everyone” has arthritis.   
I think sometimes people think “Oh you know arthritis is nothing”.  I 
think you can tell when they say to you “are you alright, are you in pain” 
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and when you go “it’s arthritis” end of story.  They asked you and that’s 
it and it’s nowt, there’s nowt wrong with you.  I find it, not everybody, a 
lot of people do understand, but you get people that don’t realise just 
how much pain you’re in.  Yeh.   
JG, Female with mixed site OA, Age 75. 
 
 
Participants reported that others engaged in treating their arthritis as a joke.  This was 
particularly evident in younger people.  They felt that as OA is seen as a disease of 
the elderly, their symptoms were considered funny to others, including their family and 
friends.  This was major concern for both of the younger women who had foot OA and 
one, who was a competitive sportsperson, expressed concerns that she did not have 
a “respectable” condition that stopped her participation in her sport: 
the fact that it's my toe I  just try and make it like a little joke that it's 
and old persons thing and that’s my way of sort of dealing with it…..  I 
remember when I was [participating in sport] people used to think it 
was really funny, not in a horrible way but that I had to strap up my 
bunion and everybody else had more respectful injuries like wrist pain 
or something.   
HL, Female with foot OA, Age 22. 
 
The final area of frustration with people’s conception is an issue associated with guilt, 
that those with OA had consciously done something to cause their disease.  Once 
again, both young female foot OA participants were angry that they had to continually 
explain that it was not poor footwear choices that lead to their OA: 
I get really awful when I think that people think that its my fault, it must 
be my fault, all older people, saying “oh you’ll get problems with your 
feet if you wear them shoes…..I feel a bit annoyed actually when 
115 
Chapter 5 Results – Qualitative Study 
people try and challenge me on it and they say no it's not it's because 
of shoes and I say well no it's not it's because of my genes and the 
length of my tendon or something like that and they say no it's not it's 
because you’ve worn bad shoes and I say I've never worn bad shoes 
you know yes it gets a little bit annoying when they try and blame me 
for it.  
HL, Female with foot OA, Age 22. 
 
The reaction of feeling guilty as having been responsible for their symptoms was 
similarly expressed by several of the participants who were overweight. 
I feel guilty because I've let myself get like this, but yet there's 
been other problems there that’s contributed to it, you know, 
because I can't say, I mean, I suppose a lot of the people will say 
this, but they don’t think they eat a great deal.  And I don’t think I 
do.   I mean I'm not piggish, you know, 10 bacon butties and chips 
and whatever, I don’t eat, I can't afford to eat anything like that.  I 
just don't do it.  Oh, I think probably it’s part genes, as well 
because both my parents were large, so I've probably inherited 
from them.  So you know, it’s just part and parcel of my make up, 
but I feel guilty for being like this, you know, and have I caused the 
trouble myself. 
JCB, Female with knee OA, Age 53. 
 
5.4.3 Coping 
During the interviews, it became apparent that there were varied and individual 
approaches to coping with OA.  Strategies for dealing with the impact of OA ranged 
from behavioural modification …. 
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I am more careful now when it comes to decorating and things like 
that I am more careful and would do it in stages rather than go at it 
hammer and thongs and get it all done because I know I'm going to 
suffer if I do it all too quickly. 
PD, Female with Knee OA, Age 60. 
 
..to cognitive strategies 
Everybody reacts differently I expect but if you let it get down it will 
do won’t it so if you think positive and act positive I think you are half 
way there to being ok. 
JJ, Female with hand OA, Age 54. 
 
 
Several participants indicated that their ability to cope in the future would be 
determined by their ability to meet their societal and/or family roles.   
As long as you can get out and about really. If I’d come to a full stop 
where I can’t get out which is annoying, I wouldn’t like that at all, to be 
house bound. That wouldn’t go down well at all. As long as I can get 
about and do things, I’ll be satisfied 
DL, Male with knee OA, Age 75. 
 
 
5.4.4  Pessimism 
A common theme expressed by participants in their interviews was that of pessimism.  
Several individuals related poor experience with how long it took to be diagnosed and 
what treatment options were presented to them.  Many expressed concern, 
particularly about taking medications and the potential problems associated with side-
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effects.  They often felt as though they had been abandoned and left to cope with their 
condition as best they could. 
What else can be done for me, and things like that, because I just feel 
as though I've been abandoned actually.  But I know there's nothing 
else anybody can do for me, but I feel as though I've been abandoned 
and left to get on with it.   
JCB, Female with knee OA, Age 53. 
 
The issue as to what the future held was associated with grave concerns for the 
majority of the participants – how the disease was going to progress, whether they 
could manage pain and physical limitations.  This was a particular concern if their 
current societal and family roles were likely to be compromised.   
I want to think that I finish work in five years time, I'm one of the 
people that can retire at sixty, and I want to feel that that’s not the end 
of everything but if in five years time this has progressed and I'm left 
not coping, you know. I'm going to be old because I can't go 
somewhere and I can't do something I can't go trotting off and join in 
the sixty year old swimming and this sort of thing and there's a sense 
that physically my life will be older, you know. I don’t expect my brain 
to be older, I just you know it has a restrictive value it's something 
that you know. You see people retiring and you think well yes they're 
off in their walking holidays in the Lake District or whatever. They’re 
doing and I can't do it. 
PA, Female with knee OA, Age 55. 
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5.4.5  Limited time; limited information 
In describing concerns with their treatment of OA, several participants expressed 
concern that treatment strategies were not tailored to individual needs.  This was 
particularly, but not exclusively, an issue with younger people with OA.   
 
I do think that people need a bit more information with arthritis, I think they 
seem to think you are in a category, you are in a box and the same, 
everybody is the same, I did find that, I mean talking to doctors, er when 
doctor ** orthopaedic, his young man referred me, he put me as non-urgent 
because they thought I could cope, nobody actually did ask if I would be able 
to cope because I was working and I was doing and they thought you would 
cope and they tend to put you in boxes and I did find that. 
JA, Female with knee OA, Age 64. 
 
 
Furthermore, concern was expressed concerning the stress associated with a 
considerable information exchange between patient and doctor.  One participant, with 
knee and foot OA was particularly vocal that her foot complaint was not addressed in 
her consultation with her hospital specialist. 
And if I don’t know to say something to **** or ****, you know, if I don't 
mention something, it's taken me how long an hour and a half to 
rabbit all these bits out - and if I don’t say the right thing in the twenty 
minutes I've got, then something is not missed because it doesn’t - it 
crops up in the end doesn’t it?  But you know it's not the whole 
picture isn’t there. 
PA, Female with knee, foot and hand arthritis, Age 55 
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5.5  Discussion main findings 
The experience of living with a chronic illness represents a considerable challenge to 
an individual.  This study has identified several themes linked to the impact of living 
with OA:  impact on societal/family roles and the consequential change in self 
perception; the misconceptions that others have of OA, particularly that the disease is 
solely related to ageing and that it is self inflicted; coping is an individual experience 
and is related to complex personality, cognitive and behavioural drivers; and finally 
there is a distinct sense of pessimism in the lack of treatment strategies, lack of 
information and limited consultation time, which is a particular issue for people who 
have complex needs. 
 
Loss of the ability to live as one would like results in a life that is vulnerable and 
results in a constant influence on family members and significant others295.  It has long 
been recognised that chronic illness has an impact on self perception, which is 
facilitated and compounded by pain, functional limitation and loss of societal roles.  
According to Bury296, people with chronic illness suffer from a “biographical 
disagreement”, a term which refers to a disagreement with in the perception of the 
individual as to what type of life they see themselves leading with a chronic illness 
compared to what type of life they think they should have.  This phenomena results in 
distress and anxiety, unless the person can adapt this altered life of living with a 
chronic illness.  This adaptation is what was referred to in Chapter 2 as a response 
shift199.  Several strategies have been identified to reduce associated anxiety and 
distress associated with this response shift, including activity adjustment, skill 
enhancement, goal adjustment and a “humanistic” approach which is centred around 
positive adaptation to altered health184.   
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Our participants certainly reflected the idea of a challenged self worth with OA.  It was 
clear that OA substantially influences the sense of self esteem, which is often 
reflected through others perceptions of their condition.   The interrelationship between 
sense of self and self worth based on other perceptions has previously been identified 
in people with OA297.  In this study, Swift and colleagues reported that feelings of self-
worth were being undermined by the attitudes of friends and strangers and that 
symptoms were perceived by others as being exaggerated.  This may indeed be 
related to the perception that OA is an expression of the ageing process and those 
who report symptoms are seen to be simply not coping with this process. 
 
Living with a chronic illness is often stressful and traumatic with social isolation, 
depression, restricted participation and a sense of dependence often reported298.  
Frustration has also been expressed that in individuals with chronic illness, the focus 
from those they seek medical advice and treatment from is directed towards functional 
ability, which does not adequately account for the experience of chronic illness299. 
 
The pessimism expressed by people with OA was evident on several levels.  The 
importance of the loss of power felt by people with a chronic illness with an uncertain 
progression has been recognised298.  However, if this is being continually undermined 
by referral to others’ perception, particularly that their OA is simply part of the ageing 
process and one which everyone else as to deal, the ability to cope with the impact of 
a disease is further diminished.   
 
Being overweight highlighted several issues in those interviewed.  Participants felt 
they were being blamed for their symptoms and were not given the same support and 
concern as others with OA.  They often felt caught in a cycle of being overweight, 
unable to exercise with their OA pain, which increased their weight even further.  
Furthermore, this guilt may have been compounded in the interview process as just 
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prior to this study commencing, several Trusts in the UK refused to provide NHS 
surgery to those who do not loose an adequate amount of weight prior to their pre-
surgical assessment. The link between obesity and psychological factors has been 
firmly established, with high incidence of depression, negative body image and lower 
self esteem reported300, which may exacerbate such symptoms in conjunction with 
OA. 
 
Pessimism was also related to the perceived lack of treatment options, with particular 
concerns raised over medication and surgery, which has previously been reported in 
the literature45-47.  This may have been heightened by the high profile withdrawal of 
several drugs commonly used to treat OA during the interview period. While several of 
those interviewed had very positive experiences with drug therapy, medication was 
often seen as dangerous and potentially addictive, and patients would often prefer to 
put up with pain, rather than expose themselves to the risks associated with taking 
medication.  The timing of this study may have contributed to a higher level of 
cautiousness:  there was a high profile withdrawal of several drugs commonly used to 
treat OA during the period of this study.   The widely publicised debate as to the 
adverse events of the drugs had the effect of undermining further the perception that 
drugs, if they were effective, were associated with a substantial risk-benefit 
consideration.   
 
Issues associated with benefits, expectations and side effects in medications taken for 
OA have been explored in the literature.  While variability of response and side effects 
to NSAIDs and COXII inhibitors have been well documented, patients with OA are 
less likely to accept side effects of anti-inflammatories and less willing to take risks 
compared with those with rheumatoid arthritis301.  While this may be associated with 
lesser symptoms in osteoarthritis compared to rheumatoid arthritis, it may also reflect 
that people consider OA not to be a “serious enough” disease to warrant potential side 
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effects.  Furthermore, the perceived risks for medication in OA are often not 
necessarily reflected by the true risk.   There has been a reluctance in patients with 
symptomatic OA to take pain killers45, due in part, to concerns over the side effects, 
particularly addiction.  Interestingly, this concern was not reflected in taking anti-
inflammatories45, where the risks are potentially greater.  This may indicate a need for 
greater patient education of potential medication’s benefits and risks. 
 
The issue of perceived guilt for individuals contributing towards their disease was 
particularly evident.  Younger females with foot pain were frustrated that they 
contributed towards their arthritis in choosing inappropriate footwear, which was 
inconsistent with the experiences of their friends and relatives who chose 
inappropriate shoes, often for many years, without any negative consequence.  The 
frustration at footwear was further compounded by the feeling of unfairness in that 
they wore “sensible” footwear and very much grieved that as young women, they 
could not be as fashionable as their peers.   
 
The feeling of abandonment by the system also highlights several issues.  If an 
individual feels that there are no treatment options that would assist, their ability to 
cope becomes compromised.  While patients and health professionals alike are often 
frustrated by the lack of development in new therapies for OA, it is often 
pharmacological treatments that are highlighted.  However, recent literature had 
demonstrated the positive benefits of physical therapy programs302, 303 in symptomatic 
treatment of OA.  Furthermore, while patients feel they get benefit from educational 
programs and should receive a high priority in future research304, almost half of knee 
OA patients have not received any such assistance.   
 
This study has several limitations, which are consistent with qualitative research 
methodology242, 248, 305, 306.  Firstly, the sample size of 44 participants, although 
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consistent with qualitative methods, limits the generalisability of the findings.  While 
gender, age and OA at different locations were purposefully selected, other factors, 
such as duration or aetiological factors were not included.  Secondly, differences in 
social support and quality of life were evident, but not well explicated.  Thirdly, as the 
interviewees were recruited from the greater Leeds area, there may be unrecognised 
problems in accessing appropriate treatment, which may have influenced feelings of 
pessimism associated with treatment options.  Finally, issues associated depression 
and anxiety, while identified in this study, were not fully explored. 
 
5.6  Conclusion 
OA is a chronic and debilitating condition, the impact of which is considerable.  Those 
with OA often feel that their condition is misunderstood as an expected part of the 
ageing process, which can undermine their self esteem and ability to cope.  Younger 
people with OA are particularly vulnerable to such misunderstanding.  Finally, patients 
are often pessimistic about their treatment options and what the future hold and feel 
that there are abandoned by the system. 
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Chapter Six  
Development and validation of the OAQoL 
 
The results of this study have been accepted for publication in Arthritis & 
Rheumatism307. 
 
6.1 Overview 
This chapter describes the development and validation of a quality of life instrument 
specific for OA, the OAQoL.  As described in Section 3.4, the development of the 
measure was conducted in four phases: in-depth interviews; cognitive debriefing; 
initial psychometric testing and test-retest assessment (See Figure 3.2).  The results 
and consequential modification of the OAQoL are described below.   
 
Participant characteristics for each phase of the study are presented in Table 6.1 and 
described in detail in each of the associated sections.   
 
6.2 Qualitative Interviews  
 
i.  Participants 
As reported in Chapter 5, forty-five participants were interviewed with different site 
and location of pain.  One participant was not included in the generation of items for 
the draft OAQoL as one was found to have co-morbidities not identified on screening.  
Participant characteristics are presented in Table 6.1.    Interviews lasted from 
between 45 minutes to four and a half hours.  The results of the qualitative study are 
presented in Chapter 5.
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  Phase 1  
Qualitative 
interviews 
Phase 2 
Cognitive 
debriefing 
Phase 3  
Psychometric 
testing 
Phase 4 
Test-retest 
N 
 44 
 
17 259 60 
Gender 
 
Male N (%) 
Female N (%) 
Missing N (%) 
 
19 (43.2) 
25 (56.8) 
0 
3  (17.6) 
14 (82.4) 
0 
72  (27.8) 
178 (68.7) 
9   (3.5) 
27 (45.0) 
33 (55.0) 
0 
Age  Mean Age (SD) 
Median Age (IQR) 
Range 
58.7 (15.0) 
64 (53 to 69) 
19 to 76 
 
69.2 (10.8) 
72 (62 to 77.5) 
46 to 81 
66.5 (12.5) 
68 (59 to 76) 
21 to 98 
66.5 (12.0) 
67 (58 to 67) 
20 to 84  
Site of OA Hip N (%) 
Knee N (%) 
Foot N (%) 
Hand N (%) 
Multiple-sites N(%) 
Median joint pain (n) 
11 (25.0) 
15 (34.1) 
5  (11.4) 
5  (11.4) 
8  (18.2) 
NA 
2   (11.8) 
10 (58.8) 
3  (17.7) 
4  (23.6) 
6  (35.4) 
      NA 
62   (23.9) 
104 (40.2) 
74   (28.6) 
104 (40.2) 
221 (85.3) 
      4 
 
24 (40.0) 
51 (84.0)  
14 (23.3 ) 
21(35.0)  
50 (83.3) 
     4 
 
Education 
Level 
No formal qualifications N (%) 
GSCE, O-Level, A-Level or 
Trade N (%) 
Diploma, degree or higher 
degree N (%) 
Missing N (%) 
NA 
 
NA 
 
NA 
5 (29.4) 
 
6 (35.3) 
 
5 (29.4) 
1 (5.9) 
109 (42.2) 
 
72   (27.7) 
 
63   (24.2) 
15    (5.8) 
30 (50.0) 
 
16 (26.7) 
 
12 (20.0) 
2    (3.3) 
 
Table 6.1.  Participant characteristics for each phase of the development of the OAQoL 
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ii.  Item Selection 
In order to develop the draft OAQoL questionnaire, direct quotations from the 
interviews of each participant were identified as possible items, as described in 
Section 3.4.1.  Duplicate items were also identified and through consensus and the 
item that appeared best to express the concept conveyed (while meeting the 
aforementioned criteria) was selected. The draft OAQoL (version 1) was developed in 
this way and consisted of 38 items with a ‘true’/’not true’ response option.  Participants 
were asked to choose the response that best applied to them at the moment. 
   
 
6.3  Cognitive debriefing 
Field test interviews were conducted with 17 individuals who completed the draft 
OAQoL (Version 1, Appendix Two) under the supervision of an interviewer. The 
measure took between 2 and nine minutes to complete (mean 4.4, SD 2.2 minutes).  
The cohort represented a range of educational experience, with just under 30% 
reporting no formal qualifications (Table 6.1). 
 
Clarity and Relevance 
The seventeen participants reported that the draft questionnaire was clear and easy to 
complete. Only one participant had difficulty in interpreting how to answer the 
questionnaire and sought clarification from the researcher.  Of the seventeen 
participants, four did not read the instructions yet completed the questionnaire 
correctly.  The remainder of the participants read the instructions, with two 
respondents referring back to them as they completed the questionnaire.  There were 
no questions reported by the participants as being too difficult and in general, the 
participants reported that the items were easy to understand and relevant to someone 
with OA, even if they did not apply to them as individuals. 
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Response Scales 
Most participants had no difficulties using the dichotomous response format. One 
participant who misunderstood the instructions completed the questions incorrectly by 
assuming that questions were grouped in threes and only one of the three questions 
had to be answered.  This was likely to be related to an unequal spacing between the 
questions.  Two participants said they would have preferred more response options 
for some of the items, but they were still able to answer, even given the response 
options available.  
 
Problematic Items 
Three items were identified as being potentially problematic by the research team 
prior to the debriefing interviews:  “I get embarrassed using stairs”, “I can't do things 
spur of the moment” and “I worry about being a nuisance to others”.  Respondents 
were asked their interpretation of the meaning of the question.   
 
Two items were changed on the basis of respondents’ comments.  “I get embarrassed 
using stairs” was changed to “I get embarrassed using stairs in public” as interviewees 
stated that people would be unlikely to become embarrassed using stairs when not 
observed.  “I can't do things spur of the moment” was considered to be confusing and 
was changed to “I can’t do things on the spur of the moment.”  One member of the 
research team was concerned that the term “nuisance” may have a predatory 
interpretation.  None of the respondents thought this to be so.  With these changes, 
the questionnaire was reformatted so the spaces between questions were identical. 
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6.4  Scaling Properties and Construct Validity 
Of 635 questionnaires sent out, 397 were returned, a response rate of 62.5%.  Of 
these, 259 completed the questionnaire and were classified as responders, while 138 
replied that they would not like to participate and were classified as non-participators.  
There were no significant differences in age or gender between responders and non-
responders, nor responders and non-participators.  The majority of the respondents 
were females (68.7% female), had a mean age of 66.5 years (range: 21 to 98, 
SD=12.5yrs) and mean symptom duration of 12.6 years (range: 0.5 to 45 years; 
SD=9.1yrs).  While the knee was the most common site of pain (40.2%), this was 
followed closely by the hand (39.8%), the foot (28.6%) and hip (23.9%), which was 
similar to that found in the epidemiology of joint pain in the community (Chapter 4).  
Multiple joint involvement was common, with the median number of joints affected 
being 4 (range 1 to 20), which was identical to the epidemiological study.  Almost one 
quarter of the sample was in paid employment and there was a wide range of 
educational achievement (Table 6.1). 
 
The strategy for Rasch Analysis and item reduction a summarised in Section 3.4.3 
and the outcomes of the iterations in the analysis are presented in Table 6.2.   Rasch 
analysis of the draft questionnaire (n=259) indicated initial misfit to the model (χ2[114] 
=250.036; p<0.0001) with the item fit residual mean =-0.363 and Person separation 
index (PSI) = 0.96032.  In the first instance, four individuals were removed as they 
had fit residuals of over 0.25.  Once these were removed, the fit to the Rasch model 
was still poor (χ2=261.264; df=114; p<0.0001), with the item fit residual mean =-0.314 
and standard deviation of 11.835 and the PSI = 0.96142.  Eleven items demonstrated 
high fit residuals, indicating that they were contributing to the poor fit.  These are 
presented in Table 6.3.  Once these items were removed, the overall fit to the Rasch  
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Item Fit Residuals  
 
Model 
 
 
Modification 
 
χ2 
 
 
df 
 
 
p 
Ideal >0.05 
 
 
PSI 
> 0.8 
 
Mean 
Ideal 0.0 
Standard 
Deviation 
Ideal 1.0 
1 Original analysis 250.036 114 p<0.0001 0.96032 -0.036 1.184 
2 Remove 4 individuals with a fit residual >0.25 261.264 114 p<0.0001 0.96142 -0.314 1.184 
3 Removal of item 32 for high fit residual 257.132 111 p<0.0001 0.96268 -0.326 1.794 
4 Removal of item 3 for high fit residual 249.002 108 p<0.0001 0.96232 -.0357 1.695 
5 Removal of item 31 for high fit residual 229.667 105 p<0.0001 0.96428 -0.376 1.530 
6 Removal of item 28 for high fit residual 172.813 102 p<0.0001 0.96609 -0.412 1.236 
7 Removal of item 17 for high fit residual 162.061 99 p<0.0001 0.96723 -0.392 1.245 
8 Removal of item 25 for high fit residual 157.715 96 p<0.0001 0.9678 -0.419 1.105 
9 Removal of item 23 for high fit residual 149.568 93 p<0.0001 0.9666 -0.431 1.068 
10 Removal of item 16 for high fit residual 132.580 90 p=0.0024 0.96717 0.492 0.804 
11 Removal of item 26 for high fit residual 109.488 87 p=0.0531 0.96608 -0.465 0.803 
12 Removal of item 5 for high fit residual 105.771 87 p=0.0835 0.96712 -0.453 0.730 
13 Removal of item 38 for high fit residual 89.513 81 p=0.2422 0.96516 -0.431 0.690 
14 Item 34 removed for DIF for site, gender and age  102.420 81 p=0.0542 0.96562 -0.490 0.688 
15 Item 36 removed for DIF for gender and age 83.602 75 p=0.2322 0.96334 -0.480 0.680 
 
Table 6.2  Summary table of Iterative analysis for initial OAQoL data 
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Item 
No Item 
 
Reason for removal 
3 It is always on my mind 
 
High fit residual 
5 Travelling distances is a problem       
 
High χ2 value 
16 I dread the future 
 
High fit residual 
17 I take it out on people close to me 
 
High fit residual 
23 I am embarrassed about the way I walk 
 
High fit residual 
25 I feel older than my years 
 
High fit residual 
26 It puts a strain on my personal 
relationships 
High χ2 value 
28 I find it difficult to sit through a film or tv 
programme 
High fit residual 
31 I feel the arthritis is affecting my 
appearance 
High fit residual 
32 I never get a good night’s sleep 
 
High fit residual 
34 I feel like a burden to other people DIF for co-morbidities, gender, 
age and location of OA 
36 Pain controls my life 
 
DIF for age and location of OA 
38 I feel lonely 
 
High χ2 value 
 
Table 6.3  Summary of Items Removed following initial Rasch Analysis 
 
 
 
Model was good (χ2[81] =89.513; p=0.2422).  A summary of the three worst fitting 
items and best fitting items is presented in Table 6.4.  Two items demonstrated 
differential item functioning (DIF) by age: “I feel like a burden to others” and “pain 
controls my life”; and the item “I feel like a burden to others” also demonstrated DIF 
for gender “I feel like a burden to others”.  Once these items were removed (13 items 
in total), the data still demonstrated good fit to the model (χ2[75]=83.602, p=0.232), 
with the item fit residual mean =-0.480, standard deviation of 0.680 and a PSI = 
0.96334, resulting in a 25 item version of the OAQoL (Version 3). There was no 
significant DIF by co-morbidity.   
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Item 
 
Location 
 
SE 
Fit 
Res 
χ2  DF P  
value 
I find it difficult to sit through 
a film or TV programme 
0.041 0.168 4.665 37.157 3 <0.001 
I feel the arthritis is affecting 
my appearance 
0.209 0.169 4.369 22.855 3 0.0004 
I take it out on people close 
to me 
1.411 0.188 0.968 15.119 3 0.0018 
I feel slowed down -3.457 0.247 -0.591 0.988 3 0.8040 
Walking for pleasure is out 
of the question 
-1.921 0.189 -0.448 0.839 3 0.8401 
I get embarrassed using 
stairs in public 
0.569 0.173 -0.282 0.542 3 0.9096 
 
Table 6.4  Summary of worst fitting and best fitting items.   Location refers to the 
location of the item along the metric ruler, SE (the standard error of the measure) and 
Fit Res (the Fit Residuals or how well each item relates to the overall model).  A 
significant χ2 indicates that an item does not fit the model. 
 
 
 
Distribution of the items indicated the range of difficulty covered by the items was 
comprehensive.  The unidimensionality of the instrument was confimed by testing of 
local dependency of items, which indicated that only 3.02% of the independent t-tests 
(95%CI = -2 to 5%) were found to be outside the range.   
 
The external validity of the OAQoL was assessed by investigating the relations with 
other measures commonly used in OA.  The 25-item version of the OAQoL (version 3) 
demonstrated significant moderate correlation with the pain and stiffness domains of 
the WOMAC (ρ=0.67 and ρ=0.71, p<0.001 respectively) and good correlation with the 
WOMAC disability domain (ρ=0.80).  There was a good correlation between the 
OAQoL and the General Well-Being Index (ρ=-0.68) and a moderate correlation with 
the Cochin Scale (ρ=0.49).  
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6.5 Test- retest reliability 
In phase 4, 125 of the 201 questionnaires were returned, a response rate of 62.3%, 
including 49 non-participators. Of the people who agreed to participate, 62 completed 
the questionnaire on two occasions. Two respondents had to be discounted, due to 
changes in their treatment and symptoms during the test-retest period.  The profile of 
this group was similar to Phase 3 (Table 6.1) with the exception that more reported 
knee OA in the test re-test participants.   Once again, there were no differences in age 
or gender between responders and non-responders.   
 
Rasch analysis of the test re-test data indicated that, while the data met model 
expectations at the summary level (χ2[44] =47.254, p=0.584, with the item fit residual 
mean =-0.279, standard deviation of 1.014 and a PSI = 0.95593), there was a high fit 
residual for one item (“I worry I let people down”), DIF associated with gender for the 
item “I worry I hold people back” and for site of OA for the item “It takes me longer to 
complete household tasks”.  These items were removed, leaving a 22 item OAQoL 
(Final Version, Appendix Three) that demonstrated good fit to the Rasch model 
(χ2[44] =44.559, p=0.533), with the item fit residual mean =-0.228, standard deviation 
of 1.022 and a PSI = 0.94992.   Two items demonstrated borderline DIF for co-
morbidities (“walking for pleasure is out of the question” and “I feel slowed down”) 
however these were not significant.  One item (“I can’t go places I want to go”) 
demonstrated borderline DIF for site of OA, but this item was retained in the final 
questionnaire.  The summary of the iterative process is presented in Table 6.5 and the 
location and details of the final items are presented in Table 6.6.  The person item 
threshold map is represented in Figure 6.1, indicating that the distribution of the items 
was comprehensive.  Once again, testing for unidimensionality indicated that only 
4.67% of the independent t-test were significant (95%CI =2 to13%), confirming there 
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Item Fit Residuals  
 
Model 
 
 
Modification 
 
χ2 
 
 
df 
 
 
p 
Ideal >0.05 
 
 
PSI 
> 0.8 
 
Mean 
Ideal 0.0 
Standard 
Deviation 
Ideal 1.0 
1 Original analysis 47.254 50 0.584223 0.95593 -0.279 1.104 
2 Removal of item 5 for hit fit residual 44.572 48 0.614121 0.96550 -0.270 0.956 
3 Removal of item 7 for DIF for site of OA 49.168 46 0.347464 0.95471 -0.260 0.983 
4 Removal of item 9 for DIF with gender 42.559 44 0.533468 0.95258 -0.243 1.027 
 
Table 6.5  Summary table of iterative analysis for test re-test analysis of OAQoL data 
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Item 
 
Location 
 
SE 
 
Fit Res 
 
χ2  
 
DF 
 
p 
21.   I feel slowed down -4.19688 0.294 0.006 1.898 3 0.593764 
9.   Walking for pleasure is out of the question -2.53514 0.217 -0.808 2.277 3 0.516932 
20.   I have to limit what I do each day -2.46136 0.217 0.64 6.316 3 0.097208 
17.   I can’t be as independent as I want -1.43437 0.198 -0.312 7.816 3 0.049961 
6.   My arthritis limits the places I can go -1.27132 0.196 -0.491 0.4 3 0.940225 
19.  I can’t live life to the full -1.19319 0.195 0.287 1.419 3 0.70099 
4.   I can't plan things too far in advance -0.82568 0.192 -0.83 6.169 3 0.103682 
7.   I can't do things on the spur of the moment -0.64772 0.191 -0.397 2.836 3 0.417578 
1.   I'm unable to join in activities with my friends or family -0.64025 0.191 -0.649 1.823 3 0.609914 
15.   I worry about being a nuisance to other people -0.47 0.191 -0.006 2.098 3 0.552347 
12.   I feel I can’t join in with social activities -0.3184 0.191 -1.395 6.809 3 0.07823 
3.   I feel like I am missing out on life -0.26229 0.191 -0.891 4.643 3 0.199879 
8.   It interferes with everything that I do 0.657439 0.196 -0.831 1.022 3 0.79596 
2.   I get embarrassed using stairs in public 0.711476 0.196 0.934 5.685 3 0.127995 
14.   I feel dependant on others 0.816447 0.198 -1.335 3.942 3 0.267764 
13.   My arthritis controls my life 1.209287 0.203 -0.869 3.724 3 0.292857 
16.   My life revolves around my arthritis 1.451653 0.207 -0.999 5.183 3 0.1589 
11.   I feel useless 1.748273 0.216 -0.679 2.093 3 0.553404 
10.   I can’t enjoy myself when I go out 2.042232 0.223 -1.016 2.872 3 0.411732 
22.   I can’t go to the places I want to go 2.119166 0.226 0.556 6.223 3 0.101263 
5.  I feel as though I’m trapped in my house 2.288998 0.234 -1.151 3.641 3 0.302932 
18.   I feel very isolated 3.211616 0.277 -0.645 3.198 3 0.362032 
Table 6.6  Summary of the final items.   Location refers to the location of the item along the metric ruler, SE (the standard error of the 
measure) and Fit Res (the Fit Residuals or how well each item relates to the overall model).  A significant χ2 indicates that an item does 
not fit the model. 
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Figure 6.1  Person-Item Threshold Distribution for the final 22 item OAQoL  
 
was no pattern in the residuals, and supporting the strict unidimensionality of the 
instrument.  
 
The test-retest for the total score was explored using Spearman’s Rho and for each 
item Cohen’s Kappa (κ).  There was an excellent correlation between the two total 
OAQoL scores from time 1 to time 2 (ρ=0.93, p<0.001) with no systematic differences 
between the scores on each occasion (z=-0.06, p=0.995), suggesting excellent test-
retest reliability.   Kappas for each item ranged from moderate (κ=0.512) to excellent 
(κ=0.926), with most items demonstrating kappas in the range 0.65 to 0.85.  
 
In order to re-assess the construct validity of the revised OAQoL, the relationship 
between the 22 item OAQoL and other measures were again calculated.  The results 
were similar to those found for the draft 25 item OAQoL (version 3): there was a 
moderate correlation to the pain and stiffness domains of the WOMAC (ρ=0.67, 
p<0.001 and ρ=0.71, p<0.001 respectively) and good correlation with the WOMAC 
disability domain (ρ=0.78, p<0.001), a moderate to good correlation with the General 
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Well-Being Index (ρ=-0.65, p<0.001) and once again a moderate correlation with the 
Cochin Scale (ρ=0.49, p<0.001). 
 
6.7  Discussion of major findings 
The aims of this study were to develop a OA-specific quality of life measure from a 
needs-based conceptual framework.  The psychometric properties of this new tool 
were evaluated. While functional impairment and pain have been reported extensively 
in the literature, themes identified during the interviews indicated that people with OA 
often reported substantial restrictions of life choices and an increased dependency on 
others.  Several issues emerged in the development of the OAQoL related to both the 
affective and cognitive impact of OA.  Given that the OAQoL was derived from a 
needs-based methodology, it was not surprising to find that the final OAQoL included 
several items that related needs associated with loss of independence, impact on 
others and a sense of frustration, fear and annoyance related to living with OA.   
 
The 22 item OAQoL is a questionnaire that is brief, easy to use and practical to 
administer in clinic, in a clinical trial or as a postal survey. The application of the 
needs-based model in OA is valuable as it provides important information on the 
global impact of the disease from the patient’s perspective. The OAQoL items were 
generated directly from statements made by patients with OA. Furthermore, the 
measure was derived from and tested against Rasch measurement principles. It is a 
unidimensional measure that has the potential for parametric analysis using Rasch 
transformed scores. As an OA-specific instrument, it is likely to be a more sensitive 
and specific outcome than that provided by generic measures but this remains to be 
determined. Finally, given that the current sample included several different OA sites 
and included participants with OA in a number of joints, the instrument has been 
validated for use with upper limb, lower limb and combination OA.   
137 
 
 
Preliminary validation of the OAQoL indicated that there was a moderate association 
with the three domains of the WOMAC and with the GWBI, indicating that the scales 
assess related but distinct concepts. Only a low correlation was observed between the 
OAQoL and the Cochin scale.   Unfortunately, as the latter scale is a relatively new 
instrument, it is difficult to make firm conclusions about the validity of the OAQoL for 
use with hand OA.  
 
The final OAQoL includes one item (“I can’t go places I want to go”) which 
demonstrated borderline DIF during the test-retest phase.  The decision to keep this 
item in the final version was based on two factors. First, the DIF had only borderline 
statistical significance and was not significant in the initial Rasch analysis of the 
OAQoL. Secondly, the item is one that is similar to items in several of the other 
needs-based QoL instruments209, 308, 309  and, therefore, has the potential to be 
included in an item bank of QoL instruments in the rheumatic diseases.   
 
6.8  Conclusion 
This study has focused on developing and validating an outcome measure for 
assessing the impact of OA on QoL using the needs-based model.   Further research 
is necessary to test the clinical responsiveness and applicability of the OAQoL across 
different cultural contexts, including adaptation for use in other languages and 
cultures.  This measure may provide valuable patient-centred information concerning 
the experience of individuals with OA and impact on their QoL.   
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Chapter Seven 
Physical and psychosocial influences of quality of life 
in osteoarthritis 
 
7.1  Overview     
This chapter presents the results of the study “The Physical and Psychosocial 
Influences of Quality of Life in Osteoarthritis”.  The purpose of this study was to 
explore the influences of quality of life using an a priori model, based on ICF 
framework and informed by the literature, the methods of which are described in 
Section 3.5.  This study describes the relationships between quality of life and 
personal factors, impairment, factors associated with their OA and psychosocial 
factors using structural equation modelling (SEM).  It explicitly tests the hypothesis of 
the thesis. 
 
7.2 Participant Profile 
Data for this study were collected in Phase 3 of the development and validation of the 
OAQoL (Chapter 6).  As described in Chapter 6.4, data were received from 259 
respondents from both primary and secondary care and with OA at a variety of sites 
including the knee, foot, hip, hand and multiple-site presentation (Table 6.1).   All data 
were explored and checked for distribution and presence of outliers.  Data for each 
individual were checked and outliers were removed, as required for SEM276.  As such, 
11 people were excluded from the analysis due to extreme scores, leaving 248 
participants included in the modelling.  The median range of joints involved was four 
(Figure 7.1).  There were more females (72.2%) than males and included those 
mainly of white, British origin.  The group displayed a range of educational 
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achievement:  just over two thirds had no tertiary qualification (70.6%), with 25% 
completing tertiary qualifications.    
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Figure 7.1  Bar chart representing the number of joints affected by OA reported 
by participants included in the modelling.  
 
 
 
7.3  Results 
7.3.1  Preparation of the data 
Data were also explored for normality of distribution in order to determine the values 
of the correlation matrix used as the basis for SEM.  These figures are presented in 
Table 7.1.  As duration, function and anxiety violated the assumptions of normality, 
the data for all interval scales would be treated as ordinal.  As such, Spearman’s rho 
was used for correlation relationships between the following variables:  age, number  
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 Age Gender 
No of 
Jts Pain Funct Depr Anx 
OA 
QoL 
Co- 
morb Dur 
 
Kn 
Ft 
 
Kn 
Bck 
 
Kn 
Hnd 
 
Nck 
Shl 
 
Kn 
Hip 
 
Kn 
Sh 
Age 1                
Gender* 0.025 1               
Number of joints 0.170 0.129 1              
Pain 0.073 0.050 0.252 1             
Function 0.267 0.190 0.262 0.642 1            
Depression 0.005 0.002 0.264 0.348 0.431 1           
Anxiety 0.030 0.022 0.299 0.500 0.601 0.777 1          
OAQoL  0.332 0.242 0.322 0.508 0.761 0.545 0.719 1         
Co-morbids 0.176 0.146 0.330 0.148 0.284 0.315 0.379 0.367 1        
Duration of OA 0.179 0.134 0.523 0.184 0.285 0.148 0.232 0.292 0.192 1       
Knee & foot* 0.018 0.372 0.830 0.165 0.204 0.218 0.223 0.213 0.227 0.37 1      
Knee & back* 0.121 0.205 0.676 0.205 0.206 0.262 0.34 0.31 0.462 0.441 0.604 1     
Knee & hand* 0.158 0.591 0.823 0.269 0.272 0.218 0.296 0.33 0.26 0.435 0.789 0.658 1    
Neck & shoulder* 0.389 0.020 0.792 0.349 0.287 0.365 0.519 0.506 0.43 0.398 0.393 0.767 0.565 1   
Knee & hip* 0.220 0.154 0.714 0.329 0.352 0.274 0.238 0.382 0.262 0.354 0.666 0.73 0.646 0.585 1  
Knee & Shoulder* 0.218 0.389 0.855 0.276 0.287 0.377 0.447 0.43 0.321 0.458 0.539 0.666 0.767 0.986 0.691 1 
Standard 
deviation 12.563 0.449 2.693 27.406 2.961 1.346 1.569 2.679 1.666 9.411 0.465 0.447 0.478 0.231 0.474 0.336 
Mean 66.27 1.72 4.63 54.592 -0.44 -1.10 -1.13 -0.43 2.088 12.47 0.315 0.274 0.351 0.056 0.339 0.129 
 
Table 7.1  Correlation matrix for variables entered into the model.  All values are Spearnman’s rho, except for relationships with gender 
and joint patterns, which are gamma correlations, indicated by an asterix*.
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of joints, number of co-morbidities, pain, WOMAC physical function (rasched 
converted scores), OAQoL (rasched converted scores), depression (rasched 
converted scores), anxiety (rasched converted scores) and duration.  Correlations  
between gender and joint pattern (nominal data) and each of the ordinal variables 
were established using gamma correlations276.  A summary table of descriptive 
statistics is presented in Table 7.2. 
 
 
 
 
Mean  
SD 
Median 
5 to 95 centile 
P value 
for K-S 
test* 
Age (Years) 66.27  
±12.56 
68 
44 to 83 
0.21 
Duration of OA (Years) 
 
12.01 
±9.41 
10 
2 to 30.5 
<0.00 
Number of joints involved (N) 
 
4.65 
±2.95 
4 
1 to 11 
<0.00 
Number of co-morbidities (N) 
 
2.10 
±1.66 
2 
0 to 5 
<0.00 
Pain VAS (mm) 
 
54.59 
±12.7 
56.0 
3.2 to 95.8 
0.13 
WOMAC Function Raw Score 
 
31.87 
±17.47 
35 
0.1 to 56.9 
0.03 
WOMAC Function Rasch Score 
 
-0.426 
±2.963 
0.55 
-6.56 to 3.51 
0.08 
HADS Anxiety Raw Score 
 
6.20 
±4.01 
6 
0 to 13 
0.02 
HADS Anxiety Rasch Score -1.122 
±1.571 
-0.841 
-4.86 to 1.093 
0.04 
HADS Depression Raw Score 
 
6.34 
±4.03 
6 
1.0 to 13.6 
0.03 
HADS Depression Rasch Score 
 
-1.018 
±1.348 
-1.033 
-4.03 to 1.052 
<0.00 
OAQoL Score Total 
 
9.76 
±7.02 
9.5 
1 to 11 
0.03 
OAQoL Rasch -0.431 
±2.684 
-0.235 
-4.95 to 4.53 
0.13 
 
Table 7.2  Descriptive statistics used non categorical data for the indicator 
variables used in the model of quality of life in OA.  The p values are for the 
Kolmogorov-Smirnov Z test to indicate if the data fits normal distribution.  A significant 
p value (less than 0.05) indicates that the data should be strictly considered ordinal 
and not interval. 
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Data from three variables were captured and were to be included in the a priori model:  
location of joint pain, hand function and participation.  Unfortunately, analysis of the 
measures in preparation for the modelling indicated that they could not be included in 
the final SEM:   
 
i. Location of joint pain:    
Exploring the data on the location of OA for modelling presented several problems.  
First, we wanted to explore the impact of hand, hip, knee and foot OA.   There was a 
statistically significant difference between the OAQoL scores for different anatomical 
sites (F=14.668, df=4, p<0.001).  Those who reported multiple site pain had the worse 
OAQoL scores, followed by knee, hip, hand and foot.  The OAQoL Raw Scores are 
presented in Figure 7.2.  Post hoc analyses revealed that the foot was significantly 
lower than the multiple site, hip and knee.  However, for inclusion in the regression 
and structural equation modelling, this represented a dilemma:  as the sample 
represented those with pain in at least one joint, and the majority had more than one 
joint involved, the logic of what we were comparing for the purposes of the modelling 
became confused.  If we were to consider the impact of hip OA, those who did not 
have hip OA included those who had other site involvement.  As we did not include 
people with no site involvement, the comparison became circular:  we would compare 
those with no hip (and therefore a complex combination of other joint involvement) 
with hip pain.  Secondly, as only had four participants in this group who reported hand 
only pain, hand only could not be included in such an analysis.  As such, it was 
decided to focus on the number of joints involved and the joint pattern (ie hip and 
knee / foot, hand and hip) rather than the location, based on the six most prevalent 
joint combinations (derived from Chapter 4) were included in the analysis.  This 
included the following joint combinations:  knee and foot; knee and back; knee and 
hands; knee, foot and hands; knee and hips; and knee and shoulder.  
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Figure 7.2  Bar chart representing the mean OAQoL raw scores based on the 
major site of pain.  (Note, all statistical testing was undertaken on the OAQoL Rasch 
transformed scores). 
  
 
ii.  Cochin  Hand Functional Scale 
The Cochin Scale was not included as there were so few participants in the hand only 
group.  Given that this scale was developed to assess solely hand function, it was 
considered inappropriate to include this in the modelling.   Furthermore, Rasch 
analysis of the Cochin revealed several problems that would have made inclusion of 
the scale in the model difficult.  Therefore, in the final model, there was no 
representation of upper limb functioning: only WOMAC physical function data were 
included as the function variable. 
 
iii. Perceived impact of the Problem Profile (PIPP) 
The PIPP310 participation subscale was used to capture data on participation.  
However, our analysis revealed two major problems with the data obtained from the 
PIPP:  first there was a considerable amount of missing data:  almost one third of the 
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data points were missing.  This may have been due to confusion and redundancy 
between the concepts of how much impact your OA has on aspects of your life versus 
how much distress this causes.  Certainly, the amount of missing data was greater in 
the distress items (39%) than it was in the impact items (24%) and there was a high 
correlation between the distress and impact items (range ρ=.85 to .96), indicating 
redundancy.  Second, the Rasch analysis of the five item participation subscale of the 
PIPP indicated that two of the items demonstrated DIF by age, reducing the subscale 
to just three items.  On the basis of these issues, the participation subscale was not 
included in the modelling.   
 
7.3.2 Hierarchical Regression Modelling 
In order to explore the multivariate relationships between each of the variables that 
would inform the structural equation modelling, hierarchical multiple regression 
analysis was performed for each of the major outcomes:  pain, function, depression, 
anxiety and quality of life.   This approach was adopted in order to explore significant 
relationships for each of the outcomes and the likely direction of the outcomes which 
would inform the theoretical model for the SEM. 
 
i. Function 
As described in Section 3.5.2, a series of hierarchical regression models, with function 
as the dependent variable, were completed.  A summary table of the iterative models 
is presented in Table 7.3.   In the first model, demographic, disease related outcomes 
and pain were included, followed by introducing depression to the model, then 
depression combined with anxiety and then just depression without anxiety.  The best 
fitting model indicated that age, duration of disease, pain and anxiety contributed 
directly to function, with pain and anxiety being the largest contributors of the variance 
(R2=0.558) .  When depression was included in the model, it did contribute to function;  
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Dependent variable:  Function 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities 
0.179 Age 
Number of co-
morbidities 
 
0.231 
0.228 
 
<0.001 
<0.001 
 
2 Model 1 +Pain  0.467 Age 
Number of co-
morbidities 
Pain VAS 
 
0.223 
0.119 
 
0. 556 
 
<0.001 
<0.001 
 
<0.001 
 
3 Model 1 + Pain and 
Anxiety 
0.560 Age 
Duration 
Pain VAS 
Anxiety 
 
0.233 
0.110 
0.386 
0.378 
<0.001 
0.045 
<0.001 
<0.001 
 
4 Model 1 + Pain, 
Anxiety and 
Depression 
0.558 Age 
Duration 
Pain VAS 
Anxiety 
 
0.233 
0.109 
0.384 
0.396 
<0.001 
0.045 
<0.001 
<0.001 
 
 
 
Table 7.3  Summary table of Iterations of Hierarchical Regression Modelling 
with Function as the dependent variable.  All models included in the table had 
tolerance >0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3   Model of resultant factors contributing to function after regression 
modelling. 
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Depression Anxiety 
Function 
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however when depression was included with anxiety, it became non-significant.  
When anxiety was included alone, the amount of variance explained was increased 
(R2=0.467 to R2=0.502).  This suggests that depression works through anxiety to 
impact on function.  This is presented schematically in Figure 7.3.   
 
ii.  Pain 
The summary table of regression models for pain is presented in Table 7.4.  Once 
again, demographic, disease activity and function was included in the first model.  
Function explained the largest amount of variance for pain in all models.  When 
anxiety was included, the amount of explained variance improved and produced the  
best fitting model (R2=0.406).  When depression was included, there model was less 
predictive, indicating that depression did not contribute significantly to pain.  Of note, 
number of joints was not related to pain when all other factors were included.  
Function, number of co-morbidities and anxiety were related to pain (Figure 7.4). 
 
iii.  Depression 
The summary table for the regression modelling for depression is in Table 7.5.  The 
first model, which included demographics, disease activity and co-morbidities did not 
explain much of the variance associated with depression (R2=0.105).  However, once 
anxiety was included, the amount of variance was substantially improved (R2=0.542) 
and was the only significant contributing factor for depression.  This is represented in 
Figure 7.5. 
 
iv.  Anxiety 
Several factors were significantly related to anxiety in the hierarchical regression 
modelling (Table 7.6).  The first model which include demographics, disease related 
measures and co-morbidities was poorly explained (R2=0.149); however, once 
depression was included, the model substantially improved (R2=0.565).  The model 
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Dependent variable:  Pain 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities 
0.052 Knee and hip 0.181 0.033 
 
 
2 Model 1 +Function  0.386 Age 
Function 
 
-0.134 
0.640 
 
0.024 
<0.001 
 
 
3 Model 1 + Function 
and Anxiety 
0.406 Number of co-
morbidities 
Function 
Anxiety 
 
 
-0.128 
0.521 
0.201 
 
0.038 
<0.001 
0.006 
4 Model 1 + Function, 
Anxiety and 
Depression 
0.405 Number of co-
morbidities 
Function 
Anxiety 
 
 
-0.126 
0.517 
0.256 
 
0.042 
<0.001 
0.008 
 
 
Table 7.4  Summary table of Iterations of Hierarchical Regression Modelling 
with Pain as the dependent variable.  All models included in the table had tolerance 
>0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4  Model of resultant factors contributing to pain after regression 
modelling. 
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was further enhanced with the addition of pain and again when function was included 
(R2=0.674).   In the best fitting model, number of co-morbidities, pain, function and 
depression were significantly predictive of anxiety, with depression the greatest 
predictor.  This is represented in Figure 7.6.   
  
v.  Quality of Life and Physical components 
Regression modelling for the physical components and quality of life was undertaken 
(Table 7.7).  The first model was which included demographics, disease activity and 
number of co-morbidities demonstrated a borderline fit (R2=0.260), with hip and knee 
pain contributing to the model.  Once pain was added, fit was improved with pain the 
largest contributing factor to quality of life (R2=0.424).  However, when function was 
added to the model, the model was substantially improved (R2=0.622) and pain 
became non-significant.  A model without pain included produced similar explanation 
(R2=0.622), suggesting that pain impacts on quality of life only through function and 
that pain is fully mediated by function.  Age and number of co-morbidities were also 
significant.  This relationship is represented in Figure 7.7.   
 
vi. Quality of Life and Psychosocial components 
Table 7.7 represents the regression models undertaken for quality of life and the 
psychosocial components.  When demographics, disease activity, number of co-
morbidities and depression demonstrated reasonable fit (R2=0.448), with age, number 
of co-morbidities and depression contributing to quality of life.  However, when anxiety 
was added to the model, the model was substantially improved (R2=0.651) and 
depression became non-significant.  A model without depression produced a slight 
improvement (R2=0.652), suggesting that depression impacts on quality of life only 
through anxiety.  Age, duration of disease and hip and knee pain also contributed 
significantly to quality of life.  This relationship is represented in Figure 7.8.  
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 Dependent variable:  Depression 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities 
0.105 Number of co-
morbidities 
0.253 <0.001 
 
2 Model 1 + Anxiety 
 
0.542 Anxiety 0.718 <0.001 
3 Model 1 + Anxiety 
and Pain 
0.541 Anxiety 0.751 <0.001 
 
4 Model 1 + Anxiety, 
Pain and Function 
0.539 Anxiety 0.761 <0.001 
 
 
Table 7.5  Summary table of Iterations of Hierarchical Regression Modelling 
with Depression as the dependent variable.  All models included in the table had 
tolerance >0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
Figure 7.5  Model of resultant factors contributing to depression after 
regression modelling. 
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Dependent variable:  Anxiety 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities  
0.149 Number of co-
morbidities 
0.308 <0.001 
2 Model 1 + 
Depression 
0.565 Depression  
Number of co-
morbidities 
0.683 
0.135 
 
<0.001  
0.008 
3 Model 1 + 
Depression and Pain 
0.633 Depression 
Gender 
Pain 
Number of co-
morbidities 
0.601 
0.089 
0.286 
0.140 
<0.001 
0.045 
<0.001  
<0.001  
 
4 Model 1 + 
Depression, Pain and 
Function 
0.674 Depression 
Pain 
Function 
Number of co-
morbidities 
0.538 
0.141 
0.292 
0.097 
<0.001  
 0.008  
<0.001  
0.034 
 
 
 
Table 7.6  Summary table of Iterations of Hierarchical Regression Modelling 
with Anxiety as the dependent variable.  All models included in the table had 
tolerance >0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6  Model of resultant factors contributing to anxiety after regression 
modelling. 
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Dependent variable:  Quality of Life 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities  
0.260 Age 
Knee and Hip 
Number of co-
morbidities 
0.268 
0.151 
0.269 
<0.001 
0.036 
<0.001 
 
 
2 Model 1 + Pain 0.424 Age 
Pain 
Number of co-
morbidities 
0.262 
0.424 
0.247 
<0.001 
<0.001 
<0.001 
 
3 Model 1 + Pain and 
Function 
0.622 Age 
Function 
Number of co-
morbidities 
0.124 
0.613 
0.125 
0.008 
<0.001 
0.010 
 
 
Table 7.7  Summary table of Iterations of Hierarchical Regression Modelling 
with QoL as the dependent variable for the physical components.  All models 
included in the table had tolerance >0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7  Model of resultant factors contributing to QoL (physical component)  
after regression modelling. 
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Dependent variable:  Quality of Life 
Model Factors included 
in the model 
R2 
(adjusted)
 
Factors significant 
in model 
β 
weights 
P 
values 
1 Age, Gender, 
Duration of disease, 
Number of joints, 
Joint pattern, 
Number of co-
morbidities  
0.260 Age 
Knee and Hip 
Number of co-
morbidities 
0.268 
0.151 
0.269 
<0.001 
0.036 
<0.001 
 
 
2 Model 1 + 
Depression 
0.448 Age 
Depression 
Number of co-
morbidities 
0.272 
0.462 
0.152 
<0.001 
<0.001 
0.007 
 
3 Model 1 + 
Depression and 
Anxiety  
0.651 Age 
Duration of disease 
Knee and hip 
Anxiety 
0.281 
0.104 
0.126 
0.686 
<0.001 
0.026 
0.012 
<0.001 
 
 
 
 
Table 7.8 Summary table of Iterations of Hierarchical Regression Modelling with 
QoL as the dependent variable for the psychosocial components.  All models 
included in the table had tolerance >0.10 and VIF less than 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8  Model of resultant factors contributing to QoL (psychosocial 
component)  after regression modelling. 
OAQoL 
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7.3.3  Structural Equation Modelling 
From the hierarchical regression modelling of the variables, a structural equation 
model was formulated to explore the impact of the physical and psychosocial factors 
on quality of life.  This model is presented in Figure 7.9, with the error and regression 
weight entered onto the model from the Rasch analysis of the anxiety, depression, 
function and quality of life scales.  A correlation matrix based around Table 7.2 was 
used with means and standard deviations to run the model. 
 
The theoretical model predicted from the regression analysis was not supported:  the 
χ2 statistic was significant (χ2=119.033, df=16, p>0.000), while the fit statistics also 
indicated poor model fit (RMSEA=0.161, GFI=0.919, CFI=0.893).  In order to improve 
model fit, the regression weights of the linked variables were explored.  Those linked 
variables with non-significant regression weights were removed in an iterative 
process: the path between the variables with the highest p value was removed first.  
Upon removal of the variable, overall model fit and the fit statistics were reviewed.  
Once all non-significant linked variables were removed, modification indices were 
explored.  The modification index suggests possible links between non-linked 
variables which may improve model fit.  A summary table of the iterations of the 
modelling indicating which variables were removed or linked is presented in Table 7.9.  
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Figure 7.9  Structural equation model testing the effects of on quality of life in OAQoL derived from hierarchical linear regression models.  
Anx=Rasch transformed anxiety score for HADS, depress=Rasch transformed depression score for HADS, funct= Rasch transformed physical 
function subscale of WOMAC and oaqol Rasch transformed OAQoL scores.  Figures in purple indicate those imported from Rasch analysis.
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Model N Modification χ2 df P 
Ideal: >0.05 
RMSEA 
Ideal: <0.05 
GFI 
Ideal: >0.95 
CFI 
Ideal: >0.95 
1 249 Predicted model from regression analysis 119.033 16 <0.001 0.161 0.919 0.893 
2 249 Removal of link anxietypain 119.036 17 <0.001 0.156 0.909 0.894 
3 249 Removal of link co-morbiditiesquality of life 119.037 18 <0.001 0.150 0.909 0.895 
4 249 Removal of link co-morbiditiespain 119.375 19 <0.001 0.146 0.909 0.895 
5 249 Removal of link duration quality of life 119.750 20 <0.001 0.142 0.908 0.896 
6 249 Removal of link function anxiety  121.021 21 <0.001 0.139 0.908 0.896 
7 249 Add link between knee and hip  duration 92.831 20 <0.001 0.121 0.932 0.924 
8 249 Add link between knee and hip  pain 71.318 19 <0.001 0.105 0.944 0.945 
9 249 Removal of link function pain 71.339 20 <0.001 0.102 0.945 0.946 
10 249 Add link between knee and hip  co-morbidities 57.558 19 <0.001 0.090 0.956 0.960 
11 249 Removal of link knee and hip quality of life 60.451 20 <0.001 0.090 0.955 0.958 
12 249 Add link between anxiety  duration 56.728 19 <0.001 0.089 0.957 0.961 
13 249 Add link between age  knee and hip 44.425 18 0.001 0.077 0.967 0.972 
14 249 Removal of link duration  function 47.428 19 <0.001 0.078 0.964 0.970 
15 249 Removal of link anxiety   depression  99.138 20 <0.001 0.126 0.925 0.917 
16 249 Removal of link  depression  anxiety 260.245 21 <0.001 0.214 0.863 0.751 
17 249 Removal of depression variable 17.728 13 0.168 0.038 0.982 0.993 
 
Table 7.9   Summary table of iterations of Structural Equation Modelling  
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The best fitting model (χ2=17.728, df=13, p=0.168, RMSEA=0.038, GFI=0.982, 
CFI=0.993) is presented in Figure 7.10.  In this model, the fit values estimated a high 
proportion of the variance of quality of life in OA (R2=0.81), indicating that the model is 
well supported.  Given that models are often published with only 25% of the variance 
explained, a model explaining over 85% represents a well defined model.  Only three 
variables feed directly into quality of life:  anxiety (Rgwt=0.57), function (Rgwt=0.34) and 
age (Rgwt=0.22), with the anxiety representing the largest predictor of quality of life.  Of 
note, depression, gender and number of joints do not feature in this model.   
 
Pain, duration of disease and number of co-morbidities do affect quality of life, but 
through mediator variables.  While not directly feeding into quality of life, increased 
pain has a direct impact of increasing anxiety (Rgwt=0.48) and decreasing function 
(Rgwt=0.39), each of which in turn has a direct impact on quality of life.  Those who 
have had their disease longer, report greater anxiety (Rgwt=0.13) and are more likely 
to report knee and hip pain (Rgwt=0.33).  Those with knee and hip pain report 
significantly more co-morbidities(Rgwt=0.23) and report greater pain (Rgwt=0.33).  
Those with more co-morbidities are likely to report higher anxiety levels (Rgwt=0.33). 
 
In addition to the direct effect of age on quality of life, age also has an effect through 
co-morbidities(Rgwt=0.12);  those who are older are likely to have more co-morbidities 
and this in turn increases the likelihood of anxiety, which then impacts on their quality 
of life.  Not surprisingly, those who are older are likely to have had OA for a longer 
period (Rgwt=0.18), which is a higher predictor of pain, anxiety and number of co-
morbidities.  Age was also associated with a greater likelihood of knee and hip pain 
(Rgwt=0.16). 
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Figure 7.10  Best fitting structural equation model for quality of life in OAQoL.  The italicised numbers at the top right hand corner of the 
variables represent the R2 value, or the percentage of variance in the variable explained by the model.  The lines demonstrate the direction the 
relationship is in and the values near these lines are the regression weights.  Larger regression weights indicate better predictors of the variable 
the arrow is feeding into. The summary statistics are χ2=17.728, df=13, p=0.168, RMSEA=0.038, GFI=0.982 and CFI=0.993. 
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Anxiety is associated with the greatest number of variables.  While pain, number of 
co-morbidities and duration all predict higher anxiety scores, it is interesting to note 
that anxiety predicts poor physical function (Rgwt=0.45). 
 
A summary table of standardised total effects, direct effects and indirect effects is 
presented in Table 7.10.  Anxiety is the highest single predictor of quality of life in this 
model, for both direct and total effects (0.721).  While function has a higher direct 
effect on quality of life, pain demonstrates larger total effects (0.473), working through 
anxiety and function.  Age has the third largest total effect on quality of life, closely 
followed by function. 
 
 
 
Variable Direct effect Indirect effect Total effect 
Anxiety 0.569 0.152 0.721 
Pain  0.000 0.473 0.473 
Age 0.217 0.166 0.383 
Function 0.337 0.000 0.337 
Number of co-morbidities 0.000 0.238 0.238 
Duration of OA 0.000 0.160 0.160 
Knee and hip 0.000 0.211 0.211 
Depression NA NA NA 
Gender NA NA NA 
Number of joints NA NA NA 
 
Table 7.10  Standardised total, direct and indirect effects for the variables as 
they related to QoL in the final model. 
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7.4 Discussion of main findings 
While several factors have been implicated in affecting “quality of life” in OA, our 
proposed model of the interaction between physical, psychosocial, demographic and 
disease factors explains 81% of the variance, which is a substantial proportion of the 
impact of OA on quality of life.  The single most important factor in predicting quality of 
life was anxiety, which has received little attention in the OA literature.  Our results 
suggest that it is anxiety and not depression, which has the greatest impact on quality 
of life.  While this is a new finding in OA, the importance of anxiety on health-related 
quality of life has, however, been reported for other chronic medical conditions 
including myocardial infarction311, diabetes and vascular disease312.   It does suggest 
an important link between general well-being and an anxious state. 
 
This finding is particularly important in light of the high levels of both anxiety and 
depression that was found in these OA participants and is consistent with that 
reported for arthritis in general practice68.  The mean anxiety raw score for the total 
OA cohort was 7.15 (Table 7.11), higher than that reported in the literature for breast 
cancer313, renal disease314 and chronic heart disease315, but lower than that reported 
for psychiatric patients316.  The mean depression raw score for the total group was 
6.34, which again was higher than breast cancer313 and renal disease314 and 
equivalent to that reported in chronic heart disease315.    
 
 
Patient Group 
Mean HADS 
Anxiety Score 
Mean HADS 
Depression Score 
OA (Current study) 7.15    5.67  
Reference Norms317 6.14 3.68 
Breast cancer*313 6.48 2.90 
End stage renal disease314 6.90 5.20 
Coronary Heart Disease315 6.14 5.41 
Psychiatric Patients316 13.5 9.40 
 
Table 7.11.   Comparison of HADS scores with the literature.  *Breast cancer 
patients are those who were receiving chemotherapy and hormone therapy. 
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In the SEM, anxiety was affected by several other factors, including the number of co-
morbidities.   The effect of co-morbidities has been described on functional 
impairment in musculoskeletal pain318 and in the elderly319 and the perception of 
musculoskeletal pain.  The number of co-morbidities has also been reported to impact 
on health-related QoL in RA320.  As the number of co-morbidities in OA is high89, this 
finding is of considerable importance.    
 
Both function and pain have a considerable impact on quality of life.  The link between 
function and health-related QoL has been established, with poorer SF-36 mental 
health scores predicting poorer functional outcomes in OA21.   Our findings also 
support those of van der Waal who suggest that somatic distress in OA is linked to 
increased pain intensity, which in turn results in poor function215.  The bi-directional 
relationship between anxiety and pain in OA has been reported previously48, 272.  Pain 
was the second highest single factor in predicting quality of life, our study suggests 
pain does not have a direct impact on quality of life, but has its impact through anxiety 
and functional impairment.   
 
The impact of age on quality of life is notable:  it has both a direct impact, where 
increasing age is associated with poorer quality of life, and has indirect effects through 
duration of disease, knee and hip pain and number of co-morbidities.  Indeed, age is 
the third highest contributor to QoL in this model, ranking only behind anxiety and pain 
(Table 7.10).  While a poorer QoL is not necessarily associated with ageing, co-
morbidities and somatic symptoms have a considerable impact321 on health-related 
quality of life322, particularly in older age323.    
 
Of note, the only joint pattern included in the modelling that had a significant impact 
on QoL was combined knee and hip pain, although their effect was manifest through 
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other variables.  Those with knee and hip pain reported greater co-morbidities and 
greater pain, both of which had a direct affect on anxiety.  The influence of the number 
of joints affected by OA had neither a direct or nor an indirect association with quality 
of life.   
 
The findings of the SEM need to be viewed in light of the limitations of the study.  
Firstly, the elements included in the modelling were based on specific outcome 
measures, each with their own limitations, as outlined in Chapter 2, and represented a 
latent, theoretical construct.  Secondly, while a functional measure for upper limb was 
to be included in the model, the hand and upper limb outcome (Cochin Scale) did not 
perform adequately well to be a candidate for the final model.  Consequently, as 
function was based only on WOMAC function, upper limb problems were not 
represented.  Thirdly, while all patients fulfilled strict criteria for the diagnosis of OA, 
joint involvement was based on self reported joint pain.  As such, joint combination 
and numbers reflect joint pathology and not necessarily OA.  Finally, QoL may be 
affected by un-modelled factors that contribute to quality of life and were not included 
in the final model.  Examples may include as measures of self efficacy; participation; 
fatigue; and environmental factors, such as social support.  The amount of variance 
explained in the model is high (R2=0.81) and this indicates that this is a strongly 
functioning model. 
 
7.5 Conclusion 
A model which explores the influence of quality of life in OA has been presented as a 
robust model.  The key influences on quality of life are physical function, anxiety and 
age.  Pain has an influence on quality of life, but only through loss of function or 
anxiety.  The factor associated with the location of joint pain on quality of life was knee 
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and hip pain, which had an indirect affect.  Of note, the number of joints affected by 
OA was not significant. 
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Chapter Eight  
Discussion and Summary  
8.1  Overview  
The impact of OA on quality of life has been investigated in this thesis.  A robust, 
multiple methodological approach was adopted to explore issues associated with 
quality of life.  In the first instance, analysis of a large, epidemiological cohort was 
undertaken to establish the prevalence and impact in the community of joint pain at 
more than one anatomical site.  An in-depth, qualitative study was then undertaken in 
order to better understand issues associated with living with OA from the individual’s 
perspective.  A disease specific, quality of life measure for OA, the OAQoL, was 
developed based on an articulated, conceptual framework, derived directly from 
quotes of people with OA and rigorously validated, using state of the art measurement 
theory.  Finally, factors which influence qualities of life were explored through a novel 
application of structural equation modelling.  This technique produced a model in 
which a substantial 81% of quality of life was explained. 
 
The hypothesis of this thesis as outlined in Chapter 2 was “the number and pattern 
of joint involvement in OA will be reflected in the level of patient perceived 
quality of life.”  The number and pattern of self reported joint involvement had a 
substantial impact on the ability to undertake the tasks of daily living; however this 
was not reflected in the impact on quality of life.  While hip and knee involvement 
contributed to poorer quality of life, other factors, particularly levels of anxiety, 
functional ability and age were more important.  As such, the hypothesis of this thesis 
is only partially supported. 
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Several important findings have been produced by this programme of work which will 
be explored in this chapter.  First, while the individual experience of living with OA is 
varied, the impact of the disease is substantial.  Second, quality of life is driven by a 
complex interaction of physical and psychological factors.  Poorer quality of life 
reported by those with OA is driven by several factors, particularly when OA impacts 
on their independence, self perception or fulfilment of their needs.   Anxiety is the 
major predictor of quality of life in OA, with functional impairment and age also directly 
contributing to quality of life.  Third, co-morbidities have a substantial impact on the 
ability to undertake tasks of daily living and also influence quality of life.  Finally, the 
pattern of joint problems will affect the ability to undertake simple tasks but has only a 
minor impact on overall quality of life.   
 
8.2  The impact of living with OA 
While OA is a common, chronic condition, the individual experience of living with OA 
is unpredictable and poorly understood.  Even though it is one of the most prevalent 
and disabling conditions7, 324, it is often regarded as a trivial disease.  OA is commonly 
seen simply as a normal joint degenerative process and as such, boundaries can 
become blurred between limitations imposed as part of normal ageing and what is 
considered a medical condition.    This was reflected by several of the people 
interviewed for this thesis, who reported frustration that OA was viewed by their family 
and friends as merely part of the ageing process.  The impact of such perceptions 
was not just to trivialise their experiences, but also to categorise them as people who 
simply could not cope with the ageing process.   
 
These findings are in agreement with a recent study investigating the perceptions of 
age and arthritis29.  Interestingly, both those with and those without OA perceived the 
disease as part of normal ageing requiring acceptance, not treatment.  This was in 
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spite of those with OA reporting a higher number of problems with relationships, work, 
leisure, social activities and, not surprisingly, pain29.  Attitudes such as this may result 
in an even greater undermining of the coping ability of people with OA; it may also 
delay in people not seeking treatment and simply living with the pain rather than being 
thought of as not coping with the ageing process.  As explored in this thesis however, 
pain and anxiety are considerable in OA:  the consequences of under treatment are 
considerable and may directly result in a reduced functional ability and overall quality 
of life.  
 
The issue of OA as being dismissed simply as part of the ageing process was 
particularly highlighted in younger patients, who expressed confusion and frustration 
of having an “older person’s disease”.  They felt that their individual needs were often 
not considered as they did not fit the profile of a person with OA.  Acknowledging 
these individual needs is of particular importance in managing younger OA patients:  
particularly so when looking at the effect of OA in areas which may be ignored if OA is 
perceived solely as an “older person’s disease”, such impairment on work and 
parenting activities.     
 
Anxiety and distress was reported commonly during the structured interviews.  This 
distress was closely related to pessimism with their prognosis and associated 
treatment options available.  Participants often felt that “nothing could be done for 
them” as there were no effective treatment strategies for OA and common treatments, 
particularly surgery and drug therapy, had unacceptable associated risks.   
 
While pessimism associated with medication may have been accentuated by the high 
profile withdrawal of several drugs used to treat OA during the period of this study, it is 
more likely to represent an ongoing concern for OA patients.  Studies undertaken prior 
to the withdrawal of these drugs reported similar fears about side effects and potential 
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addiction when taking medication to control OA45.  Indeed, the dilemma of patients 
taking unacceptable risks in managing symptoms through medication may also reflect 
the perception that OA is simply not a serious disease, which may further result in 
under medication, poor symptom control, further anxiety and greater impact on QoL.   
 
Concern about the potential risks with surgery was also expressed by participants in 
this study.  While a meta analysis suggests that joint replacement surgery outcomes 
are good325, several patients rejected outright the thought of having joint replacement, 
even as a last resort.   This is consistent with previous literature that suggests that the 
decision on whether to have surgery was an individualised process that was 
dependent not purely on symptoms or disability47, but also non-disease related issues, 
such as the positive or negative experiences of others and available social support 
following a procedure46.  Such issues need to be considered in those who may be 
assessed for potential surgery. 
 
A lack of understanding of the risk-benefit of treatment options is not isolated to 
surgery and medications.  While several studies have demonstrated the positive 
outcomes of physical therapy302, 303, exercise326 and self management strategies326, 327 
in treatment of symptomatic OA, it was the contention of several of the interviewees 
that there were no treatment options that could help with OA.  This may be associated 
with a lack of awareness, access to assessment or simply not considering the disease 
important enough to treat.  Of note, almost half of those with severe knee pain do not 
seek advice from their GP36.  It is also reflected in awareness and access to treatment 
option:  almost half of knee OA patients have not received any physical therapy or 
patient education328.    Of note, patients who have access to such programmes 
believe that these should receive a high priority in future research304.    
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It is imperative that those with OA are educated as to the possible risk and benefits 
associated with their treatments.  Educational strategies, which are informed by the 
literature, should be developed not only for medication and surgery treatments, but 
other therapies, including self management, exercise and physical therapy.  Access to 
such treatments should be given priority when developing OA services. 
 
Living with OA had a substantial impact on an individual’s self perception, particularly 
if it compromised their ability to fulfill roles and duties that were important to them.  In 
some cases, changed roles within their family unit undermined their self esteem.  
Furthermore, candidates identified their future coping as being strongly associated 
with their ability to undertake such roles and tasks.  This inability to perform valued 
tasks and activities in a social identify framework has been referred to in the 
psychology literature as “illness intrusion”329.  A recent study of people with rheumatic 
conditions found illness intrusion to be predictive of psychological well being in 
addition to having a substantial influence on adjustment to the disease and perceived 
coping330.    
 
The importance of this concept of being able to undertake valued tasks is at the basis 
of the needs-based approach to quality of life.  Life derives its quality from the ability 
and capacity of an individual to satisfy certain human needs.  Quality of life is good 
when most needs are fulfilled, and poor when few needs are satisfied214. 
 
As the conceptual framework from which these studies were derived was the needs-
based approach to quality of life, it was unsurprising that functional status and pain did 
not adequately describe the experience of living with OA.  This is found not only in 
OA:  patients with other conditions, including stroke299, traumatic brain injury299, 
rheumatoid arthritis331 and HIV/AIDS332 consistently report “an overemphasis” by 
clinicians on pain and physical function.   This thesis further demonstrates that while 
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pain and function are indeed important to people with OA, the impact is far wider than 
these constructs. 
 
8.3  Physical and psychosocial influences on QoL 
The key finding of this thesis is that quality of life in OA is associated with a complex 
relationship between physical and psychosocial factors.  An interaction of functional 
ability, age and anxiety factors strongly influenced self perceived quality of life in OA.  
These, in turn, were affected by pain, duration of disease and the number of reported 
co-morbidities.  Age was also a significant direct and indirect factor in quality of life in 
people with OA.  A combination of knee and hip pain had an effect of quality of life.   
Of note, the number of self reported painful joints affected did not contribute 
significantly to quality of life. 
 
While limited attention has been given to anxiety in OA, the impact of anxiety on 
general health is substantial:  higher anxiety symptoms have been associated with 
poor functioning, general well-being and increase health care use333.   This program of 
work found that not only was anxiety key to quality of life, but levels of anxiety and 
depression were disturbingly prominent.    Patients in this study had anxiety levels that 
were higher than that reported for breast cancer313, renal disease314 and chronic heart 
disease315.  In terms of the clinical diagnosis of anxiety, 15% of the OA participants 
were defined as “possible” cases of anxiety and a further 23% were “probable” cases 
of anxiety334.  This is much higher that those cases reported in the literature for acute 
stroke335 and fractured neck of femur335, three times that of the normal population334 
and represents a considerable burden in the OA population.   
 
While depression scores in the OA group were lower than anxiety scores, depression 
was again higher in the OA group compared to that reported in end-stage renal 
169 
Chapter 8 Discussion and Conclusions 
disease314 and breast cancer313.  Over one quarter of the OA patients reported 
possible cases of depression, with one in ten reporting severe depression.   Previous 
literature evaluating depression in OA has tended to focus on those with end-stage 
OA69, 70.   The results of this thesis indicated were similar to those reported waiting for 
surgical replacement69 and indicate that depression is substantial across the spectrum 
of the OA severity. 
 
In terms of the impact of pain on quality of life, the data presented in this thesis 
demonstrated that pain is the primary driver in increasing levels of anxiety. There was 
no direct link demonstrated between depression and quality of life.  However, given 
the high levels of depression reported in this thesis, both depression and anxiety 
needs to be given greater priority in the assessment and management of OA. 
 
The influence of anxiety and depression on health-related quality of life has been 
explored in other conditions.  While depression has been found to be the most 
significant predictor of HRQoL in neurological conditions336 and myocardial 
infarction311, anxiety was the most significant predictor in cervical dystonia337 and 
cancer338.  This is the first time that depression and anxiety have been explored in the 
needs-based model of quality of life. 
 
In this thesis, the impact of anxiety on quality of life was influenced by disease activity, 
with increasing levels of pain, number of co-morbidities and longer disease duration 
all resulting in higher levels of anxiety.  From the qualitative study, pessimism in 
treatment options was highlighted:  it is possible that this pessimism may be 
associated with increased anxiety.  Indeed, a recent study found that the odds of 
persistent pain after treatment in knee OA were higher in those who were concerned 
about their prognosis43.  
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The prominence of anxiety and depression is of particular concern because the 
psychosocial aspects of OA have been found to be under recognised by GPs339.  
Simple therapies targeted to reduce psychological stress have found to be effective in 
other conditions.  In people with rheumatoid arthritis, meditation has been 
demonstrated to improve psychological distress340 and education strategies have 
assisted those with a number of conditions, including asthma341 and cancer342.  
Importantly, group interventions have been demonstrated to enhance patient coping in 
general “arthritis” cohort, which include those with inflammatory and osteoarthritis327.  
Such strategies may be targeted towards reducing anxiety in OA and therefore 
enhancing quality of life. 
 
The issue of ageing and its impact on quality of life has received considerable 
attention over the last 20 years.  The general literature evaluating the impact of age 
on quality of life is contradictory:  while a limited number studies indicate a negative 
association between subjective well-being and ageing343, the majority of studies do 
not344, 345.  Indeed, most of the negative impact of the ageing process on QoL and 
health related QoL has been associated not directly with ageing, but with somatic 
symptoms, restricted physical function or loss of societal roles188, 219, 333.  The literature 
has demonstrated a diversity of experience within a 'good life', which was inconsistent 
with the stereotypical picture of old people as a homogeneous group346.   Several 
elements have been identified as important for a good quality of life in older age:  
relationships, activities, health, philosophy of life, the person's past and present lives 
and future perspectives344.  This complex interaction between age and quality of life is 
supported by the results of this thesis:  age directly impacted on quality of life in those 
with OA and had an indirect effect through impeding function, number of co-
morbidities and the duration of disease.   
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8.4  Joint location and number of joints affected 
One of the main aims of this thesis was to explore the prevalence and impact of OA at 
more than one joint site and to investigate any association with quality of life.  The 
epidemiological study demonstrated that joint problems are highly prevalent, with 
multiple-site involvement particularly common in those over 55.  The median number 
of joints involved was consistent at four in all studies included in this thesis.   The 
presence of joint problems was associated with a reduced ability to undertake 
functional tasks, such as using stairs and standing from a seated position.  The 
location and pattern of joint involvement increased this difficulty substantially. 
 
In the qualitative chapter of this thesis, the major concern expressed by interviewees 
relating to multiple joint problems was a lack of time during doctor and nurse 
consultations to discuss complex different problems associated with having multiple-
site OA.  Patients felt forced into focussing on the site of OA that was of most concern 
to them at time of consultation, which was generally the knee.  Peripheral sites of OA 
(hands and foot) were often ignored, even when they were causing the patient 
considerable impairment. 
 
The impact of the location, number and combination of painful joints was an important 
aspect of this thesis.   While the number and pattern of joint pain has a substantial 
influence on the ability to undertake daily tasks, the impact of this on quality of life is 
not as important as other factors, such as levels of anxiety and general functional 
ability.  The pattern of joint problems did affect quality of life however.  The top six 
most prevalent joint patterns were included in the modelling in Chapter 7, but the 
combination of hip and knee pain was the only combination that had a significant 
impact on quality of life.  The number of painful joints had no impact on quality of life, 
which was fundamental to the hypothesis of this thesis. These results do need to be 
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considered in light of establishing patterns and numbers of joint problems however.  
While inclusion for the interviews (Chapter 4), the development of a quality of life 
instrument (Chapter 5), the test-rest (Chapter 6) and the modelling for quality of life 
(Chapter 7) was based on strict diagnostic criteria for OA, the presence of OA 
elsewhere by these individuals was implied from self reporting painful joints.   From 
the data in the programme of work, it was not possible to explore the effect of specific 
joint location on quality of life.  This is an area for future research. 
 
8.5  Co-morbidities and OA  
One of the most important findings arising from the work in this thesis was the impact 
of co-morbidities in joint pain and OA.  While the impact of co-morbidities in OA on 
disability has been recognised92, 93, the results of the epidemiological study 
demonstrated that the number of co-morbidities was the most significant predictors of 
impairment in activities of daily living.  This finding is in agreement with a previous 
study which evaluated health related quality of life in OA and found that the most 
significant predictor of reduced health-related quality of life was the number of co-
morbidities347.  In this thesis, using a needs-based approach to quantify quality of life 
and a sophisticated modelling approach, it has been demonstrated that the number of 
co-morbidities directly influenced anxiety, which in turn impacts on quality of life.  That 
is, co-morbidity was fully mediated by anxiety:  having co-morbidities did not directly 
influence quality of life unless they increased the anxiety. Given the high number of 
co-morbidities reported with OA89, this of considerable importance in the assessment 
and management of OA.   
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8.6  Implications for Clinical Practice 
Recent data suggests that the cost associated with musculoskeletal pain has 
extensive economic consequences for the community348, 349.  With estimates of the 
global burden of musculoskeletal conditions reported to be increasing with an ageing 
population350, it is essential that appropriate strategies be addressed.  The data from 
this programme of work suggests that changes need to be made in the understanding 
and management of joint problems and that an approach to patient care which 
includes psychosocial assessment may be of benefit to both population health and 
provide better use of economic resources. 
 
These data suggest that there is a deficiency in the current management of joint 
problems, with the vast majority of publications and guidelines being focused on 
single joints.  In published guidelines covering the management of the knee and hip 
osteoarthritis1, 75, 351,  there is no mention of multiple-site assessment and 
management.   While the number of joints involved did not directly influence quality of 
life, there is an effect on reducing the ability to undertake simple activities.  The 
number and patterns of joint involvement should be considered in a holistic 
assessment of the individual with OA. 
 
Assessment and management strategies need to reflect the interaction of the 
psychosocial and physical factors and their impact on quality of life.  There is clearly a 
need for changes to assessment, referral and therapeutic strategies.  Intervention for 
OA should focus not only on the symptoms, but also the coping strategies.  Treatment 
for pain should be given not just to reduce pain, but also with consideration to the 
functional activities of the person.  Particular attention should be given to the 
psychosocial aspects, with strategies devised for those who have high anxiety or 
depression levels.   
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A major finding of this thesis is the levels of depression and anxiety in OA:  indeed, 
given the high levels found in this study, routine screening for anxiety and depression 
should be incorporated into initial assessment and ongoing review of people with OA.  
This should not be considered only in those with severe disease, but patients across 
the spectrum of disease in both primary and secondary care.   This is particularly 
important in light of the substantial impact and complex relationships of anxiety not 
only to quality of life, but also to pain, function and depression.    
 
Strategies for education of patients on the benefits and risks of treatments need to be 
provided as routine care for those with OA.  This needs to include information on not 
only medication, but also surgical interventions, exercise and physical therapies.  
 
Finally, the unique experience of the person living with OA should be explored as part 
of the assessment, management and monitoring of a patient with OA.   
 
 
8.7 Limitations of the research 
This thesis needs to be viewed in light of the limitations of each study, which are 
explored in the results section of each relevant chapter.  The data from the 
epidemiological study was based on self reported joint pathology and not physician 
confirmed diagnosis of OA.  As such, this study provides us with the impact of joint 
pain in the community, but not necessarily OA.    
 
In the modelling study, the elements included were based on specific outcome 
measures, each with their own limitations.  As function for the model was based only 
on WOMAC function, upper limb problems were not represented.  As a result, the 
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modelling, particularly in terms of the relationship of function to other factors, is more 
reflective of those with lower limb painful joints. 
 
The modelling did not include elements that have been indicated in studies in other 
diseases which may impact on quality of life, including measures of self efficacy, 
participation, fatigue and environmental factors, such as social support.  This may 
have meant that the model was not fully explained by the variables that were 
considered in this thesis:  however, given the high amount of variance explained 
(R2=0.81), the effect of including other measures would add only a moderate 
enhancement to a very well explained model. 
 
All participants included in the qualitative study, the development of the OAQoL and 
the modelling chapters fulfilled strict criteria for the diagnosis of OA for at least one 
joint.  Additional number and pattern of joint involvement however, was based self-
reported, painful joints.   As such, the pattern and number of joints that were included 
in the analysis were reflective of painful joints, not necessarily confirmed OA.  This 
may over represent the prevalence of multiple joint confirmed OA in this thesis, and 
instead represents painful joints in those with confirmed OA. 
 
Finally, across all studies, the cohorts were predominantly British Caucasians.  
Findings in the qualitative study may under represent needs of ethnic groups, 
particularly in terms of education and understanding of the disease.  The OAQoL has 
been developed and validated for use only in a white Caucasian population and may 
not represent the impact of OA on individuals from other communities.  Furthermore, 
the results of the modelling may be different when applied to other communities and 
cultures. 
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8.8 Directions for Future Research 
This thesis provides a platform for further research into quality of life in osteoarthritis.   
 
i.  OAQoL 
The importance of including quality of life measurements has been recognised:  the 
World Health Organisation, the International League for Rheumatology Task Force97 
and the OA Research Society 352 strongly recommended that QoL measures be used 
in OA clinical research.  While this thesis has developed and validated a disease 
specific, needs-based quality of life measure for OA, work is required to further 
explore the application of the OAQoL.  Firstly, the clinical responsiveness119 of the tool 
needs to be explored across a number of common treatments including exercise, drug 
and surgical interventions.  Secondly, an exploration of meaningful change353 or 
change in quality of life that is important to the individual is necessary.  Finally, cultural 
and language adaptations250 of the OAQoL are necessary if this instrument is to be 
used outside a Caucasian, British population. 
 
Novel uses of the OAQoL also need to be explored.  Items from the OAQoL could be 
used to contribute to an item bank of needs-based instruments, particularly in 
rheumatology.  In doing this, comparisons of the impact of QoL between 
rheumatological diseases would be possible.  The use of the OAQoL as a health utility 
measure specifically for OA should also be explored following developments with the 
needs-based RAQoL:  a recent study comparing the difference between EQ-5D 
(which is universally used as a health utility measure) and the RAQoL indicated that 
the RAQoL functioned as well as the EQ-5D354 and was more reliable and responsive 
in an RA population193.   The application of a disease specific utility measure would 
offer greater sensitivity and specificity for a prevalent and important disease such as 
OA. 
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ii.  Modelling Quality of Life in OA 
While this thesis developed a robust model explaining quality of life, further 
exploration should be undertaken and include other measures to fully map the ICF 
constructs.  Future modelling should include a greater emphasis on environmental 
factors; a robust tool for measuring participation should be included; and greater 
exploration of personal factors, including measures such as self efficacy should be 
considered.   Finally, in order to fully test the hypothesis that joint location impacts 
differently on quality of life, the model should be replicated on large cohorts of those 
with OA at different sites (knee, hip, foot and hand) in order to explore the impact of 
joint location on quality of life.  A model which includes a robust measure of upper 
limb function should be included in future work in this area. 
 
iii.  Anxiety in OA 
The high levels of anxiety and depression and the substantial influence of anxiety on 
quality of life in OA must be investigated further.  Factors that contribute to anxiety 
levels should be identified and explored in order to reduce the impact of these 
psychological factors.  Treatment strategies targeted in addressing issues that impact 
on anxiety, particularly from lessons learnt in other conditions (such educational 
strategies) should be developed and evaluated, particularly in terms of their influence 
on quality of life.  
 
iv.  Multiple Joint Assessment 
Finally, given the prevalence of OA in more than one joint, research should reflect 
multiple-site involvement.   Clinical trials need to be more reflective of the true 
representation of joint pain and involvement across several sites:  inclusion criteria 
which specifically exclude other joint involvement need to be reviewed to ensure that 
studies are representative of the population to which they are targeting treatment.  
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Assessment tools need to be explored to address issues the complex issues 
associated with multiple site involvement.  Such tools may require several domains to 
capture different anatomical sites and responsiveness to change when change may 
be different between sites.   
 
8.9  Summary 
The major findings of this thesis can be summarised as follows: 
i. Osteoarthritis has a considerable and often complex impact on the individual; 
the OAQoL, a needs-based, disease specific outcome measure to assess of 
quality of has been derived from a strong conceptual framework and has 
rigorously tested for its psychometric properties. 
ii. Anxiety and depression are high in people with OA and anxiety has a 
substantial influence on their perceived quality of life 
iii. Co-morbidities are common in OA and are related to impairment of activities of 
daily living and quality of life 
iv. While the location and number of painful joints in those with OA impacts on 
their ability to undertake the tasks of daily living, other aspects, such as 
anxiety, age and functional ability have a more substantial impact on quality of 
life.   
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Appendix 1 
Guidance Notes for OAQoL Interviews 
 
Pre-interview Introduction 
 Explain the purpose of the interview and confidentiality 
 Confirm that they have read the participant information sheet and informed 
consent. 
 Ask if they have any questions regarding the information sheet and informed 
consent. 
 Confirm that they give permission for tape record the interview.  Explain that the 
transcripts will be produced from the recording and that all references or names 
that might identify the interviewee will be removed. 
 Collect the informed consent sheet. 
 
 
1.  Personal Illness History 
1.1.  Could you tell me about when you first developed osteoarthritis (OA)? 
⇒ At what age did you start noticing problems?  What made you realize that you 
had a problem (symptoms) 
⇒ What were the main types of symptoms that you were experiencing?  (Including 
frequency, duration etc) 
 
1.2.  Can you tell me about your arthritis at the moment? 
⇒ Can you describe your symptoms?  What happens when you have a flare-up (ie 
increased symptoms)?  When was the last time that you had a flare? 
⇒ What about between flares-ups? Do you have any ongoing symptoms? 
⇒ Are you currently on any treatment (explore positive and negative, adverse 
events, compliance issues). 
 
 
2.  Impact of OA on daily life 
2.1.  We’ve talked about the symptoms that you’ve experienced.  I’d like you to think 
about how these effect your daily life. 
 
Note:  We are interested in exploring the impact of the patient’s condition in relation to the 
following areas.  Please pay attention to the impact of pain, fatigue, cognitive dysfunction. 
 
⇒ In the home – performing necessary tasks, shopping, cooking, cleaning, other 
household chores.  Doing jobs around the house (for example painting, 
mending, do-it-yourself etc). 
 
⇒ Occupation – ability to perform necessary tasks at work (or at school); to 
concentrate, think, remember details, use equipment/machinery, drive/travel to 
work.  Relationships and attitudes of people at work. 
 
⇒ Personal relationships - marital life, interactions with partners, family, friends etc, 
interest in other people.  Reactions of other people, attitudes and behaviour.  
Looking after children/grandchildren, dependents, caring for them.  Sexual 
activity, interest in love and sex. 
 
⇒ Social Life – Seeing people, going out:  for example to the pub, theatre, cinema, 
bingo, visiting friends/relatives, having people to visit at home, staying away 
from home. 
 
⇒ Cognition – ability to concentrate, think clearly, perform routine intellectual tasks 
including, for example, keeping finances in order 
 
⇒ Personal Hygiene – keeping clean, having clean clothes, washing, ironing, caring 
for self, getting hair cut.  Appetite, eating, giving oneself treats. 
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⇒ Leisure Pursuits – ability to follow usual interests, hobbies, sports etc.  Watching 
TV, listening to radio and music, reading, knitting, sewing, crosswords, playing 
a musical instrument etc. 
 
⇒ Sleep and Rest – ability to relax, ability to sleep, disturbing others by not 
sleeping, disruption to normal pattern of rest and activity, energy level. 
 
Sample questions 
Does your OA/specific symptoms make it difficult for you to do anything/stop you 
doing anything? 
How do you feel that you family react to your OA? 
What kind of things do you do for fun or relaxation? 
How does that make you feel? 
Tell me more about that? 
Can you explain that a bit more so I’m sure I understand? 
 
 
3.  Key areas of impact 
3.1.  We’ve talked about the different ways your mood changes affect you and your day 
to day life.  I’d now like you to think about what are the best and worse things 
about having OA.  Are there any particularly positive or good things about it? 
 
3.2 What would you say are the worst things about having OA? 
 
 
4.  Views on quality of life 
4.1  What does the term “quality of life” mean to you? 
⇒ How would you define it? 
⇒ What kind of things gives your life its “quality”? 
 
 
4.2  How would you describe your quality of life at the moment?  How would you rate 
the quality of life when your arthritis is bad?  How would you rate the quality of life 
when your arthritis is good? 
⇒ Good, bad, etc 
⇒ Why do you rate it that way? 
 
 
5.  Any other areas 
5.1    We’ve just talked about how you feel about your OA and abut how this affects your 
day to day life.  Is there anything else that you would like to mention? 
⇒ In relation to the impact of OA on your life? 
⇒ The impact of OA on your quality of life? 
⇒ Any other areas that you think we’ve missed? 
 
 
 
Interview closure 
I would like to thank you for taking the time to talk with me.  This has been a really 
useful and interesting interview.  I would just like to re-assure you again that all of 
this information that you have given me will remain confidential. 
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OAQoL 
Quality of Life in People with 
Osteoarthritis 
 
 
 
Please read this carefully 
 
 
On the following pages you will find some statements which  
have been made by people who have Osteoarthritis. 
 
 
Please read each statement carefully. We would like you to tick 
‘True’ if you feel the statement applies to you 
And tick ‘Not true’ if it does not 
 
 
Please choose the response that applies best to you 
at the moment 
 
 
Appendix 2 OAQoL First Draft 
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Please read this carefully 
 
On the following pages you will find some statements which  
have been made by people who have Osteoarthritis.  Please read each 
statement carefully. We would like you to tick ‘True’ if you feel the statement 
applies to you And tick ‘Not true’ if it does not. 
 
Please choose the response that applies best to you at the moment 
 
True  
1.   I'm unable to join in activities with my friends or family 
Not true  
 
  
 
True 
 
 
 
2.   I get embarrassed using stairs in public 
Not true  
 
  
 
True 
 
 
 
3.   It is always on my mind 
Not true  
   
   
True  
4.   I feel like I am missing out on life 
Not true  
   
 
True 
 
 
 
5.   Travelling distances is a problem      
Not true  
 
  
 
True 
 
 
 
6.   I can't plan things too far in advance 
Not true  
 
 
  
   
True  
7.  I worry that I let people down 
Not true  
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Please read each item carefully and tick the one response that applies  
           best to you  at the moment 
 
True 
 
 
 
8.   I feel as though I’m trapped in my house 
Not true  
 
  
 
True 
 
 9.   It takes me a long time to complete household tasks 
Not true  
   
   
True  
10.   My arthritis limits the places I can go 
Not true  
 
  
 
 
True 
 
 
 
 
 
11.   I worry that I hold others back 
Not true  
 
  
 
 
True 
 
 
 
 
 
12.   I can't do things on the spur of the moment 
Not true  
 
  
 
 
True 
 
 
 
 
 
13.   It interferes with everything that I do 
Not true  
   
   
 
True 
 
 
 
14.   Walking for pleasure is out of the question 
Not true  
   
 
 
True 
 
 
 
 
 
15.   I can’t enjoy myself when I go out 
Not true  
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Please read each item carefully and tick the one response that applies  
          best to you  at the moment 
 
True 
 
 
 
16.   I dread the future 
Not true  
   
   
 
 
True 
 
 
 
 
17.   I take it out on people close to me 
Not true  
   
 
True 
 
 
 
18.   I feel useless 
Not true  
   
 
True 
 
 
 
19.   I feel I can’t join in with social activities 
Not true  
   
 
 
True  
20.   My arthritis controls my life 
Not true  
 
  
 
True 
 
 
 
21.   I feel dependant on others 
Not true  
 
  
 
True 
 
 
 
22.   I worry about being a nuisance to other people 
Not true  
   
 
 
True 
 
 
 
23.   I am embarrassed about the way I walk Not true  
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Please read each item carefully and tick the one response that applies  
          best to you  at the moment 
 
True 
 
 24.   My life revolves around my arthritis 
Not true  
 
  
 
 
True 
 
 
 
 
 
25.   I feel older than my years 
Not true  
   
 
 
True 
 
 
 
 
26.   It puts a strain on my personal relationships Not true  
   
   
 
True 
 
 
 
27.   I can’t be as independent as I want 
Not true  
 
  
 
True 
 
 
 
28.   I find it difficult to sit through a film or TV programme 
Not true  
  
 
 
True 
 
 
  
29.   I feel very isolated Not true  
   
 
True  
30.   I can’t live life to the full  Not true  
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Please read each item carefully and tick the one response that applies  
best to you  at the moment 
 
True  
31.   I feel the arthritis is affecting my appearance Not true  
   
 
 
True 
 
 
 
 
32.   I never get a good night’s sleep 
Not true  
  
 
 
 
True 
 
 
 
 
33.   I have to limit what I do each day 
Not true  
  
 
 
 
True 
 
 
 
 
 
34.   I feel like a burden to other people 
Not true  
  
 
 
 
True 
 
 
 
 
35.   I feel slowed down 
Not true  
  
 
  
 
 
True 
 
 36.   Pain controls my life 
Not true  
  
 
 
 
True 
 
 
 
 
37.   I can’t go to the places I want to go 
Not true  
 
 
 
 
 
38.   I feel lonely 
 
 
True 
 
 
 
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Please read this carefully 
 
 
On the following pages you will find some statements which  
have been made by people who have Osteoarthritis. 
 
 
Please read each statement carefully. We would like you to tick 
‘True’ if you feel the statement applies to you 
And tick ‘Not true’ if it does not 
 
 
Please choose the response that applies best to you 
at the moment 
©Galen Research and University of Leeds 2006
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Please read this carefully 
 
On the following pages you will find some statements which have been made 
by people who have Osteoarthritis.  Please read each statement carefully. We 
would like you to tick ‘True’ if you feel the statement applies to you and tick 
‘Not true’ if it does not. 
 
Please choose the response that applies best to you at the moment. 
 
True  1.   I'm unable to join in activities with my friends or family 
Not true  
 
 
 
 
 
True  2.   I get embarrassed using stairs in public 
Not true  
 
  
True  3.   I feel like I am missing out on life 
Not true  
 
 
 
 
 
True  
4.   I can't plan things too far in advance 
Not true  
 
  
True  
5. I feel as though I’m trapped in my house 
Not true  
 
 
 
True  
6.   My arthritis limits the places I can go 
Not true  
 
 
 
True  
7.   I can't do things on the spur of the moment 
Not true  
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     Please read each item carefully and tick the one response that applies  
           best to you  at the moment 
 
 
 
 
True  
8.   It interferes with everything that I do 
Not true  
 
True  
9.   Walking for pleasure is out of the question 
Not true  
 
 
 
True  
10.   I can’t enjoy myself when I go out 
Not true  
 
 
True  11.   I feel useless 
Not true  
  
 
True  12.   I feel I can’t join in with social activities 
Not true  
  
 
13.   My arthritis controls my life True  
 Not true  
  
 
True  14.   I feel dependant on others 
Not true  
  
 
True  15.   I worry about being a nuisance to other people 
Not true  
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Please read each item carefully and tick the one response that applies  
          best to you  at the moment 
  
 
True  16.   My life revolves around my arthritis 
Not true  
 
 
 
True  17.   I can’t be as independent as I want 
Not true  
 
  
True  
18.   I feel very isolated Not true  
 
 
 
19.  I can’t live life to the full True  
 
Not true  
 
 
 
20.   I have to limit what I do each day True  
 
Not true  
 
 
 
True  21.   I feel slowed down 
Not true  
 
 
True  22.   I can’t go to the places I want to go 
Not true  
 
 
 
 
 
